<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Avenir LT Std 65 Medium";}
@font-face
	{font-family:inherit;}
@font-face
	{font-family:"\@MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:"Segoe UI Symbol";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-language:EN-US;}
h1
	{mso-style-priority:9;
	mso-style-link:"Heading 1 Char";
	margin-top:24.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2E74B5;
	mso-fareast-language:EN-US;
	font-weight:bold;}
h2
	{mso-style-priority:9;
	mso-style-link:"Heading 2 Char";
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	font-size:24.0pt;
	font-family:"Calibri",sans-serif;
	color:#E9711C;
	mso-fareast-language:EN-US;
	font-weight:normal;}
h3
	{mso-style-priority:9;
	mso-style-link:"Heading 3 Char";
	margin-top:10.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#5B9BD5;
	mso-fareast-language:EN-US;
	font-weight:bold;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-priority:99;
	mso-style-link:"Header Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-language:EN-US;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-priority:99;
	mso-style-link:"Footer Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-language:EN-US;}
span.MsoEndnoteReference
	{mso-style-priority:99;
	vertical-align:super;}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-priority:99;
	mso-style-link:"Endnote Text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:#0563C1;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-priority:99;
	color:#954F72;
	text-decoration:underline;}
p
	{mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-language:EN-US;}
pre
	{mso-style-priority:99;
	mso-style-link:"HTML Preformatted Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-language:EN-CA;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-priority:99;
	mso-style-link:"Balloon Text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-fareast-language:EN-US;}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
	{mso-style-priority:1;
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-language:EN-CA;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-language:EN-US;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-priority:9;
	mso-style-link:"Heading 1";
	font-family:"Calibri Light",sans-serif;
	color:#2E74B5;
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-priority:9;
	mso-style-link:"Heading 2";
	font-family:"Calibri",sans-serif;
	color:#E9711C;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-priority:9;
	mso-style-link:"Heading 3";
	font-family:"Calibri Light",sans-serif;
	color:#5B9BD5;
	font-weight:bold;}
span.HTMLPreformattedChar
	{mso-style-name:"HTML Preformatted Char";
	mso-style-priority:99;
	mso-style-link:"HTML Preformatted";
	font-family:"Courier New";
	mso-fareast-language:EN-CA;}
p.msonormal0, li.msonormal0, div.msonormal0
	{mso-style-name:msonormal;
	mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-language:EN-CA;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-priority:99;
	mso-style-link:Header;
	font-family:"Times New Roman",serif;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-priority:99;
	mso-style-link:Footer;
	font-family:"Times New Roman",serif;}
span.EndnoteTextChar
	{mso-style-name:"Endnote Text Char";
	mso-style-priority:99;
	mso-style-link:"Endnote Text";
	font-family:"Times New Roman",serif;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-priority:99;
	mso-style-link:"Balloon Text";
	font-family:"Tahoma",sans-serif;}
p.wordsection1, li.wordsection1, div.wordsection1
	{mso-style-name:wordsection1;
	mso-style-priority:99;
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-language:KO;}
p.Default, li.Default, div.Default
	{mso-style-name:Default;
	mso-style-priority:99;
	margin:0cm;
	margin-bottom:.0001pt;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	color:black;
	mso-fareast-language:EN-US;}
p.contributor, li.contributor, div.contributor
	{mso-style-name:contributor;
	mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-language:EN-US;}
p.roles, li.roles, div.roles
	{mso-style-name:roles;
	mso-style-priority:99;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:13.5pt;
	margin-left:0cm;
	line-height:13.5pt;
	font-size:10.0pt;
	font-family:inherit;
	mso-fareast-language:EN-CA;}
p.orcid, li.orcid, div.orcid
	{mso-style-name:orcid;
	mso-style-priority:99;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:13.5pt;
	margin-left:0cm;
	line-height:13.5pt;
	font-size:10.0pt;
	font-family:inherit;
	mso-fareast-language:EN-CA;}
span.EmailStyle40
	{mso-style-type:personal;
	font-family:"Calibri",sans-serif;
	color:windowtext;}
span.abstract
	{mso-style-name:abstract;}
span.keywordhighlight
	{mso-style-name:keyword_highlight;}
span.title-text
	{mso-style-name:title-text;}
span.visually-hidden
	{mso-style-name:visually-hidden;}
span.current-selection
	{mso-style-name:current-selection;}
span.resultspageicons1
	{mso-style-name:resultspageicons1;}
span.marginl5
	{mso-style-name:marginl5;}
span.named-content
	{mso-style-name:named-content;
	border:none windowtext 1.0pt;
	padding:0cm;
	vertical-align:baseline;}
span.anchortext6
	{mso-style-name:anchortext6;}
span.type1
	{mso-style-name:type1;
	font-weight:bold;}
span.sr-only1
	{mso-style-name:sr-only1;
	border:none windowtext 1.0pt;
	padding:0cm;}
span.size-m
	{mso-style-name:size-m;}
span.list-group-item3
	{mso-style-name:list-group-item3;
	display:none;
	border:none windowtext 1.0pt;
	padding:0cm;
	background:white;}
span.text2
	{mso-style-name:text2;}
span.author-ref
	{mso-style-name:author-ref;}
span.marginleft1
	{mso-style-name:marginleft1;}
span.apple-converted-space
	{mso-style-name:apple-converted-space;}
span.UnresolvedMention
	{mso-style-name:"Unresolved Mention";
	mso-style-priority:99;
	color:#605E5C;
	background:#E1DFDD;}
span.hlfld-title
	{mso-style-name:hlfld-title;}
span.inlineblock
	{mso-style-name:inlineblock;}
span.name
	{mso-style-name:name;}
span.contrib-role
	{mso-style-name:contrib-role;}
span.A8
	{mso-style-name:A8;
	mso-style-priority:99;
	font-family:"Avenir LT Std 65 Medium";
	color:black;
	font-weight:bold;}
span.email4
	{mso-style-name:email4;}
span.tlid-translation
	{mso-style-name:tlid-translation;}
span.highwire-citation-author
	{mso-style-name:highwire-citation-author;}
span.nlm-given-names
	{mso-style-name:nlm-given-names;}
span.nlm-surname
	{mso-style-name:nlm-surname;}
span.EmailStyle69
	{mso-style-type:personal-reply;
	font-family:"Calibri",sans-serif;
	color:#1F497D;}
.MsoChpDefault
	{mso-style-type:export-only;
	font-size:10.0pt;}
@page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
/* List Definitions */
@list l0
	{mso-list-id:203762256;
	mso-list-type:hybrid;
	mso-list-template-ids:-488232748 269025281 269025283 269025285 269025281 269025283 269025285 269025281 269025283 269025285;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1
	{mso-list-id:723407391;
	mso-list-type:hybrid;
	mso-list-template-ids:1212863942 269025281 269025283 269025285 269025281 269025283 269025285 269025281 269025283 269025285;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2
	{mso-list-id:1491285602;
	mso-list-type:hybrid;
	mso-list-template-ids:357718476 1322553874 269025283 269025285 269025281 269025283 269025285 269025281 269025283 269025285;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;
	color:black;
	mso-style-textfill-fill-color:black;
	mso-style-textfill-fill-alpha:100.0%;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3
	{mso-list-id:2137866699;
	mso-list-type:hybrid;
	mso-list-template-ids:-1521057124 269025281 269025283 269025285 269025281 269025283 269025285 269025281 269025283 269025285;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1027" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-CA" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal"><b><span lang="EN-US" style="mso-fareast-language:EN-CA">Subject:</span></b><span lang="EN-US" style="mso-fareast-language:EN-CA"> Daily Scan of COVID-19 Scientific Publications / survol journalier des publications scientifiques du COVID-19,
 2020-11-19<o:p></o:p></span></p>
<p class="MsoNormal"><o:p>&nbsp;</o:p></p>
<p class="wordsection1" style="margin-bottom:8.0pt;line-height:105%">Good afternoon,<o:p></o:p></p>
<p class="wordsection1" style="margin-bottom:8.0pt;line-height:105%">There are 349 citations in today’s scan. 229 were considered primary research or review literature.<o:p></o:p></p>
<p class="wordsection1">Highlights today include<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1"><span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p>&nbsp;</o:p></span></p>
<p class="wordsection1">CANADA<span style="mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo2">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-US"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style="color:#1F497D"><a href="https://www.medrxiv.org/content/10.1101/2020.11.16.20231399v1">Fisman and Tuite</a>
</span>hypothesized that differential ICU burden in Ontario might be explained by increased testing volumes, as well as the shift in mean case age from older to younger. Their model reproduced observed ICU admission volumes, and demonstrated good preliminary
 predictive validity. Furthermore, when admissions were used in combination with ICU length of stay, the modeled estimates demonstrated excellent convergent validity with ICU occupancy data reported by the Canadian Institute for Health Information.<span style="mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1">PUBLIC HEALTH INTERVENTION<span style="mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-left:36.0pt;text-indent:-18.0pt;mso-list:l3 level1 lfo4">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-US"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style="color:#1F497D"><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-09799-8">Lee et al</a>
</span>adapted a previously published model using contact information from Shanghai to model school reopening under various conditions. We investigated different strategies by combining the contact patterns observed between different age groups during both
 baseline and “lockdown” periods. We find that reopening schools for all children would maintain a post-intervention R0 &lt; 1 up to a baseline R0 of approximately 3.3 provided that daily contacts among children 10–19 years are reduced to 33% of baseline.<span style="mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1">IMMUNOLOGY<o:p></o:p></p>
<p class="wordsection1" style="margin-left:36.0pt;text-indent:-18.0pt;mso-list:l3 level1 lfo4">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-US"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><a href="http://biorxiv.org/content/early/2020/11/17/2020.11.17.385252.abstract">Sokal et al.,</a> We report here a longitudinal single-cell and repertoire profiling of the B cell response up to 6 months in mild and severe COVID-19
 patients. Overall, these findings demonstrate that an antigen-driven activation persisted and matured up to 6 months after SARS-CoV-2 infection and may provide long-term protection.<span style="mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1">EPIDEMIOLOGY<span style="mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-left:36.0pt;text-indent:-18.0pt;mso-list:l2 level1 lfo6">
<![if !supportLists]><span style="font-family:Symbol;color:black;mso-fareast-language:EN-US"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style="color:#1F497D"><a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3725446">Ramasamy, K.,</a>
</span>explores the current state of COVID-19 pandemic of India and the USA and understand how the COVID-19 spread is severe in India. He &nbsp;forecasted cumulative cases would be 11642764 in the USA and India, it would be 12023517 approximately.<span style="mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-left:36.0pt;text-indent:-18.0pt;mso-list:l2 level1 lfo6">
<![if !supportLists]><span style="font-family:Symbol;color:black;mso-fareast-language:EN-US"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style="color:#1F497D"><a href="https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1737/5985642">Ladhani et al</a>
</span>measured serum SARS-CoV-2 antibodies in 215 children of healthcare workers to estimate secondary attack rates (SAR). Twenty-one families had a parent with confirmed COVID-19. There was strong evidence of family clustering (P&lt;0.001): 20/21 (95.2%) children
 were seropositive in 9 families and none of 23 children in 12 other families. &nbsp;<span style="mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1">SEROPREVALENCE<span style="mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-left:36.0pt;text-indent:-18.0pt;mso-list:l3 level1 lfo4">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-US"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style="color:#1F497D"><a href="https://academic.oup.com/jpubhealth/advance-article/doi/10.1093/pubmed/fdaa199/5983393">Martin et al</a>.
</span>conducted a cross-sectional surveillance examining SARS-CoV-2 seroprevalence amongst staff at a UK hospital. 10.8% hospital staff members were seropositive. Compared to White staff (seroprevalence 9.1%), seroprevalence was higher in South Asian (12.3%)
 and Black (21.2%) staff. The occupations and department with the highest seroprevalence were nurses/healthcare assistants (13.7%) and the Emergency Department (ED)/Acute Medicine (17.5%), respectively. Seroprevalence decreased with seniority in medical/nursing
 practitioners.<span style="mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1">VACCINE RESEARCH<o:p></o:p></p>
<p class="wordsection1" style="margin-left:36.0pt;text-indent:-18.0pt;mso-list:l1 level1 lfo8">
<![if !supportLists]><span style="font-family:Symbol;mso-fareast-language:EN-US"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><a href="http://biorxiv.org/content/early/2020/11/17/2020.11.17.368258.abstract">Solforosi et al</a>., Here we assessed the immunogenicity of one- and two-dose Ad26.COV2.S vaccine regimens in adult and aged non-human primates
 (NHP).&nbsp; A second vaccine dose, administered 8 weeks post the first immunization, induced a significant increase in antigen-specific binding and neutralizing antibody responses in both adult and aged animals as compared to a single dose.
<span style="mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1">DIAGNOSTICS<o:p></o:p></p>
<p class="wordsection1" style="margin-left:36.0pt;text-indent:-18.0pt;mso-list:l2 level1 lfo6">
<![if !supportLists]><span style="font-family:Symbol;color:black;mso-fareast-language:EN-US"><span style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style="color:#1F497D"><a href="https://www.medrxiv.org/content/10.1101/2020.11.16.20230003v1">Masia et al</a>.
</span>report nasopharyngeal Panbio COVID-19 antigen test performed at point-of-care is highly sensitive in symptomatic patients, particularly with Ct&lt;30 and older age. The test to be useful to identify asymptomatic patients with lower Ct values and therefore
 with contagious risk.<span style="color:#1F497D;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1"><span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;color:#1F497D;mso-fareast-language:EN-US"><o:p>&nbsp;</o:p></span></p>
<p class="wordsection1">Regards,<o:p></o:p></p>
<p class="wordsection1">Lisa Waddell, Tricia Corrin, Rukshanda Ahmad, Robyn Odell, Maribeth Mitri, Julie Theriault, Austyn Baumeister, Anam Khan, Musaab Younis, Lien Mi Tien, Dima Ayache, Angela Sloan, Kaitlin Young, Chatura Prematunge, Ainsley Otten, Drew
 Greydanus, Jessie Varga, Vanessa Zubach, Meenu Sharma, Kristyn Burak, David Knox, Joanne Hiebert, Clifford Clark, Catherine Card, Ruey Su, Paul McLaren<o:p></o:p></p>
<p class="wordsection1"><o:p>&nbsp;</o:p></p>
<p class="wordsection1"><o:p>&nbsp;</o:p></p>
<p class="wordsection1"><o:p>&nbsp;</o:p></p>
<p class="wordsection1"><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t75" alt=" Daily Scan of COVID-19 Scientific Publications / Survol journalier des publications scientifiques du COVID-19		19/11/2020&#13;&#10;&#13;&#10;" style='position:absolute;margin-left:-4.2pt;margin-top:-13.8pt;width:938.25pt;height:30pt;z-index:251659264;visibility:visible;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;mso-height-relative:margin'>
<v:imagedata src="cid:image003.emz@01D6BE83.40FD3EA0" o:title="" />
</v:shape><![endif]--><![if !vml]><span style="mso-ignore:vglayout">
<table cellpadding="0" cellspacing="0" align="left">
<tbody>
<tr>
<td width="4" height="2028"></td>
</tr>
<tr>
<td></td>
<td><img width="1251" height="40" style="width:13.0312in;height:.4166in" src="cid:image004.png@01D6BE83.40FD3EA0" alt=" Daily Scan of COVID-19 Scientific Publications / Survol journalier des publications scientifiques du COVID-19		19/11/2020

" v:shapes="_x0000_s1026"></td>
</tr>
</tbody>
</table>
</span><![endif]><b><span style="font-size:14.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p>&nbsp;</o:p></span></b></p>
<br style="mso-ignore:vglayout" clear="ALL">
<p class="wordsection1"><b><span style="font-size:10.0pt">Focus areas:</span></b><span style="font-size:10.0pt"> Modelling/ prediction, Epidemiology, Transmission, Clinical data, Long-term Sequelae, Mental Health, Surveillance, Coronavirology, Diagnostics /
 Pathogen detection, Therapeutics, Vaccine Research, Public health interventions, Public Health response, Public Health Priorities, IPAC, Health care response, Immunology, Economics, Animal model, Zoonoses, Review Literature, Commentary/Editorial, news</span><b><span style="font-size:10.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1"><b><span lang="FR-CA" style="font-size:10.0pt">Domaines cibles:</span></b><span lang="FR-CA" style="font-size:10.0pt"> Modélisation/prédiction, Épidémiologie, Transmission, Données cliniques, Séquelles à long terme, Santé mentale ,Surveillance,
 Coronavirologie, Diagnostics / Détection d'agents pathogènes, Thérapeutique, Recherche sur les vaccins, Interventions de santé publique, Priorités de santé publique, PCI,</span><span lang="FR-CA">
</span><span lang="FR-CA" style="font-size:10.0pt">Réponse des soins de santé, Immunologie,
<span style="text-transform:uppercase">é</span>conomie, Modèle animal, Zoonoses, Revue de littérature, Commentaire/Éditorial, journaux
</span><b><span lang="FR-CA" style="font-size:10.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1"><span lang="FR-CA" style="font-size:6.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p>&nbsp;</o:p></span></p>
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="98%" style="width:98.0%;margin-left:.25pt;border-collapse:collapse">
<thead>
<tr style="height:15.5pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;background:#2F5496;padding:6.0pt 6.0pt 6.0pt 6.0pt;height:15.5pt">
<p class="MsoNormal" style="line-height:115%"><b><span style="font-size:10.0pt;line-height:115%;color:white">PUBLICATIONS<o:p></o:p></span></b></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border:solid windowtext 1.0pt;border-left:none;background:#2F5496;padding:6.0pt 6.0pt 6.0pt 6.0pt;height:15.5pt">
<p class="MsoNormal" style="line-height:115%"><b><span style="font-size:10.0pt;line-height:115%;color:white">AUTHORS / AUTEURS<o:p></o:p></span></b></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:solid windowtext 1.0pt;border-left:none;background:#2F5496;padding:6.0pt 6.0pt 6.0pt 6.0pt;height:15.5pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><b><span style="font-size:10.0pt;line-height:115%;color:white">SOURCE<o:p></o:p></span></b></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-left:none;background:#2F5496;padding:0cm 5.4pt 0cm 5.4pt;height:15.5pt">
<p class="MsoNormal" style="margin-left:-.45pt;line-height:115%"><b><span style="font-size:10.0pt;line-height:115%;color:white">FOCI / DOMAINE<o:p></o:p></span></b></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border:solid windowtext 1.0pt;border-left:none;background:#2F5496;padding:0cm 5.4pt 0cm 5.4pt;height:15.5pt">
<p class="MsoNormal" style="line-height:115%"><b><span style="font-size:10.0pt;line-height:115%;color:white">SUMMARY / SOMMAIRE<o:p></o:p></span></b></p>
</td>
</tr>
</thead>
<tbody>
<tr style="height:7.1pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:7.1pt">
<pre style="line-height:115%"><u><span style="font-family:&quot;Calibri&quot;,sans-serif;color:blue"><a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3725944" target="_parent">Measuring the Impact of COVID-19 Pandemic Fear on Stress, Anxiety, and Depression among General Public in Sindh</a></span></u><span style="font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></pre>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:7.1pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ahmed Soomro,&nbsp; Mansoor,&nbsp; Memon, et al</span><span class="anchortext6"><span style="font-size:10.0pt;line-height:115%;color:#505050;mso-fareast-language:EN-CA"><o:p></o:p></span></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:7.1pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">SSRN- Lancet prepublication</span><i><o:p></o:p></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:7.1pt">
<p class="MsoNormal" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:7.1pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The study has examined the level of stress, anxiety, and depression among the general public due to coronavirus. The
 data was collected by using a structured questionnaire from the public of Sindh province, Pakistan in March and April. A total number of 462 responses were received through an online survey. The research findings revealed that there is a significant relationship
 between COVID-19 and stress, anxiety and depression.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:8.5pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://arxiv.org/abs/2011.08664" target="_parent">Estimating, Monitoring, and Forecasting the Covid-19 Epidemics: A Spatio-Temporal Approach
 Applied to NYC Data</a></span></u><span style="font-size:10.0pt;line-height:115%;color:#007398"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Albani,&nbsp; ViniciusVL,&nbsp; Velho, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050;mso-fareast-language:EN-CA"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">arXiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:8.5pt">
<p class="MsoNormal" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">We propose an SEIR-type meta-population model to simulate and monitor the Covid-19 epidemic evolution. The basic model consists of seven compartments,
 namely susceptible (S), exposed (E), three infective classes, recovered (R), and deceased (D). We define these compartments for n age and gender groups in m different spatial locations. So, the resulting model has, for each age group, gender, and place, all
 epidemiological classes. The mixing between them is accomplished by means of time-dependent infection rate matrices. The model is calibrated with the curve of daily new infections in New York City and its boroughs, including census data, and the proportions
 of infections, hospitalizations, and deaths for each age range. We end up with a model that matches the reported curves and predicts accurately infection information for different places and age classes.</span><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:8.5pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.psep.2020.11.007" target="_parent">PMC7662076; Efficient Artificial Intelligence Forecasting Models for COVID-19 Outbreak
 in Russia and Brazil</a></span></u><span style="font-size:10.0pt;line-height:115%;color:#007398"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Al-Qaness,&nbsp; M,&nbsp; Saba, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050;mso-fareast-language:EN-CA"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Process Saf Environ Prot</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:8.5pt">
<p class="MsoNormal" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">In this paper, we propose a new short term forecasting model using an enhanced version of the Adaptive Neuro-Fuzzy Inference System (ANFIS). An improved
 Marine Predators Algorithm (MPA), called Chaotic MPA (CMPA), is applied to enhance the ANFIS and to avoid its shortcomings. More so, we compared the proposed CMPA with three artificial intelligence-based models include the original ANFIS, and two modified
 versions of ANFIS model using both of the original Marine Predators Algorithm (MPA) and Particle Swarm Optimization (PSO). The forecasting accuracy of the models was compared using different statistical assessment criteria. CMPA significantly outperformed
 all other investigated models.</span><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:8.5pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s00894-020-04603-1" target="_parent">Modelling the structural and reactivity landscapes of tucatinib with special reference
 to its wavefunction-dependent properties and screening for potential antiviral activity</a></span></u><span style="font-size:10.0pt;line-height:115%;color:#007398"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Alsalme,&nbsp; A,&nbsp; Pooventhiran, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050;mso-fareast-language:EN-CA"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Mol Model</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:8.5pt">
<p class="MsoNormal" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Coronavirology| Coronavirologie Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Tucatinib is recently developed and approved as a potential medicine to fight HER-2 type breast cancer. In this manuscript, we present the gross structural
 features of this compound and its reactivity and wave function properties using computational simulations. Density functional theory was used to optimise the ground state geometry of the molecule and molecular docking was used to predict biological activity.
 Information entropy calculations show that the compound is inherently stable. Docking with COVID-19 proteins show docking score of - 9.42, - 8.93, - 8.45 and - 8.32 kcal/mol respectively indicating high interaction between the drug and proteins. Hence, this
 is an ideal candidate to study repurposing of existing drugs to combat the pandemic.</span><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:8.5pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1002/ajh.25962" target="_parent">PMC7436379; Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease
 2019 (COVID-19)</a></span></u><span style="font-size:10.0pt;line-height:115%;color:#007398"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Al-Samkari,&nbsp; H,&nbsp; Song, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050;mso-fareast-language:EN-CA"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Am J Hematol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:8.5pt">
<p class="MsoNormal" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">We studied hospitalized adults with COVID-19 and prothrombin fragment 1.2 (PF1.2) measurements performed at any time during hospitalization. We evaluated
 the relationship between PF1.2 and synchronously measured D-dimer. A total of 115 patients were included 110 (95.7%) critically ill]. Both PF1.2 and D-dimer were moderately positively correlated (r = 0.542, P 523 pmol/L: 69.2% sensitivity, 67.7% specificity;
 &gt;924 pmol/L: 37.9% sensitivity, 87.8% specificity). In multivariable analysis, a PF1.2 &gt;500 pmol/L was significantly associated with VTE adjusted odds ratio (OR) 4.26, 95% CI, 1.12-16.21, P = .034] and any thrombotic manifestation (adjusted OR 3.85, 95% CI,
 1.39-10.65, P = .010); conversely, synchronously measured D-dimer was not significantly associated with thrombosis. 90.6% of patients with a non-elevated PF1.2 result did not develop VTE. So, PF1.2 may be a useful assay, and potentially more discriminant than
 D-dimer, in identifying thrombotic manifestations in hospitalized patients with COVID-19.</span><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:8.5pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/jalm/jfaa133" target="_parent">Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based
 ELISA for Detecting SARS-CoV-2 IgG</a></span></u><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Antoine-Reid,&nbsp; T,&nbsp; Malone, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">The journal of applied laboratory medicine</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:8.5pt">
<p class="MsoNormal" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:-.45pt;line-height:115%">
<span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Diagnostics / Pathogen detection| Diagnostics / Détection d'agents pathogènes<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:8.5pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We evaluated the performance of the Abbott Architect IgG assay vs. the GenScript SARS-CoV-2 Spike S1-RBD IgG ELISA,
 a research-use-only methodology that would require local validation to meet CLIA and FDA requirements. The Architect demonstrated 100% specificity for serum (230/230; 95% CI, 98.4%–100%) and 98.8% for plasma (235/238; 95% CI, 96.4%–99.6%) while ELISA sensitivity
 was 85.7% (18/21; 95% CI, 65.4%–95.0%) for serum and 93.5% (43/46; 95% CI, 82.5%–97.7%) for plasma (varying based on assigned positivity threshold).</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:8.5pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s00705-020-04856-4" target="_parent">ceRNA analysis of SARS-CoV-2</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Arancio,&nbsp; W</span><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:8.5pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Arch Virol</span><i><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:8.5pt">
<p class="MsoNormal" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:6.0pt;margin-left:-.45pt;line-height:115%">
<span style="font-size:10.0pt;line-height:115%;color:black">Coronavirology| Coronavirologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:8.5pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Viral RNAs can perturb the miRNA regulatory network, competing with host RNAs as part of their infective process. An
 in silico competing endogenous RNA (ceRNA) analysis has been carried on SARS-CoV-2. The results suggest that, in humans, the decrease of microRNA activity caused by viral RNAs can lead to a perturbation of vesicle trafficking and the inflammatory response,
 in particular by enhancing KLF10 activity. The results suggest also that, during the study of the mechanics of viral infections, it could be of general interest to investigate the competition of viral RNA with cellular transcripts for shared microRNAs.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:.9pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:.9pt">
<p class="wordsection1" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:blue"><a href="https://doi.org/10.1038/s41597-020-00731-8" target="_parent">CovidCounties is an interactive real time tracker
 of the COVID19 pandemic at the level of US counties</a></span></u><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:.9pt">
<p class="wordsection1" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Arneson,&nbsp; D,&nbsp; Elliott, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:.9pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Sci Data</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;background:white;padding:0cm 5.4pt 0cm 5.4pt;height:.9pt">
<p class="MsoNormal" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Epidemiology| Épidémiologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:white;padding:0cm 5.4pt 0cm 5.4pt;height:.9pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Here we report the development of CovidCounties.org, an interactive web application that depicts daily disease trends
 at the level of US counties using time series plots and maps. This application is accompanied by a manually curated dataset that catalogs all major public policy actions made at the state-level, as well as technical validation of the primary data. Finally,
 the underlying code for the site is also provided as open source, enabling others to validate and learn from this work.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:.9pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:.9pt">
<p class="wordsection1" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:blue"><a href="https://doi.org/10.1186/s12882-020-02150-8" target="_parent">Comparison of different anticoagulation strategies
 for renal replacement therapy in critically ill patients with COVID-19: a cohort study</a></span></u><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:.9pt">
<p class="wordsection1" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Arnold,&nbsp; F,&nbsp; Westermann, et al</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:.9pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMC Nephrol</span><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;background:white;padding:0cm 5.4pt 0cm 5.4pt;height:.9pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:white;padding:0cm 5.4pt 0cm 5.4pt;height:.9pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study investigated whether alternative anticoagulation strategies for renal replacement therapy (RRT) during COVID-19
 are superior to administration of unfractionated heparin (UFH).&nbsp; In patients receiving continuous veno-venous hemodialysis (CVVHD), mean treatment time in the UFH group was 21.3 h ( SEM: ±5.6 h), in the citrate group 45.6 h (SEM: ±2.7 h). Citrate anticoagulation
 significantly prolonged treatment times by 24.4 h (P = .001). In patients receiving sustained low-efficiency daily dialysis (SLEDD), mean treatment time with UFH was 8.1 h (SEM: ±1.3 h), with argatroban 8.0 h (SEM: ±0.9 h), and with low molecular weight heparin
 (LMWH) 11.8 h (SEM: ±0.5 h). LMWH significantly prolonged treatment times by 3.7 h (P = .008) and 3.8 h (P = .002), respectively. UFH fails to prevent early clotting events in the dialysis circuit during COVID-19. For patients, who do not require effective
 systemic anticoagulation, regional citrate dialysis is the most effective strategy. For patients, who require effective systemic anticoagulation, the usage of LMWH results in the longest circuit life spans.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:.9pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:.9pt">
<p class="wordsection1" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:blue"><a href="http://medrxiv.org/content/early/2020/11/17/2020.04.19.20071886.abstract" target="_parent">Tracking R of
 COVID-19: A New Real-Time Estimation Using the Kalman Filter</a></span></u><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:.9pt">
<p class="wordsection1" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Arroyo Marioli,&nbsp; Francisco,&nbsp; Bullano, et al<o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:.9pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv<o:p></o:p></span></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;background:white;padding:0cm 5.4pt 0cm 5.4pt;height:.9pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie Public health
 interventions*| Interventions de sant&amp;amp;eacute; publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:white;padding:0cm 5.4pt 0cm 5.4pt;height:.9pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study developed a new method for estimating the effective reproduction number of an infectious disease (R) and
 applied it to track the dynamics of COVID-19. The method is based on the fact that in the SIR model, R is linearly related to the growth rate of the number of infected individuals. This time-varying growth rate is estimated using the Kalman filter from data
 on new cases. The method is easy to implement in standard statistical software, and it performs well even when the number of infected individuals is imperfectly measured, or the infection does not follow the SIR model. The estimates of R for COVID-19 for 124
 countries across the world are provided in an interactive \href{https://bit.ly/Rtlive}{online dashboard}, and they are used to assess the effectiveness of non-pharmaceutical interventions in a sample of 14 European countries.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1164/rccm.202006-2568OC" target="_parent">PMC7667906; Symptoms of Anxiety, Depression, and Peritraumatic Dissociation in
 Critical Care Clinicians Managing Patients with COVID-19. A Cross-Sectional Study</a></span></u><span style="font-size:10.0pt;line-height:115%;color:black"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%;background:white"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Azoulay,&nbsp; E,&nbsp; Cariou, et al<o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Am J Respir Crit Care Med<o:p></o:p></span></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This cross-sectional study assessed the prevalence of symptoms of anxiety, depression, and peritraumatic dissociation
 in HCPs. The prevalence of symptoms of anxiety, depression, and peritraumatic dissociation was 50.4%, 30.4%, and 32%, respectively, with the highest rates in nurses. By multivariable analysis, male sex was independently associated with lower prevalence of
 symptoms of anxiety, depression, and peritraumatic dissociation (OR 0.58 95% CI, 0.42-0.79], 0.57 95% CI, 0.39-0.82], and 0.49 95% CI, 0.34-0.72], respectively). HCPs working in non-university-affiliated hospitals and nursing assistants were at high risk of
 symptoms of anxiety and peritraumatic dissociation. Importantly, identified the following six modifiable determinants of symptoms of mental health disorders: fear of being infected, inability to rest, inability to care for family, struggling with difficult
 emotions, regret about the restrictions in visitation policies, and witnessing hasty end-of-life decisions.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;background:#FCFCFC"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/07391102.2020.1845800" target="_parent">Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2
 main protease (m(pro)): a molecular docking, molecular dynamics and structure-activity relationship studies</a></span></u><span style="font-size:10.0pt;line-height:115%;color:#007398"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%;background:white"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Badavath,&nbsp; VN,&nbsp; Kumar, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Biomol Struct Dyn</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This article reports a computer-aided drug design (CADD) approach for the screening of 118 compounds with 16 distinct
 heterocyclic moieties in comparison with 5 natural products and 7 repurposed drugs. Molecular docking analysis against M(pro) protein were performed finding isatin linked with a oxidiazoles (A2 and A4) derivatives to have the best docking scores of -11.22 kcal/mol
 and -11.15 kcal/mol respectively. Structure-activity relationship studies showed a good comparison with a known active M(pro) inhibitor and repurposed drug ebselen with an IC(50) value of -0.67 μM. Molecular Dynamics (MD) simulations for 50 ns were performed
 for A2 and A4 supporting the stability of the two compounds within the binding pocket, largely at the S1, S2 and S4 domains with high binding energy suggesting their suitability as potential inhibitors of M(pro) for SARS-CoV-2.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://ssrn.com/abstract=3729394" target="_parent">SARS-CoV-2 Seroprevalence Study in Pimpri-Chinchwad, Maharashtra, India Coinciding with
 Falling Trend – Do the Results Suggest Imminent Herd Immunity?</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Banerjee,&nbsp; Amitav,&nbsp; Gaikwad, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">SSRN- Lancet prepublication</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Immunology | Immunologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">A population based seroprevalence study was conducted for IgG antibodies for SARS-CoV-2 among 5000 residents in Pimpri-Chinchwad
 township . The overall seropositivity for IgG antibodies was 34.04% (95% confidence interval 31.3% to 36.8%). Slum dwellers had positivity rate of 40.9% (95% confidence interval 37.0% to 44.7%), those in tenements had positivity of 41.2% (95% confidence interval
 37.7% to 44.8%) and more affluent people living in housing societies had positivity of 29.8% (95% confidence interval 25.8% to 33.8%). The study indicates that a considerable proportion of the population had encountered the novel coronavirus approaching partial,
 if not complete, herd immunity, which may partly explain the declining trend in spite of easing of lockdown restrictions.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1186/s12879-020-05587-2" target="_parent">Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers
 in New Jersey, at the onset of the U.S. COVID-19 pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Barrett,&nbsp; ES,&nbsp; Horton, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMC Infect Dis</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This prospective cohort study of HCW (n = 546) and non-healthcare workers (NHCW; n = 283) with no known prior SARS-CoV-2
 infection was conducted to examine SARS-CoV-2 infection status (as determined by presence of SARS-CoV-2 RNA in oropharyngeal swabs). At baseline, 41 (5.0%) of the participants tested positive for SARS-CoV-2 infection, of whom 14 (34.2%) reported symptoms.
 The prevalence of SARS-CoV-2 infection was higher among HCW (7.3%) than in NHCW (0.4%), representing a 7.0% greater absolute risk (95% confidence interval for risk difference 4.7, 9.3%). The majority of infected HCW (62.5%) were nurses. Positive tests increased
 across the two weeks of cohort recruitment in line with rising confirmed cases in the hospitals and surrounding counties.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.jpubeco.2020.104310" target="_parent">PMC7657101; Civic capital and social distancing during the Covid-19 pandemic(<span style="font-family:&quot;Segoe UI Symbol&quot;,sans-serif">☆</span>)</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Barrios,&nbsp; JM,&nbsp; Benmelech, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Public Econ</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Public Health response| Interventions de santé publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Using mobile phone and survey data, this study show that during the early phases of COVID-19, voluntary social distancing
 was greater in areas with higher civic capital and amongst individuals exhibiting a higher sense of civic duty. This effect is robust to including controls for political ideology, income, age, education, and other local-level characteristics.&nbsp; Also show that
 after U.S. states began re-opening, high civic capital counties maintained a more sustained level of social distancing, while low civic capital counties did not. The U.S. individuals reported a higher tendency to use protective face masks in high civic capital
 counties.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.18632/aging.202221" target="_parent">Cell differentiation and aging accompanied by depletion of the ACE2 protein</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Bártová,&nbsp; E,&nbsp; Legartová, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Aging (Albany NY)</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Animal model | Modèle animal<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This&nbsp; research studied the cell surface receptor of the SARS-CoV-2 virus ACE2 and its levels changed during cell differentiation
 and aging and varied in distinct cell types. Observed ACE2 depletion in the aortas of aging female mice, similarly, the aging caused ACE2 decrease in the kidneys. Compared with that in the heart, brain and kidneys, the ACE2 level was the lowest in the mouse
 lungs. In mice exposed to nicotine, ACE2 was not changed in olfactory bulbs but in the lungs, ACE2 was upregulated in females and downregulated in males. These observations indicate the distinct gender-dependent properties of ACE2. Differentiation into enterocytes,
 and cardiomyocytes, caused ACE2 depletion. The cardiomyogenesis was accompanied by renin upregulation, delayed in HDAC1-depleted cells. In contrast, vitamin D2 decreased the renin level while ACE2 was upregulated. Together, the ACE2 level is high in non-differentiated
 cells. This protein is more abundant in the tissues of mouse embryos and young mice in comparison with older animals. Mostly, downregulation of ACE2 is accompanied by renin upregulation.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1186/s13063-020-04805-1" target="_parent">CovEMERALD: Assessing the feasibility and preliminary effectiveness of remotely
 delivered Eye Movement Desensitisation and Reprocessing following Covid-19 related critical illness: A structured summary of a study protocol for a randomised controlled trial</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Bates,&nbsp; A,&nbsp; Rushbrook, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Trials</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">RCT</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This paper presents a study protocol for a randomised controlled trial to determine the feasibility of delivering a
 protocolised, remote, online, Eye Movement Desensitisation and Reprocessing (EMDR) intervention, within 12-weeks of hospital discharge, for adult survivors of Covid-19 related critical illness. And to investigate whether remotely delivered EMDR can improve
 psychological outcome following Covid-19 related critical illness, specifically Post-Traumatic Stress Disorder (PTSD), anxiety and depression.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/ageing/afaa258" target="_parent">Clinical profile and predictors of in-hospital mortality among older patients admitted
 for COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Becerra-Muñoz,&nbsp; VM,&nbsp; Núñez-Gil, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Age Ageing</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study was a post-hoc analysis of the international, multicentre, &quot;real-world&quot; HOPE COVID-19 registry of all patients
 aged ≥65 years who were hospitalised for COVID-19 to look at all cause in-hospital mortality. 1,520 patients aged ≥65 years (60.3% male, median age of 76 IQR 71-83] years) were included. Comorbidities such as hypertension (69.2%), dyslipidemia (48.6%), cardiovascular
 diseases (any chronic heart disease in 38.4% and cerebrovascular disease in 12.5%), and chronic lung disease (25.3%) were prevalent, and 49.6% were on ACEI/ARBs. Patients aged 75 years and older suffered more in-hospital complications (respiratory failure,
 heart failure, renal failure, sepsis) and a significantly higher mortality (18.4 vs. 48.2%, P 1 (OR 8.31) to be independent predictors of mortality.&nbsp; Patients aged ≥65 years hospitalised for COVID-19 had high rates of in-hospital complications and mortality,
 especially among patients 75 years or older.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.hlpt.2020.08.014" target="_parent">PMC7451099; Responses to COVID-19 in five Latin American countries</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Benítez,&nbsp; MA,&nbsp; Velasco, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Health Policy Technol</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Public health interventions*| Interventions de sant&amp;amp;eacute;
 publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This paper focuses on the first months of the pandemic in five Latin American countries: Brazil, Chile, Colombia, Ecuador
 and Peru. It analyses how the pre-pandemic context, and the government's responses to contain and mitigate the spread together with economic measures have affected the COVID-19 health outcomes. The countries were quick to implement stringent COVID-19 measures
 and incrementally scaled up their health systems capacity, although tracing and tracking have been poor. All five countries have experienced a large number of cases and deaths due to COVID-19. The analysis on the excess deaths also shows that the impact in
 deaths is far higher than the official numbers reported to date for some countries.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/17/2020.06.06.20124446.abstract" target="_parent">Estimating individual risks of COVID-19-associated
 hospitalization and death using publicly available data</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Bhatia,&nbsp; Rajiv,&nbsp; Klausner, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We describe a method to estimate individual risks of hospitalization and death attributable to non-household and household
 transmission of SARS-CoV-2 using available public data. Using the method, we estimate that risks for a 90-day period at the median daily summertime U.S. county confirmed COVID-19 case incidence of 10.8 per 100,000 and pre-pandemic contact rates range from
 0.4 to 8.9 per 100,000 for the four deciles of age between 20 and 60 years. The corresponding 90-day period risk of hospitalization ranges from 13.7 to 69.2 per 100,000. Assuming a non-household secondary infection risk of 4% and pre-pandemic contact rates,
 the share of transmissions attributable to household settings ranges from 73% to 78%.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.rinp.2020.103568" target="_parent">PMC7657089; The behaviour of infection, survival and testing effort variables of
 SARS-CoV-2: A theoretical modelling based on optimization technique</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Bhattacharya,&nbsp; S,&nbsp; Paul, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Results Phys</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie Public health
 interventions*| Interventions de sant&amp;amp;eacute; publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The present study tries to illustrate the identification of infected under two frames like discrete and continuous
 set. The importance of effort for the identification under each process can be replaced by variables like testing. Thus, number test per day is the most significant variable to overcome the disease.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://biorxiv.org/content/early/2020/11/17/2020.11.17.387092.abstract" target="_parent">Mosaic RBD nanoparticles elicit neutralizing antibodies
 against SARS-CoV-2 and zoonotic coronaviruses</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Bjorkman,&nbsp; PamelaJ,&nbsp; Cohen, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">bioRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Vaccine Research| Recherche sur les vaccins Immunology | Immunologie Animal model |
 Modèle animal<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">To evaluate immunization strategies, we made nanoparticles displaying the receptor-binding domain (RBD) of only SARS-CoV-2
 (homotypic nanoparticles) or co-displaying the SARS-CoV-2 RBD along with RBDs from animal betacoronaviruses that represent threats to humans (mosaic nanoparticles; 4-8 distinct RBDs). Mice immunized with RBD-nanoparticles, but not soluble antigen, elicited
 cross-reactive antibody binding and neutralization responses, confirming increased immunogenicity from multimerization. A single immunization with mosaic-RBD-nanoparticles provides a potential strategy to simultaneously protect against SARS-CoV-2 and emerging
 zoonotic coronaviruses.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1042/bsr20203455" target="_parent">Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia:
 a retrospective cohort study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Boari,&nbsp; GEM,&nbsp; Chiarini, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Biosci Rep</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The aim of the study was to assess simultaneously several potential predictors of outcome (co-morbidity, previous and
 in-hospital treatment, radiologic Brixia score) in patients with COVID-19. This retrospective cohort study included 258 consecutive patients with confirmed COVID-19. During hospitalization, 59 patients died, while 6 died after discharge. The following variables
 were demonstrated to be associated with a worse prognosis: Radiologic Brixia score higher than 8, presence at baseline of hypertension, diabetes, chronic obstructive pulmonary disease, heart disease, cancer, previous treatment with ACE-inhibitors or anti-platelet
 drugs. Anticoagulant treatment during hospital admission with enoxaparin at a dose higher than 4000 U per was associated to a better prognosis.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1038/s41467-020-19684-y" target="_parent">STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2
 infected hamsters</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Boudewijns,&nbsp; R,&nbsp; Thibaut, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Nat Commun</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Immunology | Immunologie Animal model | Modèle animal<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Here, we show that Syrian hamsters, in contrast to mice, are highly permissive to SARS-CoV-2 and develop bronchopneumonia
 and strong inflammatory responses in the lungs with neutrophil infiltration and edema, further confirmed as consolidations visualized by micro-CT alike in clinical practice. Moreover, we identify an exuberant innate immune response as key player in pathogenesis,
 in which STAT2 signaling plays a dual role, driving severe lung injury on the one hand, yet restricting systemic virus dissemination on the other. Our results reveal the importance of STAT2-dependent interferon responses in the pathogenesis and virus control
 during SARS-CoV-2 infection and may help rationalizing new strategies for the treatment of COVID-19 patients.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.2215/cjn.09610620" target="_parent">Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Bowe,&nbsp; B,&nbsp; Cai, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Clin J Am Soc Nephrol</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We aimed to describe rates and characterize predictors and health outcomes associated with AKI in a national cohort
 of US veterans hospitalized with COVID-19. AKI is common during hospitalization with COVID-19 and associated with higher risk of health care resource utilization and death. Nearly half of patients with AKI did not recover to baseline by discharge. Substantial
 geographic variation and temporal decline in rates and severity of AKI were observed.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://biorxiv.org/content/early/2020/11/17/2020.11.16.384917.abstract" target="_parent">Transmission of SARS-CoV-2 in domestic cats imposes
 a narrow bottleneck</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Braun,&nbsp; KatarinaM,&nbsp; Moreno, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">bioRxiv</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Transmission Coronavirology| Coronavirologie zoonoses</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Using domestic cats as a model, we show that SARS-CoV-2 consensus sequences remain largely unchanged over time within
 hosts, but dynamic sub-consensus diversity reveals processes of genetic drift and weak purifying selection. Transmission bottlenecks in this system appear narrow, with new infections being founded by fewer than ten viruses. We identify a notable variant at
 amino acid position 655 in Spike (H655Y) which arises rapidly in index cats and becomes fixed following transmission in two of three pairs, suggesting this site may be under positive selection in feline hosts. We speculate that narrow transmission bottlenecks
 and the lack of pervasive positive selection combine to constrain the pace of ongoing SARS-CoV-2 adaptive evolution in mammalian hosts.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/17/2020.06.24.20138768.abstract" target="_parent">A Randomised Trial of Covid-19 Transmission in Training
 Facilities</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Bretthauer,&nbsp; Michael</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Public health interventions*| Interventions de sant&amp;amp;eacute;
 publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We investigated SARS-CoV-2 virus transmission, Covid-19 and SARS-CoV-2 antibodies attributable to training facilities.
 We randomised members aged 18 to 64 without relevant comorbidities at five training facilities in Oslo, Norway, to access or no access to their facility. Eleven individuals in the training arm (0.8% of tested) and 27 in the no-training arm (2.4% of tested)
 tested positive for SARS-CoV-2 antibodies (p=0.001). Provided good hygiene and physical distancing measures, there was no increased transmission of SARS-CoV-2 at training facilities.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/18/2020.11.16.20232223.abstract" target="_parent">Clinical Profile of First 1000 COVID-19 Cases Admitted
 at Tertiary Care Hospitals and the Correlates of their Mortality: An Indian Experience</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Budhiraja,&nbsp; Sandeep,&nbsp; Soni, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study aimed to describe the clinical profile and factors leading to increased mortality in COVID-19 patients admitted
 to a group of hospitals in India. Male patients above the age of 60 and with co-morbidities faced the highest rates of mortality. They should be admitted to the hospital in early stage of the disease and given aggressive treatment to help reduce the morbidity
 and mortality associated with COVID-19.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.4097/kja.20511" target="_parent">Intraoperative aerosol box use: does an educational visual aid reduce contamination?</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Burnett,&nbsp; GW,&nbsp; Zhou, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Korean J Anesthesiol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Infection Prevention and Control/ Prévention et contrôle des infections (IPAC/PCI)<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We evaluated intraoperative contamination and aerosol box decontamination and the impact of a preoperative educational
 visual aid. The use of a visual aid significantly decreased intraoperative contamination and improved box cleaning. Despite these findings, a potentially clinically significant amount of viral exposure may exist. Thorough evaluation of the risks and benefits
 of the aerosol box should be completed prior to use.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.physa.2020.125520" target="_parent">PMC7644259 personal relationships that could have appeared to influence the work
 reported in this paper; Epidemic model on a network: Analysis and applications to COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Bustamante-Castañeda,&nbsp; F,&nbsp; Caputo, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Physica A</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie Public health
 interventions*| Interventions de sant&amp;amp;eacute; publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We analyze an epidemic model on a network consisting of susceptible-infected-recovered equations at the nodes coupled
 by diffusion using a graph Laplacian. We introduce an epidemic criterion and examine different isolation strategies: we prove that it is most effective to isolate a node of highest degree. The model is also useful to evaluate deconfinement scenarios and prevent
 a so-called second wave. The model has few parameters enabling fitting to the data and the essential ingredient of importation of infected; these features are particularly important for the current COVID-19 epidemic.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://pubmed.ncbi.nlm.nih.gov/33199676/" target="_parent">[Survey data as a way to estimate the prevalence of COVID-19. A pilot study in the
 city of Madrid.]</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Carabaña Morales,&nbsp; J</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Rev Esp Salud Publica</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Its goal was to evaluate the potential of interviewing such type of samples in order to assess the incidence and prevalence
 of epidemics as COVID-19. RESULTS: Prevalence for individuals. On April/3/20, 10,9% of people 18 years and older living in Madrid reported symptoms compatible with COVID19 (SCC19). Occurrence of SCC19 was similar for both sexes, being respectively above and
 below the mean for the 40-49 (18,9%) and for the &gt;69 (4%) age groups, showing no relation with household size, but being associated with economic activity (19% among working population) and, even more strongly, with the fact of living with symptomatic co-residents
 (52%).</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.xcrm.2020.100142" target="_parent">PMC7598530; Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake
 of SARS-CoV-2 by Epithelial Cells</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Carpinteiro,&nbsp; A,&nbsp; Edwards, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Cell Rep Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Here, we report that either pharmacological inhibition of acid sphingomyelinase with amitriptyline, imipramine, fluoxetine,
 sertraline, escitalopram, or maprotiline or genetic downregulation of the enzyme prevents infection of cultured cells or freshy isolated human nasal epithelial cells with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or vesicular stomatitis
 virus (VSV) pseudoviral particles (pp-VSV) presenting SARS-CoV-2 spike protein (pp-VSV-SARS-CoV-2 spike), a bona fide system mimicking SARS-CoV-2 infection.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1186/s13244-020-00939-7" target="_parent">Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in
 a paucisymptomatic population of 247 patients affected by COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Castelli,&nbsp; M,&nbsp; Maurin, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Insights Imaging</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The aim of this study was to describe the prevalence and risk factors for lung involvement in 247 patients with a visual
 score and assess the prevalence of incidental findings. METHODS: For 12 days in March 2020, 250 patients with RT-PCR positive tests and who underwent LDCT were prospectively included. The prevalence of lung involvement was 54% in a predominantly paucisymptomatic
 population. Age ≥ 55 years and diabetes were risk factors for significant parenchymal lung involvement. Rhinitis and anosmia were protective against LDCT abnormalities.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1186/s12954-020-00438-4" target="_parent">Implementation of a medical student-run telemedicine program for medications for
 opioid use disorder during the COVID-19 pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Castillo,&nbsp; M,&nbsp; Conte, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Harm Reduct J</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We describe development and implementation of a medical student-run telemedicine clinic through an academic medical
 center-operated syringe services program. RESULTS: Over the first 9 weeks in operation, 31 appointments were requested, and 22 initial telehealth appointments were completed by a team of students and attending physicians. Fifteen appointments were for MOUD
 and 7 for other health issues. All patients seeking MOUD were prescribed buprenorphine and 12/15 successfully picked up medications from the pharmacy.&nbsp; TeleMOUD is feasible and successful in providing people who inject drugs with low barrier access to life-saving
 MOUD during the COVID-19 pandemic.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/bmjopen-2020-041191" target="_parent">Characteristics and well-being of urban informal home care providers during COVID-19
 pandemic: a population-based study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Chan,&nbsp; EY,&nbsp; Lo, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMJ Open</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale<br>
Public Health response| Interventions de santé publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">A random, cross-sectional, population-based, RDD, telephone survey study was conducted to examine patterns of home
 care, characteristics of informal home care providers and the challenges experienced by these care providers during this pandemic. RESULTS: Of the respondents, 25.1% of 765 provided informal home care during the studied COVID-19 pandemic period. Among the
 informal home care providers, 18.4% of respondents took leave from school/work during the epidemic to provide care for the sick, fragile elderly and small children. Care providers tended to be younger aged, female and housewives. Approximately half of care
 providers reported additional mental strain and 37.2% reported of challenges in daily living during epidemic.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/bmjopen-2020-041397" target="_parent">Predicting the local COVID-19 outbreak around the world with meteorological conditions:
 a model-based qualitative study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Chen,&nbsp; B,&nbsp; Liang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMJ Open</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study aims to investigate the relationship between daily weather and transmission rate of SARS-CoV-2, and to develop
 a generalised model for future prediction of the COVID-19 spreading rate for a certain area with meteorological factors. RESULTS: Significant correlation of the daily new confirmed case count with the weather 3 to 7 days ago were found. SARS-CoV-2 is easy
 to spread under weather conditions of average temperature at 5 to 15°C, relative humidity at 70% to 80%, wind speed at 1.5 to 4.5 m/s and air visibility less than 10 statute miles.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/bmjopen-2020-043461" target="_parent">Characteristics of online medical care consultation for pregnant women during
 the COVID-19 outbreak: cross-sectional study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Chen,&nbsp; M,&nbsp; Liu, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMJ Open</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study described the needs of pregnant women and the contents of online obstetric consultation in representative
 areas with various severity of the epidemic in China. RESULTS: The distribution of the amount of online consultations was significantly different not only in different areas (p&lt;0.001) but also in different trimesters (p&lt;0.001). A total of 957 participants
 completed the satisfaction part of the survey. In this study, 77.95% of the participants used e-health for the first time, and 94.63% of the participants were completely or mostly satisfied with the online consultations.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-94634/v1" target="_parent">SARS-CoV-2 Infected Cardiomyocytes Recruit Monocytes by Secreting CCL2</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Chen,&nbsp; Shuibing,&nbsp; Yang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Animal model | Modèle animal</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In order to study the cause of myocardial pathology in COVID-19 patients, we used a hamster model to determine whether
 following infection SARS-CoV-2, the causative agent of COVID-19, can be detected in heart tissues. Here, we clearly demonstrate that viral RNA and nucleocapsid protein is present in cardiomyocytes in the hearts of infected hamsters.&nbsp; Moreover, we show that
 both human pluripotent stem cell-derived cardiomyocytes (hPSC-derived CMs) and adult cardiomyocytes (CMs) can be infected by SARS-CoV-2 and that CCL2 is secreted upon SARS-CoV-2 infection, leading to monocyte recruitment. Increased CCL2 expression and macrophage
 infiltration was also observed in the hearts of infected hamsters.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1177/0163278720971833" target="_parent">Notes from the Field: Effectiveness of Prevention and Control Measures for Imported
 COVID-19 in Guangming District of Shenzhen</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Chen,&nbsp; X,&nbsp; Wang, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Eval Health Prof</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Public health interventions*| Interventions de sant&amp;amp;eacute;
 publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We implemented a surveillance and screening strategy that included early detection of laboratory-confirmed COVID-19
 cases and people who were exposed to the disease in Guangming District of Shenzhen. From January 23 to March 13, 2020, we found 12 suspected cases, and 11 were confirmed as positive. After February 14, when the last case was confirmed, there were no newly
 confirmed cases for 28 consecutive days under the strict outbreak control.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/cid/ciaa657" target="_parent">Hospitalized Patients With COVID-19 and Human Immunodeficiency Virus: A Case Series</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Childs,&nbsp; K,&nbsp; Post, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We report the clinical characteristics of 18 people with human immunodeficiency virus (PWH) who were hospitalized with
 confirmed COVID-19 including the proportion who reached a composite endpoint of death, requiring mechanical ventilation or intensive treatment unit admission.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1002/acn3.51250" target="_parent">The case of a 69-year-old man with COVID-19 and encephalopathy</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Cline,&nbsp; TE,&nbsp; Sangha, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ann Clin Transl Neurol</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">A 69-year-old man positive for COVID-19 with uncontrolled type 2 diabetes presented to an outside hospital with altered
 mental status. He progressed from being argumentative to encephalopathic and agitated by the evening with urinary frequency, urinary urgency, nausea, and vomiting.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1097/adm.0000000000000779" target="_parent">The Impact of COVID-19 on Service Provision for Emergency Department Patients
 Post-Opioid Overdose: A Field Report</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Collins,&nbsp; AB,&nbsp; Beaudoin, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Addict Med</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We describe a rapid environmental assessment with senior emergency department (ED) practitioners in Rhode Island to
 understand how COVID-related procedural changes impact the provision of post-overdose care in ED. RESULTS: COVID-related policy changes challenged the provision of services to PWUD in the ED, and extended challenges in connecting people with OUD to services
 in the community. Specifically, challenges included transitions to telehealth modalities, required COVID tests for treatment services, and gaps in community resources.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/20477724.2020.1838190" target="_parent">Immunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early
 diagnosis: a bioinformatics and immunoinformatics study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Dai,&nbsp; Y,&nbsp; Chen, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Pathog Glob Health</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Diagnostics / Pathogen detection| Diagnostics / Détection d'agents pathogènes Immunology
 | Immunologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Rapid and accurate detection along with timely isolation is the key to control the COVID-19 epidemic. Authors discuss
 nucleic acid test and antibody-detection. The final construct was built based on the bioinformatics analysis, which could help to develop an antigen-capture system for the early diagnosis of SARS-CoV-2.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.2196/21434" target="_parent">COVID-19 Surveillance in a Primary Care Sentinel Network: In-Pandemic Development of an Application
 Ontology</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">de Lusignan,&nbsp; S,&nbsp; Liyanage, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">JMIR Public Health Surveill</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study aimed to develop an application ontology for COVID-19 that can be deployed across the various use-case domains
 of the RCGP RSC research and surveillance activities. The underpinning structure of the ontological approach has coped with multiple clinical coding challenges.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/14/2020.07.31.20166066.abstract" target="_parent">SARS-CoV-2 Screening Among Symptom-Free Healthcare
 Workers</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Demmer,&nbsp; RyanT,&nbsp; Ulrich, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">A cross-sectional convenience sample of symptom-free HCWs from the metropolitan area surrounding Minneapolis and St.
 Paul, Minnesota were tested for COVID-19.&nbsp; The point prevalence of SARS-CoV-2 infection was likely &lt;1% in a convenience sample of symptom-free Minnesota healthcare workers.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s11030-020-10151-w" target="_parent">Molecular docking studies, molecular dynamics and ADME/tox reveal therapeutic potentials
 of STOCK1N-69160 against papain-like protease of SARS-CoV-2</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Elekofehinti,&nbsp; OO,&nbsp; Iwaloye, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Mol Divers</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study was conducted to evaluate the efficacy of ~ 50,000 natural compounds retrieved from IBS database against
 COVID-19 PLpro using computer-aided drug design. The edge of the compound was further established by its stability in molecular dynamics (MD) simulation conducted for 30 ns employing GROMACS software.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1038/s41598-020-76914-5" target="_parent">Detection of SARS-CoV-2 antibodies is insufficient for the diagnosis of active
 or cured COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Escribano,&nbsp; P,&nbsp; Álvarez-Uría, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Sci Rep</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Diagnostics / Pathogen detection| Diagnostics / Détection d'agents pathogènes<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Authors assessed the performance of Abbott's SARS-CoV-2 IgG assay and the PanbioTM COVID-19 IgG/IgM rapid test device
 for the diagnosis of either active or cured COVID-19. They show that IgG detection alone is insufficient for the diagnosis of active or cured COVID-19.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/17/2020.10.28.20219816.abstract" target="_parent">A Multi-Factor Risk Model for Severe Covid-19, Vaccine
 Prioritization and Monitoring Based on a 16 Million Medicare Cohort</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Experton,&nbsp; Bettina,&nbsp; Tetteh, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Authors present an integrated multi-factor risk model for severe Covid-19 combining demographic and clinical data extracted
 from de-identified Medicare claims for a cohort of 16 million Medicare beneficiaries with over 900,000 Covid-19 cases, and socio-economic data at the county and zip code level from the CDC Social Vulnerability Index.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/07391102.2020.1847197" target="_parent">Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease:
 a computational-aided approach</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Fadaka,&nbsp; AO,&nbsp; Aruleba, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Biomol Struct Dyn</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study investigated the inhibitory effects of Pradimicin A, Lamivudine, Plerixafor and Lopinavir against SARS-CoV-2
 M(pro). Molecular dynamics confirmed that the ligands maintained their interaction with the protein with lower RMSD fluctuations over the trajectory period of 100 nsecs and that GLU166 residue is pivotal for binding.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.amsu.2020.11.027" target="_parent">PMC7654232; Comparison of efficacy of dexamethasone and methylprednisolone in moderate
 to severe covid 19 disease</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Fatima,&nbsp; SA,&nbsp; Asif, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ann Med Surg (Lond)</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Therapeutics| Thérapeutique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The objective of this study was to compare the efficacy and safety of dexamethasone and methylprednisolone in moderate
 to severe covid 19 disease. Dexamethasone and methylprednisolone both are equally effective in treating moderate to severe covid 19 disease.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1002/jmv.26669" target="_parent">Clinical performances of three fully automated anti-SARS-CoV-2 immunoassays targeting the
 nucleocapsid or spike proteins</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Favresse,&nbsp; J,&nbsp; Cadrobbi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Med Virol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Diagnostics / Pathogen detection| Diagnostics / Détection d'agents pathogènes<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study assesses the clinical performances of three anti-SARS-CoV-2 assays, namely EUROIMMUN anti-SARS-CoV-2 nucleocapsid
 (IgG) ELISA, Elecsys anti-SARS-CoV-2 nucleocapsid (total antibodies) assay, and LIAISON anti-SARS-CoV-2 spike proteins S1 and S2 (IgG) assay. All three anti-SARS-CoV-2 assays had equivalent sensitivities 14 days from symptom onset to diagnose past-COVID-19
 infection.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-110312/v1" target="_parent">Incidence of COVID-19 among people living with HIV in Southern Spain</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Fernandez-Fuertes,&nbsp; Marta,&nbsp; Rodriguez-Pineda, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study was carried out in order to reveal the actual incidence of SARS-CoV-2 infection in&nbsp; people living with HIV
 (PLWH) in Southern Spain.&nbsp; The incidence of COVID-19 among PLWH in our area was low and similar to that observed in the general population.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/17/2020.11.16.20231399.abstract" target="_parent">Simple Accurate Regression-Based Forecasting of Intensive
 Care Unit Admissions due to COVID-19 in Ontario, Canada</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Fisman,&nbsp; David,&nbsp; Tuite, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie Healthcare
 Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We hypothesized that differential ICU burden might be explained by increased testing volumes, as well as the shift
 in mean case age from older to younger. We constructed a negative binomial regression model using only three covariates, at a 2-week lag: log10(weekly cases); log10(weekly deaths); and mean weekly case age. This model reproduced observed ICU admission volumes,
 and demonstrated good preliminary predictive validity. Furthermore, when admissions were used in combination with ICU length of stay, our modeled estimates demonstrated excellent convergent validity with ICU occupancy data reported by the Canadian Institute
 for Health Information.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/thoraxjnl-2020-215732" target="_parent">PMC7430184; Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays
 for use in a national COVID-19 seroprevalence survey</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Flower,&nbsp; B,&nbsp; Brown, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Thorax</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Diagnostics / Pathogen detection| Diagnostics / Détection d'agents pathogènes<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Of the infected cohort, 95% (95% CI 92.2% to 97.3%) had detectable antibodies on at least one ELISA. LFIA sensitivity
 was variable, but significantly inferior to ELISA in 8 out of 11 assessed. Of LFIAs assessed in both clinic and laboratory, finger-prick self-test sensitivity varied from 21% to 92% versus PCR-confirmed cases and from 22% to 96% versus composite ELISA positives.
 Concordance between finger-prick and serum testing was at best moderate (kappa 0.56) and, at worst, slight (kappa 0.13). All LFIAs had high specificity (97.2%-99.8%).</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1097/jom.0000000000002086" target="_parent">Association Between Proportion of Workday Treating COVID-19 and Depression, Anxiety,
 and PTSD Outcomes in U.S. Physicians</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Gainer,&nbsp; DM,&nbsp; Nahhas, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Occup Environ Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The primary objective of this cross-sectional study was to examine the association between time spent treating patients
 with COVID-19 and levels of depression, anxiety, and post-traumatic stress disorder (PTSD) in U.S. physicians. In a sample of 1,724 U.S. physicians, proportion of day treating COVID-19 was positively and significantly associated with depression, anxiety, and
 PTSD scores (p &lt; .001 for each).</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1089/vim.2020.0243" target="_parent">Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Gao,&nbsp; Y,&nbsp; Wang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Viral Immunol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In this study we aim to determine whether cytokine storm is really the chief culprit for the deterioration of COVID-19.
 The confirmed COVID-19 patients were divided into moderate group (n = 89), severe group (n = 37), and critical group (n = 41). The number of patients without comorbidities exceed one third (36.1%), and patients with 1, 2, 3, 4 kinds of comorbidities accounted
 for 23.0%, 23.0%, 13.1%, and 4.9%, respectively. IL-6, IL-10, TNF, and IFN-γ, including oxygenation index, sequential organ failure assessment score, white blood cell count, lymphocyte count, lymphocyte percentage, platelet, C-reaction protein, lactate dehydrogenase,
 creatine kinase isoenzyme, albumin, D-Dimer, and fibrinogen showed significant difference between groups.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.cej.2020.127702" target="_parent">PMC7661950; Population agglomeration is a harbinger of the spatial complexity of
 COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Geng,&nbsp; X,&nbsp; Gerges, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Chem Eng J</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Transmission Public health interventions*|
 Interventions de sant&amp;amp;eacute; publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The ramifications of targeted interventions on spatial patterns of new infections were explored using the epidemiological
 susceptible-infectious-recovered (SIR) model mapped onto the population agglomeration template. These revealed that re-opening rural areas would have a smaller impact on the spread and evolution of the disease than re-opening urban (dense) centers which would
 disturb the system for months. This study provided a novel way for interpreting the spatial spread of COVID-19, along with a practical approach (multifractals/SIR/spectral slope) that could be employed to capture the variability and intermittency at all scales
 while maintaining the spatial structure.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-105233/v1" target="_parent">Adhatoda Vasica: A Potential Ayurvedic Intervention Against COVID-19 Associated
 Impaired Immune Response and Hypoxia-Inflammation Phenotype</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Gheware,&nbsp; Atish Prabhakar,&nbsp; Dholakia, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In this study we tested the effect of whole aqueous extract Adhatoda Vasica (AV), that our group has shown to have
 anti-hypoxic and anti-inflammatory effects, on various outcomes of hypoxic response.&nbsp; These genes and pathways show opposite expression in transcriptome of BALF and PBMCs of SARS-CoV2 infected patient. Molecular docking of AV constituents presents in extract
 reveal many molecules with low binding energy (≤ -8) to multiple SARS-CoV2 and host target proteins that are relevant in viral entry and replication.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.2174/1871526520666201116095440" target="_parent">A Patient with COVID-19 Pneumonia Presenting with Plural Effusion: A Case
 Report</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ghiasvand,&nbsp; F,&nbsp; SeyedAlinaghi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Infect Disord Drug Targets</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In February 2020, coronavirus disease (COVID-19) emerged in Tehran, Iran. Herein, we reported clinical features, laboratory
 tests, unusual radiological characteristics and therapeutic course of a patient with initial mild clinical symptoms at presentation with progression to pneumonia and pleural effusion in emergency unit of a referral hospital.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-108370/v1" target="_parent">Role of ROX Index in the first assessment of COVID-19 patients in the
 Emergency Department</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Gianstefani,&nbsp; Alice,&nbsp; Farina, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques Healthcare Response |
 Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The aim of the study was to evaluate the accuracy of ROX index in predicting hospitalization and mortality in patients
 with suspected diagnosis of COVID-19 in the ED. Secondary outcomes were to assess the number of readmissions and the variations of ROX index between first and second admission.&nbsp; ROX index, together with laboratory, imaging and clinical findings, can help discriminate
 patients suspected for COVID-19 requiring hospital admission, their clinical severity and their mortality risk. Furthermore, it can be useful to better manage these patients in territorial healthcare services, especially in the hypothesis of another pandemic.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://arxiv.org/abs/2011.08717" target="_parent">COVID-19 and the stock market: evidence from Twitter</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Goel,&nbsp; Rahul,&nbsp; Ford, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">arXiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Economics | Économie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">COVID-19 has had a much larger impact on the financial markets compared to previous epidemics because the news information
 is transferred over the social networks at a speed of light. Using Twitter's API, we compiled a unique dataset with more than 26 million COVID-19 related Tweets collected from February 2nd until May 1st, 2020. We find that more frequent use of the word &quot;stock&quot;
 in daily Tweets is associated with a substantial decline in log returns of three key US indices - Dow Jones Industrial Average, S&amp;P500, and NASDAQ. The results remain virtually unchanged in multiple robustness checks.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1017/s1049023x20001466" target="_parent">Characteristics of Clinically Asymptomatic Patients with SARS-CoV-2 Infections,
 Case Series</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Goldenfeld,&nbsp; M,&nbsp; Nir-Paz, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Prehosp Disaster Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Transmission Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This article aims to describe key features and the nature of asymptomatic and pauci-symptomatic SARS-CoV-2 infected
 patients.&nbsp; This case series demonstrates that asymptomatic and pauci-symptomatic patients may play a role in infection transmission by demonstrating probable transmission among asymptomatic spouses and by demonstrating a viable virus via a cell culture. Additionally,
 asymptomatic and pauci-symptomatic patients can have lung pathology and developing IgG antibodies.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/jac/dkaa466" target="_parent">Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19
 crisis at a New York City hospital</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Gomez-Simmonds,&nbsp; A,&nbsp; Annavajhala, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Antimicrob Chemother</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We sought to rapidly investigate the clinical characteristics, population structure and mechanisms of resistance of&nbsp;
 carbapenemase-producing Enterobacterales (CPE) causing secondary infections in patients with COVID-19. Most patients (11/13) had a positive respiratory culture and 7/13 developed bacteraemia; treatment failure was common. Twenty isolates were available for
 WGS. Most K. pneumoniae (16/17) belonged to ST258 and encoded KPC (15 KPC-2; 1 KPC-3); one ST70 isolate encoded KPC-2. E. cloacae isolates belonged to ST270 and encoded NDM-1. Nanopore sequencing enabled identification of at least four distinct ST258 lineages
 in COVID-19 patients, which were validated by Illumina sequencing data.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://arxiv.org/abs/2011.08632" target="_parent">Calculation of a local COVID-19 reproduction number for the northern Rhineland-Palatinate</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Götz,&nbsp; Thomas,&nbsp; Mohrmann, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">arXiv</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Transmission</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In the present article, the calculations of the RKI on a local level are examined using the example of northern Rhineland-Palatinate
 and its districts (Germany). The calculation of the daily value of Rt between the end of February and the end of October showed a similar course of the reproductive rate compared to the nationwide figures. Expectably larger statistical fluctuations were observed
 in the summer, mainly due to lower case numbers. The values for northern Rhineland-Palatinate have been consistently above 1 since about mid-September. The calculations can also be transferred to other regions and administrative districts.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1111/1346-8138.15696" target="_parent">Pyrexia by COVID-19 in a patient treated with dabrafenib/trametinib therapy</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Hashimoto,&nbsp; H,&nbsp; Ito, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Dermatol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Here, we report a case of coronavirus disease 2019 (COVID‐19) with pyrexia and fatigue while receiving BRAFi &#43; MEKi.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/18/2020.11.15.20229971.abstract" target="_parent">Genetic Liability to Cannabis Use Disorder and COVID-19
 Hospitalization</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Hatoum,&nbsp; AlexanderS,&nbsp; Morrison, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We leveraged genome-wide association study (GWAS) summary statistics to estimate whether genetic liability to Cannabis
 Use Disorder (CUD) may plausibly influence COVID-19 hospitalization . We find that at least 1/3rd of the genetic vulnerability to COVID-19 overlaps with genomic liability to (CUD) (rg=.34, p=0.0003).</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1161/circulationaha.120.051936" target="_parent">Association of Body Mass Index and Age With Morbidity and Mortality in Patients
 Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Hendren,&nbsp; NS,&nbsp; de Lemos, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Circulation</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We analyzed data from patients hospitalized with COVID-19 at 88 US hospitals enrolled in the American Heart Association’s
 COVID-19 Cardiovascular Disease Registry with data collection through July 22, 2020 in order to assess COVID-19 outcomes&nbsp; and BMI.&nbsp; After multivariable adjustment, classes I to III obesity were associated with higher risks of in-hospital death or mechanical
 ventilation (odds ratio, 1.28 [95% CI, 1.09–1.51], 1.57 [1.29–1.91], 1.80 [1.47–2.20], respectively), and class III obesity was associated with a higher risk of in-hospital death (hazard ratio, 1.26 [95% CI, 1.00–1.58]).</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1002/jmv.26674" target="_parent">Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker
 kinetics, and safety</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Hill,&nbsp; JA,&nbsp; Menon, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Med Virol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Therapeutics| Thérapeutique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We conducted a retrospective study of patients admitted to the University of Washington Hospital system with COVID‐19
 and requiring supplemental oxygen. We used Cox proportional‐hazards models with propensity score inverse probability weighting to compare outcomes in patients who did and did not receive tocilizumab. Tocilizumab treatment was associated with reduced CRP, fibrinogen,
 and temperature, but there were no meaningful differences in time to clinical improvement (adjusted hazard ratio [aHR], 0.92; 95% CI, 0.38‐2.22) or mortality (aHR, 0.57; 95% CI, 0.21‐1.52). A numerically higher proportion of tocilizumab‐treated patients had
 subsequent infections, transaminitis, and cytopenias.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/ijerph17228397" target="_parent">Impact of COVID-19 on the Hong Kong Youth Quitline Service and Quitting Behaviors of
 Its Users</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Ho,&nbsp; LLK,&nbsp; Li, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Int J Environ Res Public Health</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Public Health response| Interventions de santé publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We aimed to describe the impact of the COVID-19 pandemic on the Youth Quitline service and quitting behaviors of its
 users in Hong Kong. We conducted a telephone survey involving 201 participants of the Youth Quitline service, and retrospectively analyzed the operation and use of Quitline since the COVID-19 outbreak in Hong Kong. Many participants (68%) did not realize that
 tobacco use potentially increased their risk for developing and spreading COVID-19; however, 43% agreed that the pandemic motivated their intention to quit, and 83% changed their smoking habits during the pandemic. These changes were mainly due to wearing
 masks (30%), closure of bars/pubs (25%), suspension of classes (14%), and being unable to socialize with friends (24%). Overall, 58% reduced their tobacco use; of these participants, 66% reported a ≥50% reduction in daily cigarette consumption.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1186/s12889-020-09674-6" target="_parent">How fear and collectivism influence public's preventive intention towards COVID-19
 infection: a study based on big data from the social media</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Huang,&nbsp; F,&nbsp; Ding, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMC Public Health</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Public Health response| Interventions de santé publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The present study examines the combined effect of fear and collectivism on the public’s preventive intention towards
 COVID-19 through the analysis of a Chinese social media&nbsp; posts. The study reveals that: (a) both fear and collectivism can positively predict people’s preventive intention and (b) there is an interaction of fear and collectivism on people’s preventive intention,
 where fear and collectivism reduce each other’s positive influence on people’s preventive intention.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-108869/v1" target="_parent">Influenza Vaccination and the Risk of COVID-19 Infection and Severe Illness
 in Older Adults in the United States</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Huang,&nbsp; Kelly,&nbsp; Lin, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Public health interventions*| Interventions de sant&amp;amp;eacute;
 publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This is a retrospective cross-sectional study with investigates the impact of influenza vaccination and the risk of
 COVID-19 infection. We use data from Symphony Health database from July 1, 2019, to June 30, 2020. Participants were adults aged 65 years old or older who had received the influenza vaccine between September 1 and December 31 of 2019.&nbsp; The adjusted odds ratio
 (aOR) of COVID-19 infection risk between the influenza-vaccination group and no-influenza-vaccination group was 0.76 (95% confidence interval (CI), 0.75–0.77). Among COVID-19 patients, the aOR of developing severe COVID-19 illness was 0.72 (95% CI, 0.68–0.76)
 between the influenza-vaccination group and the no-influenza-vaccination group. When the influenza-vaccination group and the other-vaccination group were compared, the aOR of COVID-19 infection was 0.95 (95% CI, 0.93–0.97), and the aOR of developing a severe
 COVID-19 illness was 0.95 (95% CI, 0.80–1.13). In conclusion, the influenza vaccine may marginally protect people from COVID-19 infection.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/00015385.2020.1847459" target="_parent">Remote monitoring of cardiac implantable devices during COVID-19 outbreak: &quot;keep
 people safe&quot; and &quot;focus only on health care needs&quot;</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Iacopino,&nbsp; S,&nbsp; Placentino, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Acta Cardiol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We report the experience of a national tertiary electrophysiology centre in the management of patients with cardiac
 implantable electronic devices (CIEDs) through the use of a fully remote follow-up model. During the study period (25 days), we received 2,215 transmissions from 2,955 devices. Among them, 129 patients reported potential clinically actionable remote monitoring
 (RM) observations (event rate: 12.0/1000 patient-week). In 77 patients (60%), RM events triggered a clinical action, but only 5 patients needed an urgent in-hospital access (4 urgent procedures and 1 device reprogramming).</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/10410236.2020.1847450" target="_parent">Toward More Effective Public Health Interventions during the COVID-19 Pandemic:
 Suggesting Audience Segmentation Based on Social and Media Resources</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Ihm,&nbsp; J,&nbsp; Lee, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Health Commun</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We investigate the role of social and media resources in complementing limited offline communication and supporting
 mental and physical health during this pandemic. We then suggest an alternative audience segmentation strategy based on social and media resources for public health interventions. Based on online survey data from 723 adults in South Korea, the regression analysis
 results indicated that individuals with lower levels of social resources suffered more during the pandemic. The cluster analysis results revealed that, contrary to the traditional definition of vulnerable populations, a cluster of younger people were unhealthier
 than a cluster of older people because of a lack of social resources. Clusters with different levels of information communication technology skills (ICT) skills and uses for health-related activities also experienced the pandemic differently.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/18/2020.11.15.20231621.abstract" target="_parent">Accuracy of deep learning based computed tomography
 diagnostic system of COVID-19: a consecutive sampling external validation cohort study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Ikenoue,&nbsp; Tatsuyoshi,&nbsp; Kataoka, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Diagnostics / Pathogen detection| Diagnostics / Détection
 d'agents pathogènes<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In this retrospective cohort study, COVID-19 infection probabilities were calculated using Ali-M3 (an artificial intelligence
 that analyses chest computed tomography (CT)) was used in 617 symptomatic patients who underwent reverse transcription-polymerase chain reaction (RT-PCR) tests and chest CT for COVID-19 diagnosis in order to evaluate the external validity&nbsp; of Ali-M3. The area
 under the curve (AUC) of Ali-M3 for predicting a COVID-19 diagnosis was 0.797 (95% confidence intervals [CI]: 0.762‒0.833) and goodness-of-fit was P = 0.156. With a cut-off of probability of COVID-19 by Ali-M3 diagnosis set at 0.5, the sensitivity and specificity
 were 80.6% and 68.3%, respectively, while a cut-off of 0.2 yielded a sensitivity and specificity of 89.2% and 43.2%, respectively.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://arxiv.org/abs/2011.08528" target="_parent">Decision and Feature Level Fusion of Deep Features Extracted from Public COVID-19 Data-sets</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Ilhan,&nbsp; Hamza Osman,&nbsp; Serbes, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">arXiv</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Diagnostics / Pathogen detection| Diagnostics / Détection
 d'agents pathogènes<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In our study, a computer-aided diagnosis system for X-ray images based on convolutional neural networks (CNNs), which
 can be used by radiologists as a supporting tool in COVID-19 detection, has been proposed. Deep feature sets extracted by using CNNs were concatenated for feature level fusion and fed to multiple classifiers in terms of decision level fusion idea with the
 aim of discriminating COVID-19, pneumonia and no-finding classes. The experimental results show that the proposed approach has attained high COVID-19 detection performance that was proven by its comparable accuracy and superior precision/recall values with
 the existing studies.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/17/2020.11.16.20232181.abstract" target="_parent">The impact of the coronavirus disease 2019 (COVID-19)
 outbreak on hospital admissions for alcohol-related liver disease and pancreatitis: a time-series analysis</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Itoshima,&nbsp; Hisashi,&nbsp; Shin, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Public Health response| Interventions de santé publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The aim of this study was to examine the population-level change in cases of alcohol-related liver disease and pancreatitis
 that required admission during the COVID-19 outbreak in Japan. Overall admissions were 3,026,389 cases, and a total of 10,242 admissions for alcohol-related liver disease or pancreatitis occurred from 257 hospitals. The rate of admissions per 1,000 admissions
 during the COVID-19 outbreak period (April 2020 to June 2020) had a 1.2 times increase compared with the pre-outbreak period (July 2018 to March 2020) for cases of alcohol-related liver disease or pancreatitis (RR: 1.22, 95%Confidence interval [CI]: 1.12 to
 1.33).</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1017/dmp.2020.445" target="_parent">Adherence of the General Public to Self-protection Guidelines During the COVID-19 Pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Jabbari,&nbsp; P,&nbsp; Taraghikhah, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Disaster Med Public Health Prep</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Public Health response| Interventions de santé publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In this cross-sectional study, we investigated adherence of the general public to use of PPE and their knowledge regarding
 the rationale behind their use in Tehran. Approximately, half of the 431 participants did not take any measures to ensure hand hygiene, while those who did not use respiratory protection were far fewer. A considerable number of individuals, however, did not
 use these PPE correctly. On the other hand, there was a gap in the knowledge of the general public regarding different aspects of protective measures. The majority of the participants were receptive towards education on preventive measurements through public
 media.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1097/inf.0000000000003001" target="_parent">PURPURONA: A NOVEL REPORT OF COVID-19-RELATED HENOCH-SCHONLEIN PURPURA IN A CHILD</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Jacobi,&nbsp; M,&nbsp; Lancrei, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Pediatr Infect Dis J</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We describe a novel case of a 3-year-old male with a clinical diagnosis of Henoch–Schonlein Purpura vasculitis with
 concurrent SARS-CoV-2 infection. This case highlights a potentially newly described presentation of coronavirus disease 2019 infection.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1017/ice.2020.1326" target="_parent">Sensitivity of mid-turbinate versus nasopharyngeal swabs for the detection of severe
 acute respiratory syndrome coronavirus 2 (SARS-CoV-2)</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Jamal,&nbsp; AJ,&nbsp; Mozafarihashjin, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Infect Control Hosp Epidemiol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Diagnostics / Pathogen detection| Diagnostics / Détection d'agents pathogènes<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">To compare sensitivity of specimens for COVID-19 diagnosis, we tested 151 nasopharyngeal/mid-turbinate swab pairs from
 117 COVID-19 inpatients using RT-PCR. Sensitivity was 94% for nasopharyngeal and 75% for mid-turbinate swabs (p=0.0001). In 88 nasopharyngeal/mid-turbinate pairs with matched saliva, sensitivity was 86% for nasopharyngeal swabs and 88% for combined mid-turbinate
 swabs/saliva.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.nmni.2020.100814" target="_parent">PMC7661912; Use of convalescent plasma therapy in Eight mild COVID-19 patients</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Ji,&nbsp; F,&nbsp; Liu, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">New Microbes New Infect</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Therapeutics| Thérapeutique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study recruited 8 mild COVID-19 patients received at least one dose of CP transfusion. After CP therapy, all patients
 improved the clinical symptoms. The level of lymphocyte counts tended to increase, meanwhile LDH, CK and AST tended to decrease. However, CRP of 3 patients increased transiently. The median time that SARS-CoV-2 nucleic acid of the patients turned to negative
 was 2.5d after CP transfusion. The study shows the potential benefits of CP. Meanwhile, CP probably enhances the inflammatory response to SARS-CoV-2 temporarily in the patients with insufficient antiviral immunity. However, the effects of CP are not permanent.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-55111/v3" target="_parent">Prognostic value of bedside lung ultrasound score in patients with COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Ji,&nbsp; Li,&nbsp; Cao, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Diagnostics / Pathogen detection| Diagnostics / Détection
 d'agents pathogènes<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We aimed to investigate the prognostic value of the LUS score in patients with COVID-19.&nbsp; Patients in the highest LUS
 score group were more likely to have a lower lymphocyte percentage (LYM%); higher levels of D-dimer, C-reactive protein, hypersensitive troponin I and creatine kinase muscle-brain; more invasive mechanical ventilation therapy; higher incidence of ARDS; and
 higher mortality than patients in the lowest LUS score group. Patients with adverse outcomes presented a higher rate of bilateral involvement; more involved zones and B-lines, pleural line abnormalities and consolidation; and a higher LUS score than event-free
 survivors. An LUS score cut-off &gt;12 predicted adverse outcomes with a specificity and sensitivity of 90.5% and 91.9%, respectively. The LUS score devised by our group performs well at predicting adverse outcomes in patients with COVID-19 and is important for
 risk stratification in COVID-19 patients.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1038/s41392-020-00392-4" target="_parent">Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance
 protein processing, membrane fusion, and viral infectivity</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Jiang,&nbsp; X,&nbsp; Zhang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Signal Transduct Target Ther</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">it is proposed that the SARS-CoV-2 variant of G614 genotype is highly transmissible, which is probably attributed to
 an increased S2 production associated with bi-modularly altered S-trimer stability, leading to enhanced membrane fusion and host entry.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s10072-020-04866-9" target="_parent">Characteristics, onset, and evolution of neurological symptoms in patients with
 COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Kacem,&nbsp; I,&nbsp; Gharbi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Neurol Sci</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In this paper, we describe the neurological symptoms associated with COVID-19, their main characteristics, and their
 evolution in the Tunisian population followed by discussion of their underlying pathophysiological mechanisms. Neurological symptoms were isolated 22.7% (n = 106). Headache was the most frequent neurological symptom (n = 279, 41.1%): mainly frontotemporal
 (n = 143, 51.1%) and mild or moderate (n = 165, 59.1%). When associated with fever (n = 143, 51.3%), headache was more likely to be severe and present at onset. Recovery was reported in 83.2%. Smell and taste impairment were found in 37.9% (n = 245) and 36.8%
 (n = 238) respectively. Among them, 65.3% (156/239) were anosmic and 63.2% (146/231) were ageusic. A complete improvement was found in 72.1% (174/240) of smell impairment and in 76.8% (179/233) of taste impairment. Myalgia (n = 241, 37.3%) and sleep disturbances
 (n = 241, 37.3%) were also frequent. Imported cases had more neurological symptoms (p = 0.001). In 14.5%, neurological symptoms preceded the respiratory signs (RS). RS were associated with more frequent (p = 0.006) and numerous (p &lt; 0.001) neurological symptoms.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.tranon.2020.100943" target="_parent">PMC7657028; Lymphocyte subsets in haematological patients with COVID-19: Multicentre
 prospective study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kalicińska,&nbsp; E,&nbsp; Szymczak, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Transl Oncol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Immunology | Immunologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Here, we performed a comprehensive analysis of peripheral blood lymphocyte subsets in 27 SARS-CoV-2-infected patients,
 including 16 patients with haematological malignancies. We identified T cell subpopulations, B cells, NK cells and TCR α/ß and ɣ/ƍ-expressing T cells during COVID-19 infection, with significant changes observed in immune profiles during the course of disease,
 especially in haematological patients. We observed an increase in activated T lymphocytes (CD3&#43;HLA-DR&#43; and CD3&#43;CD8&#43;HLA-DR&#43;) in the early stages of SARS-CoV-2 infection with a concomitant decrease in the CD4/CD8 ratio in haematological patients compared to
 non-haematological patients affected by COVID-19. We also found a decrease in ɣ/ƍ T cells in both studied groups of patients, with lower numbers of CD25&#43; T cells and CD16&#43;CD56&#43; NK cells in haematological patients compared to non-haematological patients with
 COVID-19. Our findings demonstrate, for the first time, impaired adaptive immunity in patients with haematological malignancies infected with COVID-19, resulting in impaired cellular immune responses to SARS-CoV-2.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1038/s41598-020-76673-3" target="_parent">The κ-statistics approach to epidemiology</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kaniadakis,&nbsp; G,&nbsp; Baldi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Sci Rep</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In this paper, we use κ-statistics to formulate a statistical approach for epidemiological analysis. We validate the
 theoretical results by fitting the derived κ-Weibull distributions with data from the plague pandemic of 1417 in Florence as well as data from the COVID-19 pandemic in China over the entire cycle that concludes in April 16, 2020. As further validation of the
 proposed approach we present a more systematic analysis of COVID-19 data from countries such as Germany, Italy, Spain and United Kingdom, obtaining very good agreement between theoretical predictions and empirical observations. For these countries we also
 study the entire first cycle of the pandemic which extends until the end of July 2020. The fact that both the data of the Florence plague and those of the Covid-19 pandemic are successfully described by the same theoretical model, even though the two events
 are caused by different diseases and they are separated by more than 600 years, is evidence that the κ-Weibull model has universal features.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/bmjopen-2020-042090" target="_parent">COVID-19 outcomes in UK centre within highest health and wealth band: a prospective
 cohort study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ken-Dror,&nbsp; G,&nbsp; Wade, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMJ Open</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This prospective study describes the characteristics and outcomes of hospitalised patients with COVID-19 from UK in
 the highest decile of health and gross regional products per capita. Despite reports of worse outcomes in deprived regions, we show similar complication and mortality rates due to COVID-19 in an affluent and high life expectancy region.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.12659/ajcr.927380" target="_parent">A Giant Right-Heart Thrombus-in-Transit in a Patient with COVID-19 Pneumonia</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Khan,&nbsp; HMW,&nbsp; Khan, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Am J Case Rep</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We present a case of COVID-19 pneumonia in a warehouse worker with a giant thrombus-in-transit involving the right
 ventricle and tricuspid valve.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/ijerph17228410" target="_parent">Diesel Particulate Matter 2.5 Induces Epithelial-to-Mesenchymal Transition and Upregulation
 of SARS-CoV-2 Receptor during Human Pluripotent Stem Cell-Derived Alveolar Organoid Development</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kim,&nbsp; JH,&nbsp; Kim, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Int J Environ Res Public Health</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">we investigated the developmental toxicity of diesel fine PM (dPM2.5) exposure during hPSC-derived alveolar epithelial
 cell (AEC) differentiation and three-dimensional (3D) multicellular alveolar organoid (AO) development. We found that dPM2.5 (50 and 100 μg/mL) treatment disturbed the AEC differentiation, accompanied by upregulation of nicotinamide adenine dinucleotide phosphate
 oxidases and inflammation. Exposure to dPM2.5 also promoted epithelial-to-mesenchymal transition during AEC and AO development via activation of extracellular signal-regulated kinase signaling, while dPM2.5 had no effect on surfactant protein C expression
 in hPSC-derived AECs. Notably, we provided evidence, for the first time, that angiotensin-converting enzyme 2, a receptor to mediate the severe acute respiratory syndrome coronavirus clade 2 (SARS-CoV-2) entry into target cells, and the cofactor transmembrane
 protease serine 2 were significantly upregulated in both hPSC-AECs and AOs treated with dPM2.5.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-105798/v1" target="_parent">Depression in Public officials during the COVID-19 Pandemic in Paraguay:
 A Web-based Study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kim,&nbsp; Ji Eon,&nbsp; Lee, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study investigated the factors influencing depressive feelings in Paraguayan public officials caused by the coronavirus
 disease (COVID-19) pandemic. The results of Model 4 indicated high levels of depressive feelings among public officials, as well as concerns about COVID-19 infection among female public officials. The study also found that public officials’ high levels of
 depressive feelings were related to the duration of COVID-19 self-quarantine periods.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://www.molcells.org/journal/view.html?doi=10.14348/molcells.2020.0177&amp;sort=&amp;scale=12&amp;key=&amp;keyword=&amp;s_v=&amp;s_n=&amp;pn=&amp;year=&amp;page=" target="_parent">Expression
 Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kim,&nbsp; WR,&nbsp; Park, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Mol Cells</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie Animal model | Modèle animal<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In our research, microRNAs (miRNAs) binding to the genome sequences of severe acute respiratory syndrome coronavirus
 (SARS-CoV), Middle East respiratory-related coronavirus (MERS-CoV), and SARS-CoV-2 were identified by bioinformatic tools. We also identified miRNAs that bind to receptor proteins, such as ACE2, ADAM17, and TMPRSS2, which are important for understanding the
 infection mechanism of SARS-CoV-2. The expression patterns of those miRNAs were examined in hamster lung samples infected by SARS-CoV-2.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/ijerph17228436" target="_parent">Relationship between Phobic Anxiety in Work and Leisure Activity Situations, and Optimistic
 Bias Associated with COVID-19 among South Koreans</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kim,&nbsp; YJ,&nbsp; Kim, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Int J Environ Res Public Health</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">the present study investigated the differences in phobic anxiety between work and leisure activities according to optimistic
 bias among 533 South Korean citizens. The results showed that for leisure activities, women showed a higher perception of phobic anxiety. In addition, the group showing high optimistic bias had a higher perception of phobic anxiety in both work and leisure
 activity situations.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.24875/ric.20000451" target="_parent">Validation of Chest Computed Tomography Artificial Intelligence to Determine the Requirement
 for Mechanical Ventilation and Risk of Mortality in Hospitalized Coronavirus Disease-19 Patients in a Tertiary Care Center In Mexico City</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kimura-Sandoval,&nbsp; Y,&nbsp; Arévalo-Molina, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Rev Invest Clin</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The objectives pf the study were to analyze the performance of a chest computed tomography (CT) AI quantitative algorithm
 for determining the risk of mortality/mechanical ventilation (MV) in hospitalized COVID-19 patients and explore a prognostic multivariate model in a tertiary-care center in Mexico City. The AI-calculated CT severity score and total opacity percentage showed
 good diagnostic accuracy for mortality and met MV criteria. The proposed prognostic models using biochemical variables and imaging data measured by AI on chest CT showed good risk classification in our population of hospitalized COVID-19 patients.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1371/journal.pone.0241264" target="_parent">Clinical, regional, and genetic characteristics of Covid-19 patients from UK
 Biobank</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kolin,&nbsp; DA,&nbsp; Kulm, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">PLoS One</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In this study, we analyzed the effects of clinical, regional, and genetic factors on Covid-19 positive status. This
 prospective cohort study included 397,064 UK Biobank participants, of whom 968 tested positive for Covid-19. When assessing the association of Black race with Covid-19, adjusting for deprivation reduced the relative risk of Covid-19 by 33%. In the context
 of sociological research, these findings suggest that discrimination in the labor market may play a role in the high relative risk of Covid-19 for Black individuals. In this study, we also confirmed the association of blood type A with Covid-19, among other
 clinical and regional factors.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1088/1478-3975/abcb66" target="_parent">Potential SARS-CoV-2 protease Mpro inhibitors: Repurposing FDA-approved drugs</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kouznetsova,&nbsp; VL,&nbsp; Huang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Phys Biol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Using as a template the crystal structure of COVID-19 main protease, we developed a pharmacophore model of functional
 centers of the protease inhibitor-binding pocket. With this model, we conducted data mining of the conformational database of FDA-approved drugs. This search brought 64 compounds that can be potential inhibitors of COVID-19 protease.&nbsp; Three of the selected
 compounds were carfilzomib, cyclosporine A, and azithromycin—the drugs that already are tested for COVID-19 treatment. Among the selected compounds are two HIV protease inhibitors and two hepatitis C protease inhibitors.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1055/a-1199-7613" target="_parent">COVID-19: Characteristics, ventilation and courses of patients in the Lombardy region</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Krome,&nbsp; S</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Pneumologie</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This retrospective observational study of COVID-19 ICU patients in the Lombardy region of Italy revealed particular
 risks and treatment problems for people with COVID-19 in intensive care units. Most of the patients were older men, many of whom had to be invasively ventilated with a high PEEP. A total of every 4th sick person died. The median age of the critically ill did
 not differ from the mean age of all Italian infected people. This underpins that age alone is not a risk factor.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://biorxiv.org/content/early/2020/11/17/2020.11.15.383661.abstract" target="_parent">Multiscale PHATE Exploration of SARS-CoV-2 Data Reveals
 Multimodal Signatures of Disease</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Kuchroo,&nbsp; Manik,&nbsp; Huang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">bioRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Immunology | Immunologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">To uncover biological meaning from complex COVID-19 high dimensional datasets, we present an approach called Multiscale
 PHATE, which learns abstracted biological features from data that can be directly predictive of disease. We apply Multiscale PHATE to study the immune response to COVID-19 in 54 million cells from 168 hospitalized patients. Through our analysis of patient
 samples, we identify CD16hiCD66lo neutrophil and IFNγ&#43;GranzymeB&#43; Th17 cell responses enriched in patients who die.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/14767058.2020.1847072" target="_parent">Changes in the obstetrical emergency department profile during the COVID-19
 pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kugelman,&nbsp; N,&nbsp; Lavie, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Matern Fetal Neonatal Med</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We evaluate the effect of the COVID-19 pandemic on admission rates to the delivery room and the feto-maternal unit,
 and to assess the effect on the nature of presenting obstetrical complaints to the emergency department. The pandemic outbreak of COVID-19 caused a behavioral change among women who presented to the obstetrical emergency department. This was characterized
 by delayed arrival to the obstetrical emergency department and the delivery room, which led to a significant increase in urgent and acute interventions.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/cid/ciaa1737" target="_parent">Secondary attack rate and family clustering of SARS-CoV-2 infection in children of healthcare
 workers with confirmed COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Ladhani,&nbsp; SN,&nbsp; Andrews, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Clin Infect Dis</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Transmission</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We measured serum SARS-CoV-2 antibodies in 215 children of healthcare workers to estimate secondary attack rates (SAR).
 Twenty-one families had a parent with confirmed COVID-19. There was strong evidence of family clustering (P&lt;0.001): 20/21 (95.2%) children were seropositive in 9 families and none of 23 children in 12 other families.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/bmjopen-2020-043828" target="_parent">Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year
 mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Lai,&nbsp; AG,&nbsp; Pasea, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMJ Open</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We estimate the impact of the COVID-19 pandemic on cancer care services and overall (direct and indirect) excess deaths
 in people with cancer. Dramatic reductions were detected in the demand for, and supply of, cancer services which have not fully recovered with lockdown easing. These may contribute, over a 1-year time horizon, to substantial excess mortality among people with
 cancer and multimorbidity.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-107709/v1" target="_parent">Taylor collocation method for a system of nonlinear Volterra delay integro-differential
 equations with application to COVID-19 epidemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Laib,&nbsp; Hafida,&nbsp; Bellour, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The main purpose of this work is to provide a current numerical method based on the use of continuous collocation Taylor
 polynomials for the numerical solution of nonlinear VDIDEs systems. We apply two models to the COVID-19 epidemic in China and one for the Predator-Prey model in mathematical ecology.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1186/s12889-020-09799-8" target="_parent">Modeling the impact of school reopening on SARS-CoV-2 transmission using contact
 structure data from Shanghai</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Lee,&nbsp; B,&nbsp; Hanley, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMC Public Health</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie Public health
 interventions*| Interventions de sant&amp;amp;eacute; publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We adapted a previously published model using contact information from Shanghai to model school reopening under various
 conditions. We investigated different strategies by combining the contact patterns observed between different age groups during both baseline and “lockdown” periods. We find that reopening schools for all children would maintain a post-intervention R0 &lt; 1
 up to a baseline R0 of approximately 3.3 provided that daily contacts among children 10–19 years are reduced to 33% of baseline.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://arxiv.org/abs/2011.08741" target="_parent">A New Compartmental Epidemiological Model for COVID-19 with a Case Study of Portugal</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Lemos-Paiao,&nbsp; Ana,&nbsp; Silva, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">arXiv</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We propose a compartmental mathematical model for the spread of the COVID-19 disease, showing its usefulness with respect
 to the pandemic in Portugal, from the first recorded case in the country till the end of the three states of emergency. the proposed model allows to describe quite well the spread of COVID-19 in Portugal, fitting simultaneously not only the number of active
 infected individuals but also the number of hospitalized individuals, respectively with a L2 error of 9.2152e−04 and 1.6136e−04 with respect to the initial population.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.2196/21604" target="_parent">Prediction of COVID-19 Severity Using Chest Computed Tomography and Laboratory Measurements:
 Evaluation Using a Machine Learning Approach</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Li,&nbsp; D,&nbsp; Zhang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">JMIR Med Inform</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study aimed to develop an effective prediction model for COVID-19 severity by combining radiological outcome with
 clinical biochemical indexes. A total of 46 patients with COVID-19 (10 severe, 36 nonsevere) were examined. To build the prediction model, a set of 27 severe and 151 nonsevere clinical laboratory records and computerized tomography (CT) records were collected
 from these patients.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://biorxiv.org/content/early/2020/11/17/2020.11.16.385849.abstract" target="_parent">The Rhinolophus affinis bat ACE2 and multiple animal
 orthologs are functional receptors for bat coronavirus RaTG13 and SARS-CoV-2</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Li,&nbsp; Pei,&nbsp; Guo, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">bioRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie zoonoses</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Found that the RaTG13 spike (S) protein is significantly less fusogenic than SARS-CoV and SARS-CoV-2, and seven out
 of sixteen different ACE2s function as entry receptors for all three viruses, indicating that the viruses (RaTG13 and SARS-CoV-2) might have broad host rages. Mutagenesis analysis revealed that residues 484 and 498 in RaTG13 and SARS-CoV-2 S proteins play
 critical roles in recognition of mouse and human ACE2.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/13548506.2020.1849747" target="_parent">Psychological characteristics of parents in a Paediatric Outpatient during the
 SARS-CoV-2 Epidemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Li,&nbsp; X,&nbsp; Wu, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Psychol Health Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Analyzed and summarized the psychological status of&nbsp; parents (n=18 000)&nbsp; who visited a paediatric clinic in China during
 the COVID-19 pandemic. The analysis found that among parents, women show more anxiety than men during treatment, and that they are more inclined to express fear and anxiety. Compared with young people, elderly people over 50 years of age are more nervous and
 have more difficulty communicating.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-106038/v1" target="_parent">Changes in Emergency Department Responses Between SARS and COVID-19 in
 Taiwan</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Lin,&nbsp; Chia Wei,&nbsp; Lin, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Compared emergency department (ED) responses to the SARS and COVID-19 epidemics in Taiwan and investigate how policy
 changes affect infection prevention.&nbsp; The study concludes after the policy reforms from SARS, ED responses became earlier and more consistent.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-105739/v1" target="_parent">Development of Multivalent Nanobodies Blocking SARS CoV 2 Infection by
 Targeting RBD of Spike Protein</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Lu,&nbsp; Qizhong,&nbsp; Zhang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Multivalent nanobodies with high affinity blocking SARS CoV 2 spike interaction with ACE2 protein were developed and
 four specific nanobodies against spike protein and its RBD domain were screened from a naïve VHH library. The study concludes VHH library could be used as a potential resource for rapid acquisition and exploitation of antiviral nanobodies. Heterodimer nanobody
 Nb91 Nb3 hFc may serve as a potential therapeutic agent for the treatment of COVID 19.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/18/2020.11.15.20232132.abstract" target="_parent">Demystifying the spreading of pandemics I: The fractal
 kinetics SI model quantifies the dynamics of COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Macheras,&nbsp; Panos,&nbsp; Kosmidis, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The models used so far for the epidemic spreading, based on the “well mixed” hypothesis, are oversimplifications of
 the reality. This explains the low predictive power of these models (1). The hypothesis free fractal kinetics SI model captures the dynamics of the pathogens’ transmission from the infected to susceptible subjects since the imperfect mixing of the individuals
 and the self-organization of the societies against the pandemic through social distancing, e.g. masks, lockdowns, flight restrictions etc lie at the heart of fractal kinetics</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://biorxiv.org/content/early/2020/11/17/2020.11.17.387068.abstract" target="_parent">Assessment of protein-protein interfaces in cryo-EM
 derived assemblies</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Malhotra,&nbsp; Sony,&nbsp; Joseph, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">bioRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Developed a protein interaction score, a density-independent machine learning-based metric, trained using protein-protein
 interfaces’ features in high-resolution crystal structures to study protein protein interactions. Using PI-score, the authors identify errors at interfaces in the PDB-deposited cryo-EM structures (including SARS-CoV-2 complexes) and in the models submitted
 for cryo-EM targets in CASP13 and the EM model challenge.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s10995-020-03034-x" target="_parent">COVID-19 Quarantine-Related Mental Health Symptoms and their Correlates among Mothers:
 A Cross Sectional Study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Malkawi,&nbsp; SH,&nbsp; Almhdawi, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Matern Child Health J</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Investigated reported mental health and changes in lifestyle practices among Jordanian mothers during COVID-19 quarantine.&nbsp;
 The study found mothers with lower income, lower education, not employed, or living in cities outside the capital of Jordan reported having more depression, anxiety, and stress symptoms (p &lt; .005). Changes in their lifestyle practices included weight gain,
 increased time allocated for teaching children at home, increased familial violence at home, and increased time allocated for caring for their family members (average increase of 5 hours daily).</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.crad.2020.09.019" target="_parent">PMC7543918; Re: extent of pulmonary thromboembolic disease in patients with COVID-19
 on CT: relationship with pulmonary parenchymal disease</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Marsland,&nbsp; L,&nbsp; Fang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Clin Radiol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Report the incidence of PTE in hospitalised patients with severe COVID-19 who have persistent respiratory illness well
 after their initial presentation, follow-up study. Study observations suggest that anticoagulation therapy is an effective treatment in COVID-19 patient with PTE.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://academic.oup.com/jpubhealth/advance-article/doi/10.1093/pubmed/fdaa199/5983393" target="_parent">Demographic and occupational determinants
 of anti-SARS-CoV-2 IgG seropositivity in hospital staff</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Martin,&nbsp; CA,&nbsp; Patel, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Public Health (Oxf)</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Healthcare Response | Réponse des soins de santé Immunology
 | Immunologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Conducted a cross-sectional surveillance examining seroprevalence of anti-SARS-CoV-2 IgG amongst staff at a UK hospital.
 10.8% hospital staff members were seropositive. Compared to White staff (seroprevalence 9.1%), seroprevalence was higher in South Asian (12.3%) and Black (21.2%) staff. The occupations and department with the highest seroprevalence were nurses/healthcare assistants
 (13.7%) and the Emergency Department (ED)/Acute Medicine (17.5%), respectively. Seroprevalence decreased with seniority in medical/nursing practitioners.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/17/2020.11.16.20230003.abstract" target="_parent">Nasopharyngeal Panbio COVID-19 antigen performed
 at point-of-care has a high sensitivity in symptomatic and asymptomatic patients with higher risk for transmission and older age</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Masia,&nbsp; Mar,&nbsp; Fernandez-Gonzalez, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Diagnostics / Pathogen detection| Diagnostics / Détection d'agents pathogènes<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Evaluate the performance of the nasopharyngeal Panbio COVID-19 antigen Rapid Test Device in real-life conditions in
 different clinical scenarios. The study concludes the nasopharyngeal Panbio COVID-19 antigen test performed at point-of-care is highly sensitive in symptomatic patients, particularly with Ct&lt;30 and older age. The test was useful to identify asymptomatic patients
 with lower Ct values and therefore with contagious risk.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s11239-020-02340-z" target="_parent">Clinical features of patients with acute coronary syndrome during the COVID-19
 pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Matsushita,&nbsp; K,&nbsp; Hess, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Thromb Thrombolysis</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Investigate the incidence, clinical presentation, and outcomes of patients with ACS during the COVID-19 pandemic. The
 study reports The COVID-19 outbreak was associated with a 40% decrease in AMI. The delay of STEMI care was minimal in our center, suggesting that the healthcare system effectiveness was maintained despite the pandemic. ACS patients tested positive for COVID-19
 was clearly characterized by elevated D-dimer levels on admission, reflecting enhanced COVID-19 related thrombogenicity.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s11845-020-02438-6" target="_parent">A prospective study on the incidence of postponed time-sensitive urological procedures
 during the SARS-CoV-2 pandemic due to patient preference</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">McDermott,&nbsp; A,&nbsp; O'Kelly, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ir J Med Sci</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Investigate the incidence of postponed, medically necessary, time-sensitive urological procedures due to a patient’s
 unwillingness to proceed to a recommended surgical intervention during the first phase of the SARS-CoV-2 pandemic in Ireland. The incidence for patients postponing urological procedures due to the risk of acquiring nosocomial SARS-CoV-2 is 10%. Endourological
 procedures for urolithiasis are the most frequently postponed procedures by patients. This study demonstrates that a subset of patients will decline urgent urological surgery during the SARS-CoV-2 pandemic.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s00431-020-03876-1" target="_parent">Compassionate use of remdesivir in children with COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Méndez-Echevarría,&nbsp; A,&nbsp; Pérez-Martínez, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Eur J Pediatr</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">A nationwide multicenter observational study was conducted on children with confirmed SARS-CoV-2 receiving compassionate
 treatment with Remdesivir RDV in Spain.&nbsp; In the cohort, most of the patients achieved successful clinical outcome, without observing adverse events, as such the authors call for clinical trials of RDV therapy for children with COVID-19.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/ageing/afaa260" target="_parent">Effect of the COVID-19 Lockdown on Disease Recognition and Utilization of Healthcare
 Services in the Older Population in German: A Cross-sectional Study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Michalowsky,&nbsp; B,&nbsp; Hoffmann, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Age Ageing</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We aimed to describe the utilization of physician consultations, specialist referrals, hospital admissions, and the
 recognition of incident diseases in Germany for the older population during the COVID-19 lockdown. Physician consultations decreased in April and May 2020 compared to the same periods in 2019. Volumes of hospital admissions decrease earlier and more intensely
 than physician consultations. Diabetes, dementia, depression, cancer, and stroke were diagnosed less frequently during the lockdown, meaning that the decrease in the recognition of diseases was greater than the decrease in physician consultations.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1038/s41467-020-19587-y" target="_parent">Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2
 compared with other respiratory viruses</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Mick,&nbsp; E,&nbsp; Kamm, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Nat Commun</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Diagnostics / Pathogen detection| Diagnostics / Détection
 d'agents pathogènes Immunology | Immunologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Here, we examine the upper airway host transcriptional response in patients with COVID-19 with other acute respiratory
 illnesses (ARIs). Compared with other viral ARIs, COVID-19 is characterized by a pronounced interferon response but attenuated activation of other innate immune pathways, including toll-like receptor, interleukin and chemokine signaling.&nbsp; We further use machine
 learning to build 27-, 10- and 3-gene classifiers that differentiate COVID-19 from other ARIs with AUROCs of 0.981, 0.954 and 0.885, respectively.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1145/3340531.3412179" target="_parent">A Methodology Based on Deep Q-Learning/Genetic Algorithms for Optimizing COVID-19
 Pandemic Government Actions</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Miralles-Pechuán,&nbsp; L,&nbsp; Jiménez, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">&nbsp;</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie Public health
 interventions*| Interventions de sant&amp;amp;eacute; publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We implement the SEIR epidemiological model to represent the evolution of the COVID-19 virus on the population. To
 optimize the best sequences of actions governments can take, we propose a methodology with two approaches, one based on Deep Q-Learning and another one based on Genetic Algorithms. The sequences of actions (confinement, self-isolation, two-meter distance or
 not taking restrictions) are evaluated according to a reward system focused on meeting two objectives: firstly, getting few people infected so that hospitals are not overwhelmed, and secondly, avoiding taking drastic measures which could cause serious damage
 to the economy.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1017/s1047951120004400" target="_parent">Lessons learnt from COVID-19 in Adult Congenital Heart Patient in Tehran: A survey-based
 study of prevention, exposure, susceptibility, and outcomes</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Mohammadzadeh,&nbsp; S,&nbsp; Mehrakizadeh, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Cardiol Young</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques Public Health response|
 Interventions de santé publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The aim of the study is to report the Tehran experience with respect to preventative self-care measures, disease exposure,
 susceptibility and outcomes after COVID-19 infection in adults with congenital heart disease (ACHD) patients. 309 ACHD patients were assessed. 67.3% of patients practiced high level preventative self-care measures. After community exposure, 33.3% developed
 COVID-19, and after household exposure 43.7% developed COVID-19. There was only 1 mortality in a post-operative patient. Age&nbsp; and contact with confirmed COVID-19 cases were independently associated with COVID-19 infection.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/15/2020.10.28.20221697.abstract" target="_parent">U-shaped-aggressiveness of SARS-CoV-2: Period between
 initial symptoms and clinical progression to COVID-19 suspicion. A population-based cohort study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Morgenstern-Kaplan,&nbsp; Dan,&nbsp; Buitano-Tang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The objective of this cohort study was to determine the aggressiveness of SARS-CoV-2 using symptom progression in COVID-19
 patients. We measured the period between initial symptoms and clinical progression to COVID-19 suspicion (PISYCS) and compared it to the primary outcomes (mortality and pneumonia) in Mexican patients. 65,500 patients were included. Reported fatalities and
 pneumonia were 3.32%, and 17.66%, respectively. According to the PISYCS, patients were distributed as follows: 14.89% in &lt;24 hours, 43.25% between 1-3 days, 31.87% between 4-7 days and 9.97% &gt;7 days. The distribution for mortality and pneumonia was 5.2% and
 22.5% in &lt;24 hours, 2.5% and 14% between 1-3 days, 3.6% and 19.5% between 4-7 days, 4.1% and 20.6% &gt;7 days, respectively (p&lt;0.001).</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.xcrm.2020.100144" target="_parent">PMC7598305; Inflammatory Biomarker Trends Predict Respiratory Decline in COVID-19
 Patients</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Mueller,&nbsp; AA,&nbsp; Tamura, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Cell Rep Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In this single-center, retrospective cohort analysis of hospitalized coronavirus disease 2019 (COVID-19) patients,
 we investigate whether inflammatory biomarker levels predict respiratory decline in patients who initially present with stable disease.&nbsp; Our work shows that rising CRP predicts subsequent respiratory deterioration in COVID-19.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/17/2020.11.16.20232397.abstract" target="_parent">Effect of Vitamin D3 Supplementation vs Placebo on
 Hospital Length of Stay in Patients with Severe COVID-19: A Multicenter, Double-blind, Randomized Controlled Trial</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Murai,&nbsp; IgorH,&nbsp; Fernandes, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques Therapeutics| Thérapeutique
 RCT<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The objective of this multicenter, double blind, randomized, placebo controlled trial was to investigate the efficacy
 and safety of vitamin D3 supplementation in patients with severe COVID-19. The analysis included 232 hospitalized patients with severe COVID-19. Among hospitalized patients with severe COVID-19, vitamin D3 supplementation was safe and increased 25-hydroxyvitamin
 D levels, but did not reduce hospital length of stay or any other relevant outcomes vs placebo. This trial does not support the use of vitamin D3 supplementation as an adjuvant treatment of patients with COVID-19.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-105797/v1" target="_parent">Age-structured Impact of Mitigation Strategies on COVID-19 Severity and
 Deaths in Kenya</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Mwalili,&nbsp; Samuel,&nbsp; Kimathi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie Public health
 interventions*| Interventions de sant&amp;amp;eacute; publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We developed age-structured model for describing the COVID-19 pandemic in Kenya under different non-pharmaceutical
 interventions. The peak dates for unmitigated (UM), the 45% NPI (M45) and School closure-curfew-partial lockdown NPI (SCL) are May 21st, October 17th and December 13th 2020, respectively. Their respective cumulative infections peaks are 43M, 24M and 25M. The
 daily reported severe cases, critical cases and death proportionately increased with age.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://biorxiv.org/content/early/2020/11/17/2020.11.16.384222.abstract" target="_parent">Comparative analysis of antibody- and lipid-based multiplexing
 methods for single-cell RNA-seq</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Mylka,&nbsp; Viacheslav,&nbsp; Aerts, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">bioRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Immunology | Immunologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Here, we compare the hashing performance of TotalSeq-A and -C antibodies, custom synthesized lipids and MULTI-seq lipid
 hashes in four cell lines, both for single-cell RNA-seq and single-nucleus RNA-seq. Antibody hashing was evaluated on clinical samples using PBMCs from healthy and SARS-CoV-2 infected patients, where we demonstrate a more affordable approach for large single-cell
 sequencing clinical studies, while simultaneously reducing batch effects.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.4414/smw.2020.20398" target="_parent">Perceptions of immunity and vaccination certificates among the general population:
 a nested study within a serosurvey of anti-SARS-CoV-2 antibodies (SEROCoV-POP)</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Nehme,&nbsp; M,&nbsp; Stringhini, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Swiss Med Wkly</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Public Health response| Interventions de santé publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Our objective was to determine social and individual perceptions of COVID-19 immunity certificates through a population-based
 study.&nbsp; This study shows that the general adult population in Geneva, Switzerland can envisage scenarios where COVID-19 immunity, and eventually vaccination, certificates would be useful. Provided an effective vaccine was available, 55% of participants agreed
 that vaccination should be mandatory and 49% agreed that a vaccination certificate should be mandatory.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/17/2020.11.15.20231001.abstract" target="_parent">Central and peripheral nervous system complications
 of COVID-19: A prospective tertiary center cohort with 3-month follow-up</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Nersesjan,&nbsp; Vardan,&nbsp; Amiri, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The objective of this prospective observational study was to systematically describe central and peripheral nervous
 system (CNS and PNS) complications in hospitalized COVID-19 patients. From April-September 2020, we enrolled 61 consecutively admitted COVID-19 patients, 35 (57%) of whom were referred to ICU for respiratory failure. Evaluation revealed a higher frequency
 of CNS/PNS symptoms in ICU patients compared to non-ICU patients. The most common CNS and PNS complications were encephalopathy and critical illness polyneuromyopathy, respectively. Cerebrospinal fluid was negative for SARS-CoV-2 RNA in all 5 patients investigated.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1371/journal.pone.0242537" target="_parent">Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics
 of COVID-19 patients in Hanoi, Vietnam</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Nguyen,&nbsp; TT,&nbsp; Pham, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">PLoS One</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques Coronavirology| Coronavirologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We describe 44 SARS-CoV-2 RT-PCR positive patients admitted to a hospital in Hanoi between March 6 and April 15 2020.
 Forty-one cases had symptoms at admission, typically dry cough, fever, sore throat and diarrhoea. All SARS-CoV-2 genomes were similar to the reference sequence Wuhan_1, and 32 strains belonged to the B.1.1 lineage. The three most common variants were linked,
 and included C3037T, C14408T (nsp12: P323L) and A23403G (S: D614G) mutations. This group of mutations often accompanied variant C241T (39/44 genomes) or GGG 28881..28883 AAC (33/44 genomes). The prevalence of the former reflected probable European origin of
 viruses, and the transition D614G was dominant in Vietnam. New variants were identified; however, none could be associated with disease severity.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1186/s13052-020-00928-y" target="_parent">Health-care organization for the management and surveillance of SARS-CoV-2 infection
 in children during pandemic in Campania region, Italy</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Nunziata,&nbsp; F,&nbsp; Bruzzese, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ital J Pediatr</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques Healthcare Response |
 Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The management of children with suspected or confirmed COVID-19 needs to be appropriately targeted. We designed a hub-and-spoke
 system to provide healthcare indications based on the use of telemedicine and stringent admission criteria, coordinate local stakeholders and disseminate information. Between March 24th and September 24th 2020, the Hub Centre managed a total of 208 children,
 of which 104 (50%) received a final diagnosis of SARS-CoV-2 infection. Application of stringent criteria for hospital admission based on clinical conditions, risk factors and respect of biocontainment measures, allowed to manage the majority of cases (74,
 71.1%) through telemedicine. Thirty children (28%) were hospitalized.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/healthcare8040484" target="_parent">Professional Quality of Life and Perceived Stress in Health Professionals before
 COVID-19 in Spain: Primary and Hospital Care</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Ortega-Galán Á,&nbsp; M,&nbsp; Ruiz-Fernández, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Healthcare (Basel)</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study aimed to analyze the professional quality of life and the perceived stress of health professionals before
 COVID-19 in Spain, in primary and hospital care professionals. A cross-sectional observational study on health professionals working in health centers during the health crisis caused by COVID-19 was conducted. A total of 537 professionals participated, both
 in hospital care (54.7%) and in primary care (45.3%). When primary care participants were grouped by profession, significant differences were found in relation to perceived stress and to the three subscales of professional quality of life. In hospital care,
 the differences were observed when comparing compassion fatigue and perceived stress by gender. The COVID-19 health crisis has had an impact on mental health and the quality of professional life of health professionals.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-48863/v2" target="_parent">Detection of SARS-CoV-2 from Patient Fecal Samples by Whole Genome Sequencing</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Papoutsis,&nbsp; Andreas,&nbsp; Borody, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Here were sought to identify SARS-CoV-2 by enrichment NGS from fecal samples, and to utilize whole genome analysis
 to characterize SARS-CoV-2 mutational variations in COVID-19 patients. Study participants underwent testing for SARS-CoV-2 from fecal samples by whole genome enrichment NGS (n = 14), and RT-PCR nasopharyngeal swab analysis (n = 12). The concordance of SARS-CoV-2
 detection by enrichment NGS from stools with RT-PCR nasopharyngeal analysis was 100%. Unique variants were identified in four patients, with a total of 33 different mutations among those in which SARS-CoV-2 was detected by whole genome enrichment NGS. These
 results highlight the potential viability of SARS-CoV-2 in feces, its ongoing mutational accumulation, and its possible role in fecal-oral transmission.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/07391102.2020.1844804" target="_parent">Computational investigation of binding of chloroquinone and hydroxychloroquinone
 against PLPro of SARS-CoV-2</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Patel,&nbsp; D,&nbsp; Athar, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Biomol Struct Dyn</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study carried out molecular docking and dynamics simulation studies of FDA approved Chloroquine (CQ)and Hydroxychloroquine
 (HCQ)against SARS-CoV-2 Papain-like proteases (PLpro). The end aim is to characterise the binding mode of CQ and HCQ and identify the key amino acid residues involved in the mechanism of action. Further, molecular dynamics simulations (MDS) were carried out
 with the docked complex to search for the conformational space and for understanding the integrity of binding mode. We showed that the CQ and HCQ can bind with better binding affinity with PLpro as compared to reference known PLpro inhibitor. Based on the
 presented findings, it can be anticipated that the SARS-CoV-2 PLpro may act as molecular target of CQ and HCQ, and can be projected for further exploration to design potent inhibitors of SARS-CoV-2 PLpro in the near future.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.21203/rs.3.rs-108301/v1" target="_parent">Machine Learning Based Predictors for COVID-19 Disease Severity</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Patel,&nbsp; Dhruv,&nbsp; Kher, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Predictors of the need for intensive care and mechanical ventilation can help healthcare systems in planning for surge
 capacity for COVID-19. We used socio-demographic data, clinical data, and blood panel profile data at the time of initial presentation to develop machine learning algorithms for predicting the need for intensive care and mechanical ventilation. Among the algorithms
 considered, the Random Forest classifier performed the best with AUC = 0.80 for predicting ICU need and AUC = 0.82 for predicting the need for mechanical ventilation. We also determined the most influential features in making this prediction, and concluded
 that all three categories of data are important. Finally, we determined the relative importance of blood panel profile data and noted that the AUC dropped by 0.12 units when this data was not included, thus indicating that it provided valuable data in predicting
 disease severity.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-50546/v4" target="_parent">Suspected Heparin-Induced Thrombocytopenia in a COVID-19 Patient on Extracorporeal
 Membrane Oxygenation Support: A Case Report</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Phan,&nbsp; XuanT,&nbsp; Nguyen, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In this report, we present a case of a COVID-19 patient on Extracorporeal membrane oxygenation (ECMO) support who was
 diagnosed with Heparin-induced thrombocytopenia (HIT.)and required intensive treatment. Initially, HIT was only suspected due to newly-developed thrombocytopenia and oxygenator dysfunction, with thrombi observed later. Regarding his treatment, since there
 was no recommended replacement to heparin available to us at the time of diagnosis, we decided to use rivaroxaban temporarily. No adverse events were recorded during that period. The patient was able to make a full recovery.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1212/01.wnl.0000719968.10580.81" target="_parent">Increasing Traumatic Brain Injury Incidence during COVID-19 Pandemic in
 the Emergency Department of Cipto Mangunkusumo National General Hospital-A National Referral Hospital in Indonesia</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Prawiroharjo,&nbsp; P,&nbsp; Pangeran, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Neurology</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Retrospective study comparing&nbsp; traumatic brain injury (TBI) incidence before and during COVID-19 pandemic era starting
 from the declaration of national pandemic date (March 16, 2020) until June 14, 2020 with the comparison of the same period in the previous year. There was an increase in admission rate due to TBI during COVID-19 pandemic compared with the previous year (157/752
 (20.9%) vs 106/766 (13.8%), p &lt; 0.001, respectively). During the pandemic era, road traffic injury (97/157 (61.8%) vs 56/106 (52.8%), p = 0.149) as well as moderate-to-severe brain injury tended to increase (30/157 (19.1%) vs 17/106 (16.0%) p = 0.524) albeit
 statistically insignificant. TBI incidence remained increasing despite entering the COVID-19 era.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3399/bjgpopen20X101137" target="_parent">Clinical and serological profile of asymptomatic and non-severe symptomatic COVID-19
 cases: Lessons from primary care in Latin America</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Puschel,&nbsp; K,&nbsp; Ferreccio, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BJGP Open</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Diagnostics / Pathogen detection| Diagnostics / Détection d'agents pathogènes Immunology
 | Immunologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The aim of this study is to assess the effectiveness of rapid serologic testing in detection and surveillance of Covid-19
 cases in primary care. Longitudinal study based on non-random sample of 522 participants including 304 symptomatic patients and 218 high-risk asymptomatic individuals receiving care at four primary health clinics in an underserved area in Santiago. Participants
 were systematically assessed and tested for Covid-19 with RT-PCR and serology at baseline and followed clinically and serologically for a three weeks period. The prevalence rate of RT-PCR confirmed Covid-19 cases was 3.5 times higher in symptomatic patients
 (27.5% (22.1-32.8; 95% CI) compared to asymptomatic participants (7.9% (4.3-11.6; 95% CI). Sensitivity of serologic testing was 57.8% (44.8-70.1; 95% CI) during the third week of follow-up and specificity was 98.4% (95.5-99.7; 95% CI). Rapid serologic testing
 is ineffective for detecting asymptomatic or non-severe cases of COVID-19 at early stages of the disease but can be of value for surveillance of immunity response in primary care.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/07391102.2020.1845980" target="_parent">In silico screening and molecular dynamics of phytochemicals from Indian cuisine
 against SARS-CoV-2 M(Pro)</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Rajendran,&nbsp; M,&nbsp; Roy, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Biomol Struct Dyn</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In the present study, phytochemicals from spices were assessed for their ability to interact with SARS-CoV-2 M(Pro).
 Structure based virtual screening was performed with 146 phytochemicals from spices using Autodock Vina. Phytochemicals with binding energy ≥ -8.0 kcal/mol were selected to understand their interaction with M(Pro). Virtual screening was further validated by
 performing molecular docking to generate favorable docked poses and the participation of important amino acid residues. The finding shows that cinnamtannin B2 and cyanin showed favorable binding affinity values with SARS-CoV-2 M(Pro). The results are comparable
 in terms of docked poses, important amino acid participation and thermodynamic properties with the standard control drugs remdesivir, benazepril and hydroxychloroquine diphosphate. The results computed using Prime MM-GBSA show that cinnamtannin B2 (-68.54940214 kcal/mol)
 and cyanin (-62.1902835 kcal/mol) have better binding affinity in comparison to hydroxychloroquine diphosphate (-54.00912412 kcal/mol) and benazepril (-53.70242369 kcal/mol).</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://dx.doi.org/10.2139/ssrn.3725446" target="_parent">COVID-19 Pandemic: India is Heading Towards the First Place</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ramasamy,&nbsp; Dr Kannamani</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">SSRN- Lancet prepublication</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The objective of this research paper is to explore the current state of COVID-19 pandemic of India and the USA and
 understand how the COVID-19 spread is severe in India. The secondary aim of the research is to predict the confirmed cases and death rates for the forthcoming days for the USA and India as well and conclude India’s future state in COVID-19. For this research,
 we have used the data from 20 January 2020 to 13 October 2020 from the World Health Organization. To forecast the COVID-19 cumulative confirmed and death cases for the United States America and India, we have used FORECAST.ETS function in Microsoft Excel.
 The prediction calculated till 31 December 2020. By 31 Oct 2020, the forecasted cumulative cases would be 8569864 in the USA and India, it would be 8288117 approximately. By 27 Nov 2020, the forecasted cumulative cases would be 9930000 in the USA and India,
 it would be 9941491 approximately. By 31 Dec 2020, the forecasted cumulative cases would be 11642764 in the USA and India, it would be 12023517 approximately. So, by the last week of November, India will have more COVID-19 cases than the USA and hence India
 will take first place globally. Along with the guidelines and advisory from WHO, the government of India and the department of health is taking various initiatives to control the COVID-19 spread and maintain the lower number of COVID-19 cases. However, the
 number of confirmed and death rates are increasing in an uncontrolled manner in the Indian subcontinent.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://arxiv.org/abs/2011.08498" target="_parent">Political Partisanship and Anti-Science Attitudes in Online Discussions about Covid-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Rao,&nbsp; Ashwin,&nbsp; Morstatter, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">arXiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Public Health response| Interventions de santé publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Here, we use social media data to study complexity of polarization. We analyze a large dataset of tweets related to
 the pandemic collected between January and May of 2020, and develop methods to classify the ideological alignment of users along the moderacy (hardline vs moderate), political (liberal vs conservative) and science (anti-science vs pro-science) dimensions.
 While polarization along the science and political dimensions are correlated, politically moderate users are more likely to be aligned with the pro-science views, and politically hardline users with anti-science views. Contrary to expectations, we do not find
 that polarization grows over time; instead, we see increasing activity by moderate pro-science users. We also show that anti-science conservatives tend to tweet from the Southern US, while anti-science moderates from the Western states.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://biorxiv.org/content/early/2020/11/17/2020.11.17.385500.abstract" target="_parent">An Engineered Antibody with Broad Protective Efficacy
 in Murine Models of SARS and COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Rappazzo,&nbsp; CG,&nbsp; Tse, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">bioRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Here, we employed a directed evolution approach to engineer three SARS-CoV-2 antibodies for enhanced neutralization
 breadth and potency. One of the affinity-matured variants, ADG-2, displays strong binding activity to a large panel of sarbecovirus receptor binding domains (RBDs) and neutralizes representative epidemic sarbecoviruses with remarkable potency. Structural and
 biochemical studies demonstrate that ADG-2 employs a unique angle of approach to recognize a highly conserved epitope overlapping the receptor binding site. In murine models of SARS-CoV and SARS-CoV-2 infection, passive transfer of ADG-2 provided complete
 protection against respiratory burden, viral replication in the lungs, and lung pathology. Altogether, ADG-2 represents a promising broad-spectrum therapeutic candidate for the treatment and prevention of SARS-CoV-2 and future emerging SARS-like CoVs.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1161/jaha.120.018379" target="_parent">Impact of Coronavirus Disease 2019 Pandemic on the Incidence and Management of Out-of-Hospital
 Cardiac Arrest in Patients Presenting With Acute Myocardial Infarction in England</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Rashid Hons,&nbsp; M,&nbsp; Gale Hons, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Am Heart Assoc</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Acute myocardial infarction hospitalizations with OHCA during the COVID-19 period (February 1-May 14, 2020) from the
 Myocardial Ischaemia National Audit Project and British Cardiovascular Intervention Society data sets were analyzed. Acute myocardial infarction hospitalizations during COVID-19 period were reduced by &gt;50% (n=20 310 versus n=9325). OHCA was more prevalent
 during the COVID-19 period compared with the pre-COVID-19 period (5.6% versus 3.6%), with a 56% increase in the incidence of OHCA (IRR, 1.56; 95% CI, 1.39-1.74). The overall rates of invasive coronary angiography (58.4% versus 71.6%; P&lt;0.001) were significantly
 lower among the OHCA group during COVID-19 period with increased time to reperfusion (mean, 2.1 versus 1.1 hours; P=0.05) in those with ST-segment-elevation myocardial infarction.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://chemrxiv.org/articles/preprint/Natural_Compounds_as_Inhibitors_of_SARS-CoV-2_Main_Protease_3CLpro_A_Molecular_Docking_and_Simulation_Approach_to_Combat_COVID-19/12362333/2" target="_parent">Natural
 Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Rehman,&nbsp; MT,&nbsp; AlAjmi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Curr Pharm Des</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We have adopted a computational approach to identify lead molecules from nature. Ligands from natural compounds library
 available at Selleck Inc (L1400) have been screened for their ability to bind and inhibit the main protease (3CLpro) of SARS-CoV-2. We found that Kaempferol, Quercetin, and Rutin were bound at the substrate binding pocket of 3CLpro with high affinity (105-106
 M-1) and interact with the active site residues such as His41 and Cys145 through hydrogen bonding and hydrophobic interactions. The results suggest that natural compounds such as flavonoids have the potential to be developed as novel inhibitors of SARS-CoV-2
 with a comparable/higher potency as that of Remdesivir. Their clinical usage on COVID-19 patients is a subject of further investigations and clinical trials.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/jof6040286" target="_parent">Is the Frequency of Candidemia Increasing in COVID-19 Patients Receiving Corticosteroids?</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Riche,&nbsp; CVW,&nbsp; Cassol, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Fungi (Basel)</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Corticosteroids have potent anti-inflammatory and immunosuppressive effects. Recently, these medications have gained
 importance in the treatment of severe COVID-19. Here we present data demonstrating a marked (10-fold) increase in frequency of candidemia in hospitalized patients with COVID-19 receiving corticosteroids in Brazil. Overall mortality was 72.7%, despite antifungal
 therapy. Physicians should be aware of the potential risk for candidemia among severely ill COVID-19 patients receiving high-doses of corticosteroids.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1111/jsr.13231" target="_parent">Profiles of sleep changes during the COVID-19 pandemic: Demographic, behavioural and psychological
 factors</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Robillard,&nbsp; R,&nbsp; Dion, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Sleep Res</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study aimed to evaluate changes in sleep during the COVID-19 outbreak, and used data-driven approaches to identify
 distinct profiles of changes in sleep-related behaviours. Demographic, behavioural and psychological factors associated with sleep changes were also investigated. In 5,525 Canadian respondents (67.1% females, 16-95 years old: Mean ± SD = 55.6 ± 16.3 years),
 wake-up times were significantly delayed relative to pre-outbreak estimates (p &lt; .001, ηp2 = 0.04). Occurrences of clinically meaningful sleep difficulties significantly increased from 36.0% before the outbreak to 50.5% during the outbreak (all p &lt; .001, g
 ≥ 0.27). The emergence of new sleep difficulties was independently associated with female sex, chronic illnesses, being employed, family responsibilities, earlier wake-up times, higher stress levels, as well as heavier alcohol use and television exposure.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1161/circulationaha.120.052278" target="_parent">Racial and Ethnic Differences in Presentation and Outcomes for Patients
 Hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Rodriguez,&nbsp; F,&nbsp; Solomon, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Circulation</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We sought to identify racial/ethnic differences in presentation and outcomes for patients hospitalized with COVID-19.
 Among 7,868 patients hospitalized with COVID-19, 33.0% were Hispanic, 25.5% were non-Hispanic Black, 6.3% were Asian, and 35.2% were non-Hispanic White. Hispanic and Black patients were younger than non-Hispanic White and Asian patients and were more likely
 to be uninsured. Black patients had the highest prevalence of obesity, hypertension, and diabetes. Black patients also had the highest rates of mechanical ventilation (23.2%) and renal replacement therapy (6.6%) but the lowest rates of remdesivir use (6.1%).
 Overall mortality was 18.4% with 53% of all deaths occurring in Black and Hispanic patients. The adjusted odds ratios (ORs) for mortality were 0.93 (95% confidence interval CI] 0.76-1.14) for Black patients, 0.90 (95% CI 0.73-1.11) for Hispanic patients, and
 1.31 (95% CI 0.96-1.80) for Asian patients compared with non-Hispanic White patients. The median OR across hospitals was 1.99 (95% CI 1.74-2.48). Asian patients had the highest COVID-19 cardiorespiratory severity at presentation (adjusted OR 1.48, 95% CI 1.16-1.90).&nbsp;
 Black and Hispanic patients bore a greater burden of mortality and morbidity due to their disproportionate representation among COVID-19 hospitalizations.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1097/ccm.0000000000004752" target="_parent">Early Percutaneous Tracheostomy in Coronavirus Disease 2019: Association With
 Hospital Mortality and Factors Associated With Removal of Tracheostomy Tube at ICU Discharge. A Cohort Study on 121 Patients</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Rosano,&nbsp; A,&nbsp; Martinelli, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Crit Care Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques Healthcare Response |
 Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Aim of the study was to analyze the hospital mortality of coronavirus disease 2019 patients who had received early
 percutaneous tracheostomy and factors associated with removal of tracheostomy cannula at ICU discharge. One-hundred and twenty-one patients (74%) were tracheostomized, whereas the other 43 (26%) were managed with translaryngeal intubation only. In multivariable
 analysis, early percutaneous tracheostomy was associated with lower hospital mortality. Sixty-six of tracheostomized patients (55%) were discharged alive from the hospital. Age and male sex were the only characteristics that were independently associated with
 mortality in the tracheostomized patients (45.5% and 62.8% in tracheostomized and nontracheostomized patients, respectively; p = 0.009). Tracheostomy tube was removed in 47 of the tracheostomized patients (71%). The only variable independently associated with
 weaning from tracheostomy at ICU discharge was a faster start of spontaneous breathing after tracheotomy was performed.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/ijerph17228444" target="_parent">Behavioral Changes During COVID-19 Confinement in France: A Web-Based Study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Rossinot,&nbsp; H,&nbsp; Fantin, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Int J Environ Res Public Health</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale<br>
Public Health response| Interventions de santé publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The objective of this study was to understand what the determinants of the changes in participants' behavior and mental
 state were during the confinement. In total, 28.7% reported having a more balanced diet, against 17.1% with a less balanced diet, 22.7% of respondents reported an increased alcohol consumption, as opposed to only 12.2% declaring a decrease, and 11.2% of respondents
 increased their tobacco consumption, while 6.3% decreased it. In total, 50.6% of the participants reported being more depressed, stressed, or irritable since the beginning of the lockdown. Confinement had a negative effect on every behavior studied in this
 survey, except for nutrition. We also found that negative mental state changes were strongly associated with nutrition, sleep, physical activity and alcohol consumption changes.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/healthcare8040483" target="_parent">The Demand for Elective Neurosurgery at a German University Hospital during the
 First Wave of COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Rupa,&nbsp; R,&nbsp; Sass, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Healthcare (Basel)</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This single-center retrospective study aims to analyze temporal relationships of the first wave of the COVID-19 pandemic
 in Germany with the number of patients who sought and received elective neurosurgical treatment at a German university hospital. The beginning of the COVID-19 pandemic was correlated to an immediate and significant decrease in ON, and to a significant decrease
 in the number of EP performed. The subsequent increase in ON was delayed. Adequate measures to promote timely discharge of patients may become increasingly relevant as the pandemic proceeds.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.docwirenews.com/abstracts/the-effect-of-novel-coronavirus-disease-2019-covid-19-on-fibromyalgia-syndrome/" target="_parent">The
 effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Salaffi,&nbsp; F,&nbsp; Giorgi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Clin Exp Rheumatol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The aim of this study was to observe the behaviour of fibromyalgia (FM) symptoms during the course of COVID-19. Eight
 hundred and ninety-seven (93%) of the 965 patients (881 women 91.3%] and 84 men 8.7%]) were followed up on an outpatient basis because of FM and 68 (7.0%) were either followed up as out-patients or hospitalised because of COVID-19. The major differences between
 the score of the items (those with the greatest disease impact) were the following related symptoms: sleep quality (FIQR15), fatigue/energy (FIQR13), pain (FIQR12), stiffness (FIQR14). The mean total and subdomain scores of all the tests were significantly
 higher in the patients with COVID-19, which suggests that global FM symptoms are more severe in patients with infection.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1148/radiol.2020203465" target="_parent">Chest CT in the Emergency Department for Diagnosis of COVID-19 Pneumonia: Dutch
 Experience</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Schalekamp,&nbsp; S,&nbsp; Bleeker-Rovers, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Radiology</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Diagnostics / Pathogen detection| Diagnostics / Détection
 d'agents pathogènes<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">To assess the real-life performance of radiologist emergency department chest CT interpretation for diagnosing COVID-19
 during the acute phase of the pandemic, using the COVID-19 reporting and data system (CO-RADS). A total of 1070 patients (median age 66, IQR 54-75, 626 men) were included, of whom 536/1070 (50%) had a positive RT-PCR, 137/1070 (13%) patients were considered
 to have a possible or probable COVID- 19 based on the clinical reference standard. Chest CT yielded an AUC of 0.87 (95%CI 0.84-0.89) compared with RT-PCR and 0.87 (95%CI 0.85-0.89) compared with the clinical reference standard. A CO-RADS score ≥4 yielded an
 OR of 25.9 (95%CI 18.7-35.9) for a COVID-19 diagnosis by RT-PCR, and an OR of 30.6 (95%CI 21.1-44.4) by the clinical reference standard. For symptom duration of less than 48 hours, the AUC fell to 0.71 (95%CI 0.62-0.80; P&lt;.001). Chest CT analysis using the
 COVID-19 reporting and data system (CO-RADS) enables rapid and reliable diagnosis of COVID-19, particularly when symptom duration is greater than 48 hours.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/17/2020.11.16.20232009.abstract" target="_parent">The total number and mass of SARS-CoV-2 virions in
 an infected person</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Sender,&nbsp; Ron,&nbsp; Bar-On, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Coronavirology| Coronavirologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We integrate the best current knowledge about the abundance of potential SARS-CoV-2 host cells and typical concentrations
 of virions in bodily fluids to estimate the total number and mass of SARS-CoV-2 virions in an infected person. Knowledge of the absolute number of virions in an infected individual can put into perspective parameters of the immune system response, minimal
 infectious doses and limits of detection in testing.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1186/s40249-020-00776-2" target="_parent">Assessing preventive health behaviors from COVID-19: a cross sectional study with
 health belief model in Golestan Province, Northern of Iran</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Shahnazi,&nbsp; H,&nbsp; Ahmadi-Livani, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Infect Dis Poverty</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Public Health response| Interventions de santé publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The present study aimed to determine the preventive behaviors from the disease based on constructs of the health belief
 model. Results of the present study indicated that female gender, perceived barriers, perceived self-efficacy, fatalistic beliefs, perceived interests, and living in city had the greatest preventive behaviors from COVID-19 respectively. Preventive interventions
 were necessary among males and villagers.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.jvscit.2020.08.003" target="_parent">PMC7441069; Acute upper limb ischemia as the first manifestation in a patient
 with COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Shao,&nbsp; T,&nbsp; In-Bok Lee, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Vasc Surg Cases Innov Tech</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We report a case of acute upper extremity ischemia as the initial clinical presentation of a patient with COVID-19.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s12144-020-01195-0" target="_parent">PMC7661558; COVID-19 anxiety scale (CAS): Development and psychometric properties</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Silva,&nbsp; WAD,&nbsp; de Sampaio Brito, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Curr Psychol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The objective of the present research is to develop and validate the COVID-19 Anxiety Scale (CAS). Three studies to
 gather evidence regarding content and construct validity, as well to evaluate the reliability of the measure. Results demonstrate that CAS is a reliable and adequate instrument to assess COVID-19 related anxiety.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/07391102.2020.1847688" target="_parent">Computational investigation for identification of potential phytochemicals and
 antiviral drugs as potential inhibitors for RNA-dependent RNA polymerase of COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Singh,&nbsp; J,&nbsp; Malik, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Biomol Struct Dyn</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In the present study, we have used the insilico approach for the prediction of novel drug molecules that can be best
 target the RNA-dependent RNA-polymerase (Pol/RdRp) protein of SARS-CoV-2. Three antiviral and three phyto-chemicals were further evaluated in molecular dynamics studies.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1177/1010539520968455" target="_parent">Prevalence of Posttraumatic Stress Disorder and Depression in General Population
 in India During COVID-19 Pandemic Home Quarantine</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Singh,&nbsp; SP,&nbsp; Khokhar, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Asia Pac J Public Health</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">A web-based survey was conducted using Google Forms during April 2020 home quarantine. A prevalence of 28.2% for PTSD
 and 14.1% for depression was observed. A significant (P &lt; .05) association was reported between depression and number of household members, and between depression and occupation (P&lt;.001).</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1021/acs.jpcb.0c07890" target="_parent">Computational Design of 25-mer Peptide Binders of SARS-CoV-2</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Sitthiyotha,&nbsp; T,&nbsp; Chunsrivirot, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Phys Chem B</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study developed an approach to design SARS-CoV-2 recptor binding domain (RBD) 25-mer peptide binders, and these
 peptides may be promising candidates as potential SARS-CoV-2 inhibitors.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1111/his.14215" target="_parent">PMC7405484; Third-trimester placentas of severe acute respiratory syndrome coronavirus 2
 (SARS-CoV-2)-positive women: histomorphology, including viral immunohistochemistry and in-situ hybridization</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Smithgall,&nbsp; MC,&nbsp; Liu-Jarin, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Histopathology</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The aim of our study, in addition to describing histomorphology, was to utilize in‐situ hybridization (ISH) for the
 S‐gene encoding the spike protein and immunohistochemistry (IHC) with the monoclonal SARS‐CoV‐2 spike antibody 1A9 for placental evaluation.&nbsp; Evidence of maternal-fetal vascular malperfusion was identified, with placentas from SARS-CoV-2-positive women being
 significantly more likely to show villous agglutination (P = 0.003) and subchorionic thrombi (P = 0.026) than placentas from SARS-CoV-2-negative women. No evidence of direct viral involvement was identified with ISH and IHC.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://biorxiv.org/content/early/2020/11/17/2020.11.17.385252.abstract" target="_parent">Maturation and persistence of the anti-SARS-CoV-2 memory
 B cell response</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Sokal,&nbsp; Aurelien,&nbsp; Chappert, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">bioRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Immunology | Immunologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We report here a longitudinal single-cell and repertoire profiling of the B cell response up to 6 months in mild and
 severe COVID-19 patients. Overall, these findings demonstrate that an antigen-driven activation persisted and matured up to 6 months after SARS-CoV-2 infection and may provide long-term protection.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://biorxiv.org/content/early/2020/11/17/2020.11.17.368258.abstract" target="_parent">Immunogenicity of one- and two-dose regimens of the
 Ad26.COV2.S COVID-19 vaccine candidate in adult and aged rhesus macaques</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Solforosi,&nbsp; Laura,&nbsp; Kuipers, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">bioRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Vaccine Research| Recherche sur les vaccins Immunology | Immunologie Animal model |
 Modèle animal<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Here we assessed the immunogenicity of one- and two-dose Ad26.COV2.S vaccine regimens in adult and aged non-human primates
 (NHP).&nbsp; A second vaccine dose, administered 8 weeks post the first immunization, induced a significant increase in antigen-specific binding and neutralizing antibody responses in both adult and aged animals as compared to a single dose.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://ssrn.com/abstract=3730476" target="_parent">Student Body Temperature and Physical Distance Management Device in Classroom Using 3D Stereoscopic
 Distance Measurement</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Soni,&nbsp; Vishal Dineshkumar,&nbsp; Soni, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">SSRN- Lancet prepublication</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Public Health response| Interventions de santé publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We designed an Internet of Things (IoT) and Artificial intelligence based paradigm that makes use of object detection
 to assess the maintenance of&nbsp; physical distance between students in Class room. To mitigate problems posed by overlapping images we a used stereoscopic distance measurement algorithm</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-110295/v1" target="_parent">Serological response and disease-specific neutralizing antibodies in kidney
 transplant recipients with SARS-CoV-2 infection – a case series</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Speer,&nbsp; Claudius,&nbsp; Schnitzler, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Immunology | Immunologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Immunocompromised kidney transplant recipients showed a functional serological response with disease-specific neutralizing
 antibodies upon SARS-CoV-2 infection that was sustained for 15 weeks..</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1002/jmv.26676" target="_parent">High value of Mid-regional proAdrenomedullin in COVID-19: a marker of widespread endothelial
 damage, disease severity and mortality</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Spoto,&nbsp; S,&nbsp; Agrò, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Med Virol</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The aim of this study was to evaluate the role of Mid‐regional proAdrenomedullin (MR‐proADM) as a marker of SARS CoV2‐related
 widespread endothelial damage, clinically identified by organs damage, disease severity and mortality. MR‐proADM values ≥ 2 nmol/l identify those patients with high mortality risk related to a multiorgan dysfunction syndrome.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s11010-020-03981-7" target="_parent">Computational study of pomegranate peel extract polyphenols as potential inhibitors
 of SARS-CoV-2 virus internalization</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Suručić,&nbsp; R,&nbsp; Tubić, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Mol Cell Biochem</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The results showed that the constituents of pomegranate peel extracts, namely punicalagin and punicalin had very promising
 potential for significant interactions with the selected protein targets</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1002/jmv.26671" target="_parent">COVID-19 in HIV infected patients: A Case series and Literature Review</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Swaminathan,&nbsp; N,&nbsp; Moussa, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Med Virol</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This case-series reviews the clinical and laboratory characteristics of COVID in PLWH admitted in a community-hospital.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1097/ccm.0000000000004786" target="_parent">Validation of Inflammopathic, Adaptive, and Coagulopathic Sepsis Endotypes in
 Coronavirus Disease 2019</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Sweeney,&nbsp; TE,&nbsp; Liesenfeld, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Crit Care Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Immunology | Immunologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The aim of this study was to test whether our predefined 33-messenger RNA bacterial endotype classifier recapitulates
 the same three clinical and immunological endotypes in coronavirus disease 2019: Adaptive, Coagulopathic, Inflammopathic .Adaptive patients had lower rates of sever respiratory failure and no deaths.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/22221751.2020.1843973" target="_parent">The values and limitations of mathematical modelling to COVID-19 in the world:
 a follow up report</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Tang,&nbsp; Y,&nbsp; Tang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Emerg Microbes Infect</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Our original paper prepared in March 2020 analyzed the outbreaks of COVID-19 in the US and its selected states to identify
 the rise, peak, and decrease of cases within a given geographic population, as well as a rough calculation of accumulated total cases in this population from the beginning to the end of June 2020. The current report will describe how well the later actual
 trend from March to June fit our model and prediction. Similar analyses are also conducted to include countries other than the US. From such a wide global data analysis, our results demonstrated that different US states and countries showed dramatically different
 patterns of pandemic trend.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.childyouth.2020.105703" target="_parent">PMC7654299; Suicidal ideation among Bangladeshi university students early
 during the COVID-19 pandemic: Prevalence estimates and correlates</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Tasnim,&nbsp; R,&nbsp; Islam, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Child Youth Serv Rev</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Mental Health |
<br>
santé mentale<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study aimed to assess suicidal ideation and associated factors among university students in Bangladesh during
 the early stages of the COVID-19 pandemic. Potential protective factors were being male, regular exercise, and good studies. Potential risk related to sleep, cigarette smoking, and prior/familial suicidality.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1038/s41467-020-19706-9" target="_parent">Immune suppression in the early stage of COVID-19 disease</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Tian,&nbsp; W,&nbsp; Zhang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Nat Commun</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Immunology | Immunologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Here we analyze urine samples from COVID-19 infection cases, healthy donors and non-COVID-19 pneumonia cases using
 quantitative proteomics. The molecular changes suggest that immunosuppression and tight junction impairment occur in the early stage of COVID-19 infection. Further subgrouping of COVID-19 patients into moderate and severe types shows that an activated immune
 response emerges in severely affected patients.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://biorxiv.org/content/early/2020/11/17/2020.11.17.386904.abstract" target="_parent">Preclinical evaluation of Imatinib does not support
 its use as an antiviral drug against SARS-CoV-2</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Touret,&nbsp; Franck,&nbsp; Driouich, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">bioRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In this preprint,&nbsp; we present the pre-clinical evaluation of Imatinib and other similar tyrosine kinase inhibitors
 (TKIs) targeting the Abelson kinase 2 against pathogenic coronaviruses in multiple models.&nbsp; In vivo, Imatinib therapy failed to impair SARS-CoV-2 replication in a golden Syrian hamster model despite high concentrations in plasma and in the lung. Overall, these
 results do not support the use of Imatinib and similar TKIs as antivirals in the treatment of Covid-19.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3399/bjgpo.2020.0151" target="_parent">Recovery, Restoration and Risk: A Cross Sectional Survey of the Impact of COVID-19
 on General Practitioners in the First UK City to Lockdown</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Trivedi,&nbsp; N,&nbsp; Trivedi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BJGP Open</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study focuses on assessing the impact of COVID-19 on GPs in Leicestershire, the first UK city to lockdown locally.
 The COVID-19 prevalence in GPs was 8.1%. 79.3% of GPs felt supported by their practice but only 59.5% felt supported with mental health. GPs described feeling more stressed during the COVID-19 pandemic than they had been previously. National Health Service
 England should focus on GP stress and wellbeing as they work towards the restoration and recovery of primary care and prepare for a second peak.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s00787-020-01680-8" target="_parent">Vulnerability and resilience in children during the COVID-19 pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Tso,&nbsp; WWY,&nbsp; Wong, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Eur Child Adolesc Psychiatry</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We conducted a large-scale cross-sectional population study of Hong Kong families with children aged 2–12 years using
 simple and multiple linear regression analyses to explore factors associated with child psychosocial problems and parental stress during the pandemic. This study identifies vulnerable groups of children and highlights the importance of strengthening family
 coherence, adequate sleep and exercise, and responsible use of electronic devices in promoting psychosocial wellbeing during the COVID-19 pandemic.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1017/dmp.2020.444" target="_parent">An Eye on the Future of COVID'19: Prediction of Likely Positive Cases and Fatality in
 India over A 30 Days Horizon using Prophet Model</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Tulshyan,&nbsp; V,&nbsp; Sharma, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Disaster Med Public Health Prep</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie Public health
 interventions*| Interventions de sant&amp;amp;eacute; publique<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study, using the Prophet Model, a time series analysis model, analyses the effects of COVID 19 based on Likely
 Positive Cases and fatality in India during and after the lockdown period from 24 March 2020 to 24 May 2020. Prediction depicts that during the lockdown, the total cases were rising but in a controlled manner with an accuracy of 87%. After the relaxation of
 lockdown rules, the predictions have shown an obstreperous situation with an accuracy of 60%.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/18/2020.11.15.20231845.abstract" target="_parent">A Predictive Internet-Based Model for COVID-19 Hospitalization
 Census</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Turk,&nbsp; PhilipJ,&nbsp; Tran, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Healthcare Response | Réponse des soins
 de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Preprint. We propose a vector error correction model (VECM) for the number of COVID-19 patients in a healthcare system
 (Census) that incorporates Google search term activity and healthcare chatbot scores. The VECM provided a good fit to Census and very good forecasting performance as assessed by hypothesis tests and mean absolute percentage prediction error. We have demonstrated
 the VECM can potentially be a valuable component to a COVID-19 surveillance program in a healthcare system.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/17/2020.10.26.20219659.abstract" target="_parent">Detecting COVID-19 infection hotspots in England
 using large-scale self-reported data from a mobile application: a prospective, observational study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Varsavsky,&nbsp; Thomas,&nbsp; Graham, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Preprint. We performed modelling on longitudinal, self-reported data from users of the COVID Symptom Study app in England
 between 24 March and 29 September, 2020. More than 2.8 million app users in England provided 120 million daily reports of their symptoms, and recorded the results of 170,000 PCR tests. Self-reported data from mobile applications can provide an agile resource
 to inform policymakers during a fast-moving pandemic, serving as an independent and complementary resource to more traditional instruments for disease surveillance.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1371/journal.pone.0242535" target="_parent">An efficient mixture of deep and machine learning models for COVID-19 diagnosis
 in chest X-ray images</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Wang,&nbsp; D,&nbsp; Mo, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">PLoS One</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Diagnostics / Pathogen detection| Diagnostics / Détection
 d'agents pathogènes<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">The use of computer-aided diagnosis to screen X-ray images of COVID-19 cases can provide experts with auxiliary diagnosis
 suggestions, which can reduce the burden of experts to a certain extent. In this study, we first used conventional transfer learning methods, using five pre-trained deep learning models, and we propose an efficient diagnostic method that uses a combination
 of deep features and machine learning classification. Compared with the baseline Xception model, our proposed method has higher classification accuracy and efficient diagnostic performance.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-105230/v1" target="_parent">Invasive Mechanical Ventilation May Be an Important Factor of Mortality
 in Severe/Critical COVID-19 Pneumonia: A Retrospective Cohort Study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Wei,&nbsp; Jing,&nbsp; Shi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">In this retrospective study, all inpatients confirmed severe or critical COVID-19 from two tertiary hospital in Huangshi
 were included, who had been discharged or died by March19,2020 (n=81). The univariable and multivariable logistic regression analysis was used to analyze the risk factors associated with in-hospital death. The proportion of coronary heart disease in non-survivors
 group was significantly higher than that in survivors group(26.9% vs 7.3%, P=0.032), but there were no differences in hypertension, diabetes and COPD between the non-survivors group and the survivors group. Multivariable logistic regression analysis showed
 increasing odds of in-hospital death associated with aspartate aminotransferase(AST) and invasive mechanical ventilation (IMV) (P&lt;0.001)(P=0.017</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;MS Gothic&quot;;color:black">）</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.medrxiv.org/content/10.1101/2020.11.12.20230391v1">Correlation of Body Mass Index (BMI), initial neutralizing antibodies (nAb),
 ABO group and kinetics of nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibodies in convalescent plasma (CCP) donors – A longitudinal study with proposals for better quality of CCP</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Wendel,&nbsp; S, &nbsp;Fontão-Wendel, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques Therapeutics| Thérapeutique Immunology | Immunologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Preprint. A cohort (n=78) of previously RT-PCR&#43;ve (detected by nasopharyngeal swab during the acute phase), male convalescent
 patients, all with mild symptoms, were enrolled on serial blood sample collection for evaluation of longitudinal neutralizing antibody (nAb) titers and anti-nucleocapsid (NP) antibodies (IgM, IgG and IgA). Selection of convalescent plasma (CCP) donors for
 multiple collections based on initial high nAb titers (≥1280) or overweight/obese (BMI) provides a simple strategy to achieve higher quality in CCP programs. High IgG anti-NP levels can also be used as surrogate markers for high nAb screening.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s11239-020-02338-7" target="_parent">Ecchymosis in critical coronavirus disease 2019 (COVID-19) patient in Tangerang,
 Indonesia: a case report</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Widysanto,&nbsp; A,&nbsp; Wahyuni, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Thromb Thrombolysis</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">We present a case of ecchymosis in COVID-19-positive ICU hospitalized patient. The pathophysiology of ecchymosis in
 COVID-19 might be caused by microvascular injury and thrombosis, vasculitis, and disseminated intravascular coagulation (DIC). The presence of ecchymosis in COVID-19 patients is indicating an occuring coagulopathy and associated with increased mortality in
 COVID-19 infection.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1017/ice.2020.1321" target="_parent">Epidemiological and clinical characteristics of SARS-CoV-2 infection among healthcare
 workers in Hubei Province of China</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Wu,&nbsp; M,&nbsp; Xie, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Infect Control Hosp Epidemiol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Epidemiology| Épidémiologie Clinical data| Données cliniques<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This retrospective cohort study evaluated the epidemiological and clinical characteristics of SARS-CoV-2 infection
 among healthcare workers in Hubei Province, China. A total of 1,989 healthcare workers and 41,137 other occupational cases were included for analysis. Compared with COVID-19 cases in other occupational groups, healthcare workers with COVID-19 have half the
 risk of death, although they have been shown to have higher rates of fatigue and myalgia.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.childyouth.2020.105634" target="_parent">PMC7603991; Psychological effects of the COVID-19 pandemic on Wuhan's high
 school students</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Yang,&nbsp; D,&nbsp; Swekwi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Child Youth Serv Rev</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study explored the protective potential of resilience and positive emotion regulation against psychological trauma
 among Wuhan’s high school students during COVID-19. They found that psychological trauma was a negative predictor of mental health and this could be mitigated through resilience and positive emotion regulation.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://biorxiv.org/content/early/2020/11/17/2020.11.17.386532.abstract" target="_parent">The Development of a Novel Nanobody Therapeutic for
 SARS-CoV-2</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Ye,&nbsp; Gang,&nbsp; Gallant, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">bioRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Therapeutics| Thérapeutique</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study tested a series of single-domain antibodies (nanobodies) that bind the SARS-CoV-2 spike protein receptor-binding
 domain (RBD). The top candidate (Nanosoat-1) tightly bound to the RBD, completely blocked ACE2 binding and neutralized SARS-CoV-2 infection in vitro and in vivo.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.annaliitalianidichirurgia.it/prodotto/comparison-of-the-emergency-and-oncological-surgery-before-and-during-the-covid-19-pandemic-a-single-center-retrospective-study/" target="_parent">Comparison
 of the emergency and oncological surgery before and during the COVID-19 pandemic. A single-center retrospective study</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Yiğit,&nbsp; B,&nbsp; Çitgez, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ann Ital Chir</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study aimed to identify changes and delays in diagnosis or treatment of malignancies during the COVID-19 pandemic
 (March 11 - May 31, 2020) in a single hospital in Italy. They observed that there was a progressive reduction in surgical activity March - May, 2020 and all types of oncological surgeries decreased significantly in the pandemic period compared to previous
 years.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.isci.2020.101806" target="_parent">PMC7661939; Innate and adaptive immunity of murine neural stem cell-derived piRNA
 exosomes/microvesicles against pseudotyped SARS-CoV-2 and HIV-based lentivirus</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Yu,&nbsp; B,&nbsp; Ikhlas, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">iScience</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Immunology | Immunologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Through testing pseudotyped SARS-CoV-2 lentiviral vectors, this study reports that exosomes/microvesicles (Ex/Mv) isolated
 from murine hypothalamic neural stem/progenitor cells have antiviral effects. The proposed mechanism of action is through cell-free innate antiviral responses that degrade the virus.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1371/journal.pone.0242399" target="_parent">Association of SARS-CoV-2 genomic load trends with clinical status in COVID-19:
 A retrospective analysis from an academic hospital center in New York City</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zacharioudakis,&nbsp; IM,&nbsp; Zervou, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">PLoS One</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This is a retrospective cohort study investigating the correlation between SARS-CoV2 viral load (assessed by Ct value)
 and clinical status (assessed using the Sequential Organ Failure Assessment (SOFA) score ) in adult patients with COVID-19 pneumonia in New York. 42 patients with at least 2 positive nasopharyngeal tests at least 24 hours were identified. 20 out of 42 patients
 had a lower SOFA score on their subsequent tests and and change in the Ct value associated with a decrease in SOFA score suggesting Ct value may be of prognostic value.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1017/s0022215120002480" target="_parent">Patient satisfaction from ENT telephone consultations during the coronavirus disease
 2019 pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zammit,&nbsp; M,&nbsp; Siau, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Laryngol Otol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This is a prospective questionnaire-based project assessing patient satisfaction with telephone ENT consultation before
 and after implementation of a structured consultations format during COVID-19 restrictions. 100 surveys were administered between April and June 2020 and a significant improvement in patient satisfaction was observed after implementation of structured consultation.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1073/pnas.2012331117" target="_parent">Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight
 viral genes</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zeng,&nbsp; HL,&nbsp; Dichio, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Proc Natl Acad Sci U S A</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study investigated whether the 50,000&#43; SARS-CoV2 genomes deposited in the Global Initiative on Sharing All Influenza
 Data (GISAID) repository show effects of epistatic contributions to fitness. The study identified eight significant epistatic interactions including viral genes ORF3a, ORF8, nsp2, nsp4, nsp6, nsp12, nsp13, and nsp14. Interacting sites may serve as a starting
 point to search for weaknesses of recombinant viral pathogens.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1038/s41564-020-00824-5" target="_parent">Spike-specific circulating T follicular helper cell and cross-neutralizing antibody
 responses in COVID-19-convalescent individuals</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zhang,&nbsp; J,&nbsp; Wu, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Nat Microbiol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Immunology | Immunologie</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study investigated antibody response after SARS-CoV2 infection in 67 convalescent patients. The majority of convalescent
 individuals maintained anti-spike S1- and S2-specific antibodies with neutralizing activity against pseudotyped virus, and that some of antibodies cross-neutralized SARS-CoV, MERS-CoV or both pseudotyped viruses. Convalescent individuals with severe COVID-19
 showed higher neutralizing antibody titres and a higher frequency of CXCR3&#43; T follicular help (TFH) that were spike specific and positively associated with neutralizing antibody titres.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-108402/v1" target="_parent">Research and Analysis of the Effect of Refined Nursing Intervention on
 COVID-19 Epidemic in Hemodialysis Center Runing Title:Effect of Refined Nursing Intervention on COVID-19 Epidemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zhang,&nbsp; Qinglai,&nbsp; Wang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Mental Health |
<br>
santé mentale<br>
Healthcare Response | Réponse des soins de santé<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study looked at the impact of a refined nursing intervention on depression and anxiety in hemodialysis patients
 who are at high risk of severe disease. The Symptom Checklist90 (SCL90) score was used to assess psychological state of 172 hemodialysis patients before, during and after dialysis. Depression and anxiety of patients were reduced after implementation of refined
 nursing intervention.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1186/s12879-020-05570-x" target="_parent">Epidemiological and clinical based study on four passages of COVID-19 patients:
 intervention at asymptomatic period contributes to early recovery</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zhang,&nbsp; X,&nbsp; Wang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMC Infect Dis</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Clinical data| Données cliniques</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study investigated the impact of early treatment on 4 passages of SARS-CoV2, where a passage is defined as a linked
 transmission event. 78 patients were identified with 4 distinct passages. Early passages received treatment while symptomatic where late passages were treated asymptomatically. Significant decrease in several disease severity metrics were observed in the late
 passage/early treatment groups.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://biorxiv.org/content/early/2020/11/17/2020.11.16.384040.abstract" target="_parent">A continuously self-sterilizing form of copper capable
 of 99% SARS-CoV-2 deactivation in 30 seconds</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zinn,&nbsp; AlfredA,&nbsp; Izadjoo, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">bioRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Coronavirology| Coronavirologie Infection Prevention and Control/ Prévention et contrôle
 des infections (IPAC/PCI)<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study describes a rapid-acting, self-sterilizing copper configuration capable of killing SARS-CoV-2 particles.
 The material maintains antimicrobial efficacy over consecutive uses and is shelf stable. The material could offer broad spectrum, non-selective defense against most microbes via integration into masks and other PPE.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://ssrn.com/abstract=3729913" target="_parent">Predicting Global Trends in COVID-19 Cases Via Online Symptom Checkers Self-Assessments</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zobel,&nbsp; Marc,&nbsp; Martin, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">SSRN- Lancet prepublication</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Modelling/ prediction| Modélisation/prédiction Epidemiology| Épidémiologie<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">This study assessed the use of the online symptom checker Symptoma during the COVID-19 pandemic and correlated use
 with spatial and temporal data. The study observed a high correlation between the number of users assessed to have a high risk of a COVID-19 infection and the official infection numbers. It also showed that the symptom checker is predictive (median &#43;5 days)
 of the official infection numbers.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-108776/v2" target="_parent">Can Physical exercise be an effective adjuvant before the potential COVID-19
 vaccine? Insights from serological responses and severity of re-infected cases</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">AbdelMassih,&nbsp; Antoine,&nbsp; Menshawey, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/medhum-2020-011969" target="_parent">The dying patient: taboo, controversy and missing terms of reference for designers-an
 architecturaperspective</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Bellamy,&nbsp; A,&nbsp; Clark, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Med Humanit</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/ijms21228612" target="_parent">The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic
 Approach to COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Bellis,&nbsp; A,&nbsp; Mauro, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Int J Mol Sci</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1002/ejhf.2058" target="_parent">Hemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome
 requiring mechanical ventilation. An invasive assessment using right heart catheterization</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Caravita,&nbsp; S,&nbsp; Baratto, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Eur J Heart Fail</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.bja.2020.06.060" target="_parent">PMC7438995; Epigenetic susceptibility to severe respiratory viral infections and
 its therapeutic implications: a narrative review</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Crimi,&nbsp; E,&nbsp; Benincasa, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Br J Anaesth</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1513/AnnalsATS.202004-317CME" target="_parent">Mechanical Ventilation Supply and Options for the COVID-19 Pandemic: Leveraging
 All Available Resources for a Limited Resource in a Crisis</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Dar,&nbsp; M,&nbsp; Swamy, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ann Am Thorac Soc</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1159/000511760" target="_parent">Adherence to Immunization: Rebuttal of Vaccine Hesitancy</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Etzioni-Friedman,&nbsp; T,&nbsp; Etzioni, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Acta Haematol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/molecules25225318" target="_parent">Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and
 Chronic Diseases: A Systematic Review</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Faraone,&nbsp; I,&nbsp; Labanca, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Molecules</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">SR: systematic search of Scopus and PubMed databases was performed. By contrast, HCQ arises as a first-line treatment
 in managing autoimmune diseases such as rheumatoid arthritis, lupus erythematosus, and Sjögren syndrome. It also improves glucose and lipid homeostasis and reveals significant antibacterial activity.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/mi11111003" target="_parent">Applications of CMOS Devices for the Diagnosis and Control of Infectious Diseases</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Forouhi,&nbsp; S,&nbsp; Ghafar-Zadeh, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Micromachines (Basel)</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.hlpt.2020.08.015" target="_parent">PMC7452848; The COVID-19 pandemic in Greece, Iceland, New Zealand, and Singapore:
 Health policies and lessons learned</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Fouda,&nbsp; A,&nbsp; Mahmoudi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Health Policy Technol</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.2196/22045" target="_parent">Impact of the COVID-19 Pandemic on the Education of Plastic Surgery Trainees in the United States</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Hamidian Jahromi,&nbsp; A,&nbsp; Arnautovic, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">JMIR Med Educ</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/cells9112475" target="_parent">An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus:
 The Central Role of β-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Hayden,&nbsp; MR</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Cells</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1371/journal.pone.0241955" target="_parent">Prognostic factors for severity and mortality in patients infected with COVID-19:
 A systematic review</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Izcovich,&nbsp; A,&nbsp; Ragusa, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">PLoS One</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">SR:&nbsp; conducted highly sensitive searches in PubMed/MEDLINE, the Cochrane Central Register of Controlled Trials (CENTRAL)
 and Embase. The searches covered the period from the inception date of each database until April 28, 2020.&nbsp; Identified prognostic factors can help clinicians and policy makers in tailoring management strategies for patients with COVID-19 infectious disease
 while researchers can utilise our findings to develop multivariable prognostic models that could eventually facilitate decision-making and improve patient important outcomes.
</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-105883/v1" target="_parent">What is the Efficacy and Safety of Rapid Exercise Tests for Exertional
 Desaturation in Covid-19: A Rapid Systematic Review</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kalin,&nbsp; Asli,&nbsp; Javid, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">SR: AMED, CINAHL, EMBASE MEDLINE, Cochrane and PubMed using LitCovid, Scholar and Google databases were searched to
 September 2020. We found no studies on the 40-step walk test (a less demanding test that is widely used in clinical practice to assess Covid-19 patients). Discussion Exertional desaturation tests have not yet been validated in patients with (or suspected of
 having) Covid-19. </span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1142/s0192415x20500767" target="_parent">The Potential of Glycyrrhizinate in the Management of COVID-19: A Systematic Review
 of the Efficacy and Safety of Glycyrrhizin Preparations in the Treatment of SARS and MERS</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Li,&nbsp; H,&nbsp; Hu, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Am J Chin Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">SR:&nbsp; Electronic databases were systematically searched from inception to February 2020. Based on the available evidence
 regarding glycyrrhizin preparations for treating SARS and MERS, we infer that compound glycyrrhizin could be an optional therapeutic strategy for SARS-CoV-2 infections, especially those complicated with liver damage. Further research using well-designed randomized
 clinical trials (RCTs) is warranted to determine the dosage and duration of use of compound glycyrrhizin and to monitor its specific adverse effects.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1097/mao.0000000000002986" target="_parent">Middle Ear Viral Load Considerations in the COVID-19 Era: A Systematic Review</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Liaw,&nbsp; J,&nbsp; Saadi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Otol Neurotol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">SR: DATA SOURCES: PubMed, MEDLINE, and Cochrane databases.&nbsp; The medical literature has consistently demonstrated the
 presence of nucleic acids of respiratory viruses involving the middle ear, including SARS-CoV2 in a recent postmortem study. Although no in vivo studies have been conducted, due to the likely risk of transmission, middle ear and mastoid procedures, particularly
 involving the use of a drill should be deferred, if possible, during the pandemic and enhanced personal protective equipment (PPE) used if surgery is necessary.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/nu12113512" target="_parent">Vitamin D3 as Potential Treatment Adjuncts for COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Malaguarnera,&nbsp; L</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Nutrients</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/pharmacy8040216" target="_parent">Pharmacy Internal Controls: A Call for Greater Vigilance during the COVID-19 Pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Mason,&nbsp; AN</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Pharmacy (Basel)</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.2174/1871526520666201116095934" target="_parent">Transmission Modes of COVID-19: A Systematic Review</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Mehraeen,&nbsp; E,&nbsp; Salehi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Infect Disord Drug Targets</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">SR: We searched selected keywords in six important databases to discover related sources on the main objective of the
 study. Droplet and contact with contaminated surfaces were the most frequent transmission modes of COVID-19. Fecal excretion, environmental contamination, and fluid pollution might contribute to a viral transmission. The possibility of fecal transmission of
 COVID-19 has implications, especially in areas with poor sanitation and the environmental pollution can be caused by patients with SARS-CoV-2 through respiratory droplets and feces, subsequently, the human environment will change to a potential medium of virus
 transmission.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.18632/aging.103991" target="_parent">Impact of cardiovascular and metabolic diseases on the severity of COVID-19: a systematic
 review and meta-analysis</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Meng,&nbsp; M,&nbsp; Zhao, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Aging (Albany NY)</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">SR-MA: performed a comprehensive, systematic literature search for studies published between December 2019 and July
 5, 2020 in five databases. Our findings suggest patients with CHD, hypertension and diabetes are at greater risk for developing severe COVID-19 than those without these conditions.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s00068-020-01542-7" target="_parent">Prone ventilation as treatment of acute respiratory distress syndrome related to
 COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Petrone,&nbsp; P,&nbsp; Brathwaite, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Eur J Trauma Emerg Surg</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://dx.doi.org/10.2139/ssrn.3729704" target="_parent">Potential Detrimental Role of Soluble ACE2 in Severe COVID-19 Comorbid Patients</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Rahman,&nbsp; Mohammad Mahmudur,&nbsp; Hasan, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">SSRN- Lancet prepublication</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1177/1941738120974747" target="_parent">Implications of SARS-CoV-2-Associated Myocarditis in the Medical Evaluation of Athletes</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Raukar,&nbsp; NP,&nbsp; Cooper, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Sports Health</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.ibmed.2020.100005" target="_parent">PMC7531283; Zero-shot learning and its applications from autonomous vehicles to
 COVID-19 diagnosis: A review</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Rezaei,&nbsp; M,&nbsp; Shahidi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Intell Based Med</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1042/etls20200260" target="_parent">Endothelial pulsatile shear stress is a backstop for COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Sackner,&nbsp; MA,&nbsp; Adams, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Emerg Top Life Sci</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/17434440.2020.1852079" target="_parent">Personal Protective Equipment during COVID-19 Pandemic: A Narrative Review on
 Technical Aspects</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Saran,&nbsp; S,&nbsp; Gurjar, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Expert Rev Med Devices</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1002/bies.202000240" target="_parent">The genetic structure of SARS-CoV-2 does not rule out a laboratory origin: SARS-COV-2
 chimeric structure and furin cleavage site might be the result of genetic manipulation</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Segreto,&nbsp; R,&nbsp; Deigin, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Bioessays</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1038/s41565-020-00790-3" target="_parent">Eliciting B cell immunity against infectious diseases using nanovaccines</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Singh,&nbsp; A</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Nat Nanotechnol</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/vaccines8040680" target="_parent">Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging
 Public Health Threats</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Vrba,&nbsp; SM,&nbsp; Kirk, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Vaccines (Basel)</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3892/etm.2020.9402" target="_parent">PMC7664603; Lactoferrin for the treatment of COVID-19 (Review)</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Wang,&nbsp; Y,&nbsp; Wang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Exp Ther Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="http://medrxiv.org/content/early/2020/11/17/2020.11.16.20149377.abstract" target="_parent">The effects of hypertension as an existing comorbidity
 on mortality rate in patients with COVID-19: a systematic review and meta-analysis</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Whiteman,&nbsp; Elena</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">medRxiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">SR-MA: literature search in several databases was performed to identify studies that comment on hypertension as an
 existing comorbidity, and its effect on mortality in hospitalized patients with confirmed COVID- 19 infection.
</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/ageing/afaa259" target="_parent">Venous thromboembolic events in patients with COVID-19: A systematic review and meta-analysis</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Wu,&nbsp; T,&nbsp; Zuo, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Age Ageing</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">SR-MA: VTE is a common complication in severe COVID-19 patients and thromboembolic events are also associated with
 adverse outcomes.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/antiox9111129" target="_parent">The Pivotal Role of Adipocyte-Na K peptide in Reversing Systemic Inflammation in Obesity
 and COVID-19 in the Development of Heart Failure</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Xie,&nbsp; ZJ,&nbsp; Novograd, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Antioxidants (Basel)</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1002/jmv.26677" target="_parent">Obesity aggravates COVID-19: an updated systematic review and meta-analysis</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Yang,&nbsp; J,&nbsp; Tian, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Med Virol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">SR-MA: ubMed, EMBASE, and Web of Science were searched to find articles published between December 1, 2019, and July
 27, 2020. Obesity could promote the occurrence of the whole course of COVID-19. A higher degree of obesity may predict a higher risk.
</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3346/jkms.2020.35.e387" target="_parent">A Systematic Narrative Review of Comprehensive Preparedness Strategies of Healthcare
 Resources for a Large Resurgence of COVID-19 Nationally, with Local or Regional Epidemics: Present Era and Beyond</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Yoon,&nbsp; YK,&nbsp; Lee, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Korean Med Sci</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/13811118.2020.1830242" target="_parent">Suicide in the Time of COVID-19: Review and Recommendations</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Zalsman,&nbsp; G,&nbsp; Stanley, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Arch Suicide Res</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.ijid.2020.11.145" target="_parent">Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated
 with COVID-19: a meta-analysis and insights into pathogenesis</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zou,&nbsp; H,&nbsp; Lu, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Int J Infect Dis</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Review Literature| Revue de littérature<o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">SR-MA:&nbsp; systematic review on PubMed and Embase from the time of inception to June 24th 2020 in order to find relevant
 cases.Our study documented three common types of PMIS clinical presentation: persistent fever and gastrointestinal symptoms, shocked with heart dysfunction and Kawasaki disease-like syndrome. PMIS patients proved with a marked inflammatory state were possibly
 associated with SARS-CoV-2 infection.</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1017/dmp.2020.452" target="_parent">Alcohol misuse may increase the severity of COVID-19 infections</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Abbasi-Oshaghi,&nbsp; E,&nbsp; Mirzaei, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Disaster Med Public Health Prep</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/16549716.2020.1841963" target="_parent">Establishment of COVID-19 testing laboratory in resource-limited settings: challenges
 and prospects reported from Ethiopia</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Abera,&nbsp; A,&nbsp; Belay, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Glob Health Action</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://arxiv.org/abs/2011.08278" target="_parent">A bibliometric methodology to unveil territorial inequities in the scientific wealth to combat
 COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Abramo,&nbsp; Giovanni,&nbsp; D'Angelo, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">arXiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s13167-020-00230-1" target="_parent">PMC7661834; Infections of the lung: a predictive, preventive and personalized perspective
 through the lens of evolution, the emergence of SARS-CoV-2 and its pathogenesis</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ahluwalia,&nbsp; P,&nbsp; Ahluwalia, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">EPMA J</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://ssrn.com/abstract=3730373" target="_parent">Availability of COVID-19 Vaccine: Regulation and Indonesian Policy to Deal With It</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Al Mukarramah,&nbsp; Nurul Habaib,&nbsp; Maskun, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">SSRN- Lancet prepublication</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-41970/v2" target="_parent">Burnout And Depression Among Psychiatry Residents During Covid-19 Pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Alkhamees,&nbsp; AbdulmajeedA,&nbsp; Assiri, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.diagmicrobio.2020.115147" target="_parent">PMC7425544; Changes in healthcare managing COVID and non-COVID-19 patients
 during the pandemic: striking the balance</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Al-Tawfiq,&nbsp; J,&nbsp; Al-Yami, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Diagn Microbiol Infect Dis</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s00296-020-04744-9" target="_parent">COVID-19 pandemic in Japan</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Amengual,&nbsp; O,&nbsp; Atsumi, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Rheumatol Int</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1017/s0266462320001890" target="_parent">Prioritizing critical-care resources in response to COVID-19: lessons from the development
 of Thailand's Triage protocol</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Archer,&nbsp; RA,&nbsp; Marshall, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Int J Technol Assess Health Care</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s00393-020-00932-x" target="_parent">[Statement of the German Society for Rheumatology (DGRh) on the use of video consultations
 in rheumatology]</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Aries,&nbsp; P,&nbsp; Welcker, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Z Rheumatol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1002/jmv.26672" target="_parent">Angiotensin-converting enzyme inhibitors (ACEIs) and Angiotensin-receptor blockers (ARBs)
 benefits outweigh the risks in COVID-19 hypertensive patients</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ateya,&nbsp; AM,&nbsp; Sabri, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Med Virol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1002/jmv.26668" target="_parent">COVID-19 and Arboviral Diseases: Another Challenge for Pakistan's Delipidated Healthcare
 System</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Awan,&nbsp; UA,&nbsp; Zahoor, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Med Virol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.aprim.2020.04.012" target="_parent">Is Spain prepared to provide psychological support during the COVID-19 crisis?</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Barbosa-Torres,&nbsp; C</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Atencion Primaria</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1210/endocr/bqaa131" target="_parent">Metabolic Syndrome and COVID-19: Endocrine-Immune Vascular Interactions Shape the Clinical
 Course</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Barthel,&nbsp; A,&nbsp; Mohanraj, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Endocrinology</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/S1473-3099(20)30870-7" target="_parent">Expecting the unexpected with COVID-19 vaccines</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Bar-Zeev,&nbsp; Naor,&nbsp; Kochhar, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">The Lancet Infectious Diseases</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1017/s0007087420000473" target="_parent">Two BSHS online alternatives to conventional conferences</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Boon,&nbsp; T,&nbsp; Sleigh, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Br J Hist Sci</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/abbs/gmaa140" target="_parent">The role of D-dimer in relation to the clinical course of patients with COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Bosevski,&nbsp; M,&nbsp; Krstevski, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Acta Biochim Biophys Sin (Shanghai)</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1051/medsci/2020245" target="_parent">[The pandemic caused by SARS-CoV-2: more than a serious health crisis, a change of
 time and lessons to be learned urgently]</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Bréchot,&nbsp; C</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Med Sci (Paris)</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1177/2165079920967966" target="_parent">COVID-19: Understanding Testing</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Cadet,&nbsp; MJ</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Workplace Health Saf</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.23736/s0026-4970.20.04436-2" target="_parent">Reduce the spread of COVID-19 within the dental practice: the era of single
 use</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Ceraulo,&nbsp; S,&nbsp; Lauritano, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Minerva Stomatol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/jmedgenet-2020-107394" target="_parent">Canadian College of Medical Geneticists (CCMG) points to consider: resuming
 genetic services in a pandemic-a summary</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Chad,&nbsp; L,&nbsp; Dawson, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Med Genet</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/biolre/ioaa211" target="_parent">The SARS-CoV-2 receptor, Angiotensin converting enzyme 2 (ACE2) is required for human
 endometrial stromal cell decidualization</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Chadchan,&nbsp; SB,&nbsp; Popli, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Biol Reprod</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1038/s41598-020-76763-2" target="_parent">Risk attitudes and human mobility during the COVID-19 pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Chan,&nbsp; HF,&nbsp; Skali, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Sci Rep</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://arxiv.org/abs/2011.08409" target="_parent">Conspiracy and debunking narratives about COVID-19 origination on Chinese social media: How
 it started and who is to blame</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Chen,&nbsp; Kaiping,&nbsp; Chen, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">arXiv</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.sleep.2020.11.001" target="_parent">Corrigendum to 'The many faces and fangs of COVID-19: an editorial by Sudhansu
 Chokroverty' [Sleep Med 72 (2020) 164-166]</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Chokroverty,&nbsp; S</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Sleep Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-110013/v1" target="_parent">The effects of the first and second wave of COVID-19 pandemic on public
 health</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Coccia,&nbsp; Mario</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1057/s11369-020-00190-4" target="_parent">PMC7661802; Measuring employment during COVID-19: challenges and opportunities</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Cohen,&nbsp; GD</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Bus Econ</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1038/s41575-020-00389-y" target="_parent">COVID-19 and acute pancreatitis: examining the causality</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">de-Madaria,&nbsp; E,&nbsp; Capurso, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Nat Rev Gastroenterol Hepatol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/S2213-2600(20)30407-0" target="_parent">Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Dhawan,&nbsp; RanjuT,&nbsp; Gopalan, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">The Lancet Respiratory Medicine</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1186/s12936-020-03488-y" target="_parent">Addressing budget reduction and reallocation on health-related resources during
 COVID-19 pandemic in malaria-endemic countries</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Diptyanusa,&nbsp; A,&nbsp; Zablon, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Malar J</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1503/cmaj.76844" target="_parent">A team-based approach in primary care can alleviate the burden created by the COVID-19
 surgical backlog for people with hip and knee osteoarthritis</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ezzat,&nbsp; AM,&nbsp; McCracken, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">CMAJ</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/jclinpath-2020-207114" target="_parent">Choosing wisely during the COVID-19 pandemic: optimising outpatient cancer care
 while conserving resources with a new algorithm to report automated ANC results</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Fenelus,&nbsp; M,&nbsp; Graham, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Clin Pathol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.cmaj.ca/content/192/46/E1495"><span lang="FR-CA">Principes de soins cliniques aux patients atteints de la COVID-19 dans les unités
 médicales</span></a></span></u><span lang="FR-CA" style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Frost,&nbsp; DW,&nbsp; Shah, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">CMAJ</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/bmj.m4436" target="_parent">Mass testing for covid-19 in the UK</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Gill,&nbsp; M,&nbsp; Gray, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMJ</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/00325481.2020.1852784" target="_parent">Cutaneous manifestations of COVID-19 in skin of color: a firsthand perspective
 of three cases in a tertiary care center in India</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Goyal,&nbsp; S,&nbsp; Prabhu, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Postgrad Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1057/s11369-020-00193-1" target="_parent">PMC7661819; COVID-19's impact on the U.S. labor market as of September 2020</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Groshen,&nbsp; EL</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Bus Econ</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3238/arztebl.2020.0602" target="_parent">COVID-19 Rash</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Hartmann,&nbsp; M,&nbsp; Salbach, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Deutsches Arzteblatt international</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1002/ptr.6956" target="_parent">An approach of fatty acids and resveratrol in the prevention of COVID-19 severity</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Hoang,&nbsp; T</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Phytother Res</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/bmj.m4390" target="_parent">Covid-19 communication-a matter of life and death?</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Hodes,&nbsp; S</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMJ</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1038/s41392-020-00391-5" target="_parent">GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome
 in-vitro</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Hong,&nbsp; KS,&nbsp; Ahn, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Signal Transduct Target Ther</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/cid/ciaa1738" target="_parent">The impact of tocilizumab on the mortality of patients with COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Huang,&nbsp; YT,&nbsp; Chao, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Clin Infect Dis</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1089/pop.2020.0279" target="_parent">Collaboration Between Public Health and Marketing Experts as a Response to COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Hughes,&nbsp; MC,&nbsp; Tang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Popul Health Manag</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/ijerph17228449" target="_parent">Protocol for a Mixed-Method Investigation of the Impact of the COVID-19 Pandemic and
 Gambling Practices, Experiences and Marketing in the UK: The &quot;Betting and Gaming COVID-19 Impact Study&quot;</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Hunt,&nbsp; K,&nbsp; Critchlow, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Int J Environ Res Public Health</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/14787210.2021.1851197" target="_parent">COVID-19 and inhibitors of the renin-angiotensin-aldosterone system</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Hussain,&nbsp; M,&nbsp; Jabeen, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Expert Rev Anti Infect Ther</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.vaccine.2020.11.011" target="_parent">The role of manufacturers in the implementation of global traceability standards
 in the supply chain to combat vaccine counterfeiting and enhance safety monitoring</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Jarrett,&nbsp; S,&nbsp; Wilmansyah, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Vaccine</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3346/jkms.2020.35.e389" target="_parent">Manual Fever Check Is More Sensitive than Infrared Thermoscanning Camera for Fever
 Screening in a Hospital Setting during the COVID-19 Pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Jung,&nbsp; J,&nbsp; Kim, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Korean Med Sci</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.2174/1871526520666201116100310" target="_parent">Pharmacological inhibition of MMP3 as a potential therapeutic option for
 COVID-19 associated acute respiratory distress syndrome</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Kadry,&nbsp; R,&nbsp; Newsome, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Infect Disord Drug Targets</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/geriatrics5040092" target="_parent">Frailty Assessment in Clinical Practice: Opportunity in the Midst of a Pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Keevil,&nbsp; VL,&nbsp; Osuafor, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Geriatrics (Basel)</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/occmed/kqaa193" target="_parent">Presenteeism during the COVID-19 pandemic: risks and solutions</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kinman,&nbsp; G,&nbsp; Grant, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Occup Med (Lond)</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1097/npt.0000000000000338" target="_parent">Navigating Through a COVID-19 World: Avoiding Obstacles</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Klatt,&nbsp; BN,&nbsp; Anson, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Neurol Phys Ther</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s00592-020-01629-y" target="_parent">Use of DPP-4 inhibitors in patients with COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kow,&nbsp; CS,&nbsp; Hasan, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Acta Diabetol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1186/s10194-020-01199-y" target="_parent">Correction to: Hospital-based headache care during the Covid-19 pandemic in Denmark
 and Norway</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kristoffersen,&nbsp; ES,&nbsp; Faiz, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Headache Pain</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.metop.2020.100066" target="_parent">PMC7661945; The combination of bromelain and curcumin as an immune-boosting nutraceutical
 in the prevention of severe COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Kritis,&nbsp; P,&nbsp; Karampela, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Metabol Open</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1001/jama.2020.22082" target="_parent">Partnership to Make 120 Million COVID-19 Rapid Tests Available</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Kuehn,&nbsp; BM</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">JAMA</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/0167482x.2020.1839170" target="_parent">Identifying pregnant women at risk of developing COVID-19 related mental health
 problems - a call for enhanced psychoeducation and social support</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Lambregtse-van den Berg,&nbsp; M,&nbsp; Quinlivan, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Psychosom Obstet Gynaecol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1021/acs.jmedchem.0c01348" target="_parent">Triterpenoid-Mediated Inhibition of Virus-Host Interaction: Is Now the Time for
 Discovering Viral Entry/Release Inhibitors from Nature?</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Li,&nbsp; H,&nbsp; Sun, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Med Chem</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.jcot.2020.11.008" target="_parent">PMC7661944; Response to &quot;Letter to the Editor: Coronavirus disease 2019 (COVID-19)
 markedly increased mortality in patients with hip fracture: A systematic review and meta-analysis&quot;</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Lim,&nbsp; M</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Clin Orthop Trauma</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/10410236.2020.1848066" target="_parent">The Effects of Agency Assignment and Reference Point on Responses to COVID-19
 Messages</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Ma,&nbsp; H,&nbsp; Miller, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Health Commun</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3399/bjgp20X713573" target="_parent">Falling through the cracks: the impact of COVID-19 on postnatal care in primary care</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">MacGregor,&nbsp; R,&nbsp; Hillman, et al</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Br J Gen Pract</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1111/liv.14732" target="_parent">Genetic insight into COVID-19 related liver injury: a note on MBOAT7</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Machill,&nbsp; A,&nbsp; Bals, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Liver Int</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1213/ane.0000000000005333" target="_parent">Educating Anesthesiologists During the COVID-19 Pandemic and Beyond</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Martinelli,&nbsp; SM,&nbsp; Chen, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Anesth Analg</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/emermed-2020-210319" target="_parent">Ambulance documentation of stroke symptoms during the UK COVID-19 'Stay at Home'
 message</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">McClelland,&nbsp; G,&nbsp; Wilson, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Emerg Med J</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.mayocpiqo.2020.08.002" target="_parent">PMC7661943; Fibromyalgia and Chronic Fatigue Syndrome in the Age of COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Mohabbat,&nbsp; AB,&nbsp; Mohabbat, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Mayo Clin Proc Innov Qual Outcomes</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1057/s11369-020-00189-x" target="_parent">PMC7661827; Central bank responses to COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Mosser,&nbsp; PC</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Bus Econ</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/10410236.2020.1840754" target="_parent">Introduction to the Special Forum on &quot;Public Health Communication in an Age
 of COVID-19&quot;</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Nan,&nbsp; X,&nbsp; Thompson, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Health Commun</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://arxiv.org/abs/2011.08682" target="_parent">SeekNet: Improved Human Instance Segmentation via Reinforcement Learning Based Optimized
 Robot Relocation</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Narayanan,&nbsp; Venkatraman,&nbsp; Manoghar, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">arXiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/annrheumdis-2020-219448" target="_parent">COVID-19 cytokine storm: what is in a name?</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Nigrovic,&nbsp; PA</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ann Rheum Dis</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.4414/smw.2020.20402" target="_parent">Crisis of emerging antibiotic resistances mirroring that of the COVID-19 in the age
 of globalisation</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Nordmann,&nbsp; P,&nbsp; Poirel, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Swiss Med Wkly</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/10410236.2020.1838092" target="_parent">Communicating Uncertainties during the COVID-19 Outbreak</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Paek,&nbsp; HJ,&nbsp; Hove, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Health Commun</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.4155/tde-2020-0092" target="_parent">Therapeutic potential of inhalable medications to combat coronavirus disease-2019</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Parvathaneni,&nbsp; V,&nbsp; Kulkarni, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ther Deliv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.hrtlng.2020.05.013" target="_parent">COVID-19 and Crimean-Congo Hemorrhagic Fever: Similarities and Differences</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Pazarlı,&nbsp; AC,&nbsp; Parlak, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Heart and Lung</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1017/dmp.2020.441" target="_parent">Iran Coping Experiences with COVID-19: Strategies and Recommendations</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Peyravi,&nbsp; M,&nbsp; Soltani, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Disaster Med Public Health Prep</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/ijerph17228398" target="_parent">Focus on the Potential Role of Lung Ultrasound in COVID-19 Pandemic: What More to Do?</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Ragnoli,&nbsp; B,&nbsp; Malerba, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Int J Environ Res Public Health</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.pw.nl/achtergrond/2020/inzet-lmwh-in-eerste-lijn-plausibel-bij-covid-19" target="_parent">Use of low molecular weight heparin (LMWH)
 in primary care is plausible in patients with COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Reinders,&nbsp; C</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Pharmaceutisch weekblad</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1111/ijcp.13839" target="_parent">Social disparity in magnifying glass: the inequality among the vulnerable people during
 COVID-19 pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ribeiro Ribeiro,&nbsp; AL,&nbsp; Alves Sousa, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Int J Clin Pract</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/ajh/hpaa188" target="_parent">Response to: How important is the assessment of soluble ACE-2 in COVID-19?</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Rieder,&nbsp; M,&nbsp; Bode, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Am J Hypertens</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.7326/l20-1194" target="_parent">The Role of Medical Students During the COVID-19 Pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Riva,&nbsp; MA,&nbsp; Paladino, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Ann Intern Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1017/s0007087420000497" target="_parent">Innovation in a crisis: rethinking conferences and scholarship in a pandemic and
 climate emergency</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Robinson,&nbsp; S,&nbsp; Baumhammer, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Br J Hist Sci</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1017/S0714980820000343" target="_parent"><span lang="FR-CA">La COVID-19 et les priorités de la recherche sur le vieillissement</span></a></span></u><span lang="FR-CA" style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Rylett,&nbsp; RJ,&nbsp; Alary, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Canadian Journal on Aging</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/eurheartj/ehaa872" target="_parent">Implications of renal ACE2 expression in the age of COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Salah,&nbsp; HM,&nbsp; Arthur, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Eur Heart J</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.hlpt.2020.08.011" target="_parent">PMC7450947; Rapid response to crisis: Health system lessons from the active period
 of COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Salvador-Carulla,&nbsp; L,&nbsp; Rosenberg, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Health Policy Technol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1111/dth.14551" target="_parent">Possible association between IgA vasculitis and COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Sandhu,&nbsp; S,&nbsp; Chand, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Dermatol Ther</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3390/v12111308" target="_parent">Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast
 Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Schwartz,&nbsp; DA,&nbsp; Morotti, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Viruses</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s12574-020-00494-6" target="_parent">PMC7528449; Correction to: Review of the efforts of the Japanese Society of Echocardiography
 for coronavirus disease 2019 (COVID-19) during the initial outbreak in Japan</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Seo,&nbsp; Y,&nbsp; Daimon, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Echocardiogr</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1002/jmv.26667" target="_parent">The other side of COVID-19 pandemic: Effects on male fertility</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Seymen,&nbsp; CM</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Med Virol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://arxiv.org/abs/2011.08309" target="_parent">Change point detection for COVID-19 excess deaths in Belgium</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Shang,&nbsp; Han Lin,&nbsp; Xu, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">arXiv</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://ssrn.com/abstract=3727270" target="_parent">Why Is Headache Protective for COVID-19? Migraine as An Evolutionary Adaptation</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Shapiro,&nbsp; RobertE,&nbsp; Pozo-Rosich, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">SSRN- Lancet prepublication</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/bmj.m4455" target="_parent">Covid-19: North Dakota and Belgium have let infected health staff work on wards</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Silberner,&nbsp; J</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMJ</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1111/anae.15296" target="_parent">Should we be re-starting elective surgery?</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Simoes,&nbsp; J,&nbsp; Bhangu, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Anaesthesia</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/tbm/ibaa110" target="_parent">Characteristics associated with changes in food security status among college students
 during the COVID-19 pandemic</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Soldavini,&nbsp; J,&nbsp; Andrew, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Transl Behav Med</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s00592-020-01630-5" target="_parent">Reply to letter to the editor regarding &quot;Use of DPP-4 inhibitors in patients with
 COVID-19&quot;</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Solerte,&nbsp; SB,&nbsp; D'Addio, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Acta Diabetol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1073/pnas.2009875117" target="_parent">Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions,
 opportunities, and challenges</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Sriram,&nbsp; K,&nbsp; Loomba, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Proc Natl Acad Sci U S A</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1177/0025817220965381" target="_parent">Legislative preparedness for the control of pandemics - using Taiwan as an example</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Su,&nbsp; YC</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Med Leg J</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1002/jmv.26673" target="_parent">Newly identified limitations of diagnostic tools for COVID-19 and consequences</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Syal,&nbsp; K</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Med Virol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.purol.2020.07.011" target="_parent"><span lang="FR-CA">Évaluation du risque de contamination par le coronavirus après
 chirurgie robotique durant la pandémie COVID-19</span></a></span></u><span lang="FR-CA" style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Tabourin,&nbsp; T,&nbsp; Sarfati, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3399/bjgp20X713561" target="_parent">Point-of-care testing for respiratory infections during and after COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Thornton,&nbsp; HV,&nbsp; Khalid, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Br J Gen Pract</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.hlpt.2020.08.005" target="_parent">PMC7451008; COVID-19 pandemic in Finland - Preliminary analysis on health system
 response and economic consequences</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Tiirinki,&nbsp; H,&nbsp; Tynkkynen, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Health Policy Technol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1093/cid/ciaa1735" target="_parent">The misleading &quot;pooled effect estimate&quot; of crude data from observational studies at critical
 risk of bias: The case of Tocilizumab in COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Tleyjeh,&nbsp; IM</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Clin Infect Dis</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/bmj.m4451" target="_parent">Covid-19: Third candidate vaccine will be tested in UK</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Torjesen,&nbsp; I</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMJ</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1177/1129729820968415" target="_parent">Choice and management of vascular access in the context of COVID-19 outbreak in Italy:
 Recommendations from clinical practice</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Vailati,&nbsp; D,&nbsp; Montrucchio, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Vasc Access</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s11606-020-06342-8" target="_parent">Mitigating the Impact of COVID-19 on Funded Clinical Research: Crucial Next Steps</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Walker,&nbsp; RJ,&nbsp; Jackson, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">J Gen Intern Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1073/pnas.2009961117" target="_parent">Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious
 adverse reactions?</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Wang,&nbsp; Y,&nbsp; Mao, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Proc Natl Acad Sci U S A</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/bjsports-2020-103288" target="_parent">Youth sports in the wake of COVID-19: a call for change</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Watson,&nbsp; A,&nbsp; Koontz, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Br J Sports Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/bmj.m4389" target="_parent">Covid-19 test and trace: localised approach urgently needed</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Watson,&nbsp; MC,&nbsp; Coufopoulos, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">BMJ</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.xkme.2020.11.002" target="_parent">PMC7661925; COVID-19 and Elder Health Inequity in Dialysis</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Wong,&nbsp; LP</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Kidney Med</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1182/blood.2020008903" target="_parent">How should we use convalescent plasma therapies for COVID-19?</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Wood,&nbsp; EM,&nbsp; Estcourt, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Blood</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1111/cts.12936" target="_parent">Dose Selection in a Pandemic: A Framework Informed by the FDA Animal Rule</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Wu,&nbsp; K,&nbsp; Bergman, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Clin Transl Sci</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1057/s41287-020-00336-2" target="_parent">Correction to: A New Normal or Business-as-Usual? Lessons for COVID-19 from Financial
 Crises in East and Southeast Asia (The European Journal of Development Research, (2020), 10.1057/s41287-020-00327-3)</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Yap,&nbsp; OF</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">European Journal of Development Research</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.nmni.2020.100815" target="_parent">PMC7661909; Natural history of COVID-19: Back to the Basics</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zayet,&nbsp; S,&nbsp; Gendrin, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">New Microbes New Infect</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://europepmc.org/article/med/33164035" target="_parent">Adapting to the &quot;New Normal&quot; in Orthopaedic Trauma During COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zhang,&nbsp; J,&nbsp; Yam, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Annals of the Academy of Medicine, Singapore</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/S1473-3099(20)30843-4" target="_parent">Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine
 in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zhang,&nbsp; Yanjun,&nbsp; Zeng, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">The Lancet Infectious Diseases</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1016/j.ejrad.2020.109401" target="_parent">Corrigendum to &quot;COV is a readily available quantitative indicator of metabolic
 heterogeneity for predicting survival of patients with early and locally advanced NSCLC manifesting as central lung cancer&quot; [Eur. J. Radiol. 132 (2020) 109338]</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zhao,&nbsp; P,&nbsp; Pan, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Eur J Radiol</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1038/s41586-020-2951-z" target="_parent">Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat
 origin</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zhou,&nbsp; P,&nbsp; Yang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Nature</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.3389/fimmu.2020.615275" target="_parent">Corrigendum: Interferon-α2b Treatment for COVID-19 (Frontiers in Immunology, (2020),
 11, (1061), 10.3389/fimmu.2020.01061)</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zhou,&nbsp; Q,&nbsp; Chen, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Frontiers in Immunology</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://www.researchsquare.com/article/rs-108442/v1" target="_parent">The Effect of Different Ventilation Modes on the Outcomes of Patients
 Infected with Coronavirus Disease 2019 (COVID-19): a Protocol of Systematic Review and Network Meta-Analysis</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zhu,&nbsp; Yihao,&nbsp; Wang, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Research Square prepub</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1007/s13760-020-01543-8" target="_parent">Be aware: COVID-19 the new stroke mimicker</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:black">Zuurbier,&nbsp; SM,&nbsp; Verschelde, et al</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Acta Neurol Belg</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.15585/mmwr.mm6945a8" target="_parent">Erratum: Vol. 69, No. 43: COVID-19-Associated Hospitalizations Among Health Care Personnel
 - COVID-NET, 13 States, March 1-May 31, 2020</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">MMWR Morb Mortal Wkly Rep</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1177/1526924820963388" target="_parent">Erratum to New York Transplant Teams Versus COVID-19</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Prog Transplant</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1080/00405000.2020.1829868" target="_parent">Correction to: From containment to harm reduction from SARS-CoV-2: a fabric
 mask for enhanced effectiveness, comfort, and compliance(The Journal of the Textile Institute, (2020), 10.1080/00405000.2020.1805971)</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">Journal of the Textile Institute</span><i><span style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
<tr style="height:1.15pt">
<td width="25%" valign="top" style="width:25.14%;border:solid windowtext 1.0pt;border-top:none;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><u><span style="font-size:10.0pt;line-height:115%;color:blue"><a href="https://doi.org/10.1136/bmj.m4232" target="_parent">Erratum: Convalescent plasma in the management of moderate covid-19 in adults in India:
 Open label phase II multicentre randomised controlled trial (PLACID Trial) (The BMJ (2020) 371 (m3939) DOI: 10.1136/bmj.m3939)</a></span></u><span style="font-size:10.0pt;line-height:115%"><o:p></o:p></span></p>
</td>
<td width="17%" valign="top" style="width:17.24%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;color:#C00000"><o:p></o:p></span></p>
</td>
<td width="12%" valign="top" style="width:12.02%;border:none;border-bottom:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 0cm;height:1.15pt">
<p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;color:black">The BMJ</span><i><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;color:#505050"><o:p></o:p></span></i></p>
</td>
<td width="14%" valign="top" style="width:14.14%;border:solid windowtext 1.0pt;border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="margin-left:-.45pt;line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">Commentary/Editorial| Commentaire/Éditorial</span><span lang="FR-CA" style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black"><o:p></o:p></span></p>
</td>
<td width="31%" valign="top" style="width:31.46%;border-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.15pt">
<p class="MsoNoSpacing" style="line-height:115%"><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style="font-size:10.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif"><o:p></o:p></span></p>
</td>
</tr>
</tbody>
</table>
<p class="wordsection1CxSpFirst" align="center" style="margin-bottom:10.0pt;mso-add-space:auto;text-align:center">
<span lang="FR-CA" style="font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p>&nbsp;</o:p></span></p>
<p class="wordsection1" style="margin-bottom:10.0pt;line-height:115%"><b><span lang="FR-CA" style="font-size:11.0pt;line-height:115%;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p>&nbsp;</o:p></span></b></p>
<p class="wordsection1CxSpMiddle" style="margin-bottom:10.0pt;mso-add-space:auto">
<b>Appendix</b>: Process and definitions.&nbsp; <span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US">
<o:p></o:p></span></p>
<p class="wordsection1CxSpMiddle" style="margin-bottom:10.0pt;mso-add-space:auto">
<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p>&nbsp;</o:p></span></p>
<p class="wordsection1CxSpMiddle" style="margin-bottom:10.0pt;mso-add-space:auto">
A daily search for new publications is conducted in PubMed, Scopus, <a href="https://www.biorxiv.org/search">
BioRxiv</a> and MedRxiv, <a href="https://www.ssrn.com/index.cfm/en/">SSRN</a><span class="MsoHyperlink">,
</span><a href="https://www.researchsquare.com/">Research Square</a><span class="MsoHyperlink">,
</span><a href="https://arxiv.org/">arXiv</a><span class="MsoHyperlink"> </span><span class="MsoHyperlink"><span style="color:windowtext">f</span></span>or all publications related to COVID-19 disease or SARS-CoV-2 using the search terms (COVID-19 OR SARS-CoV-2
 OR &quot;novel CoV&quot; OR &quot;novel coronavirus&quot; OR nCoV) adapted to each database.&nbsp; The capture is cross-referenced with publication announcements on the COVID-19 dashboards set up by a number of publishers and google.&nbsp; Publishers include
<a href="https://www.thelancet.com/coronavirus">Lancet</a>, <a href="https://www.elsevier.com/connect/coronavirus-information-center">
Elsevier</a>, <a href="https://www.nejm.org/coronavirus?utm_source=Nature&#43;Briefing&amp;utm_campaign=42f46b0957-briefing-dy-20200131&amp;utm_medium=email&amp;utm_term=0_c9dfd39373-42f46b0957-44724905">
The New England Journal of Medicine</a>, <a href="https://www.bmj.com/coronavirus?utm_source=Nature&#43;Briefing&amp;utm_campaign=42f46b0957-briefing-dy-20200131&amp;utm_medium=email&amp;utm_term=0_c9dfd39373-42f46b0957-44724905">
BMJ</a>, <a href="https://novel-coronavirus.onlinelibrary.wiley.com/">Wiley</a>, <a href="https://www.springernature.com/gp/researchers/campaigns/coronavirus?utm_source=Nature&#43;Briefing&amp;utm_campaign=42f46b0957-briefing-dy-20200131&amp;utm_medium=email&amp;utm_term=0_c9dfd39373-42f46b0957-44724905">
Springer Nature</a><span class="MsoHyperlink">, </span><a href="http://weekly.chinacdc.cn/en/search">ChinaCDCweekly</a><span class="MsoHyperlink">.
</span>Additionally the database is cross-referenced with other literature scans and activities by collaborators.&nbsp; Members of the Emerging Sciences group examine and shorten the abstract or develop 1 -2 point summaries of each publication. Please email Lisa
 Waddell for additional information: <a href="mailto:Lisa.Waddell@canada.ca">Lisa.Waddell@canada.ca</a><span class="MsoHyperlink"><span style="color:windowtext">.
</span></span>&nbsp;References are compiled in a reworks database that has citations since the beginning of the outbreak.&nbsp; All references can be accessed at this<b>
</b><a href="http://www.refworks.com/refshare2?site=031021128139200000/71471580905923745/All_References"><b>link</b></a> and by the categories listed below.&nbsp; The daily scan has also been compiled in an excel sheet and copies can be provided upon request or
 accessed <a href="https://drive.google.com/drive/folders/1dk9gOzOl1UvbwAwK7vANk6XiOF8CrD2M?usp=sharing">
here</a>.<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1CxSpMiddle" style="margin-bottom:10.0pt;mso-add-space:auto">
<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p>&nbsp;</o:p></span></p>
<p class="wordsection1CxSpMiddle" style="margin-bottom:10.0pt;mso-add-space:auto">
<u>Category Definitions: </u><u><span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></u></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b>Modelling/ prediction:</b> Predictive modeling is a process that uses data mining and probability to forecast outcomes. Each model is made up of a number of predictors, which are variables that are likely
 to influence future results.<b><span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b>Epidemiology: </b><span style="background:white">the branch of medicine which deals with the incidence, distribution, and possible control of diseases and other factors relating to health. Includes Ro,
 attack rates, case number doubling time, case fatality rate, serial interval, clinical attack rate, asymptomatic fraction, proportion of asymptomatic and infective*</span><b><span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b>Transmission: T</b>he passage of a pathogen causing communicable disease from an infected host to an uninfected host via direct or indirect routes.
<b><span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b>Clinical data </b>of cases: Includes clinical parameters such as incubation period, latent period, period of communicability, duration of illness, duration of hospitalization, host risk factors, as well
 as clinical profiles of patients; presenting symptoms, symptoms over course of illness, comorbidities.*&nbsp;
<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US">
<o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b>Long-term Sequelae</b>: Data or Studies that describe the long-term effects of COVID-19 from lingering symptoms to severe conditions that persiste after acute infection has resolved.<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b>Mental Health:</b> All studies on mental health impacts or consequences of the pandemic for both general population and healthcare workers.&nbsp;
<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US">
<o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b>Surveillance</b>: Public health surveillance is the continuous, systematic collection, analysis and interpretation of health-related data.&nbsp; Surveillance data will likely be number of cases suspected/confirmed,
 number of deaths, number recovered. *<span style="font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b>Coronavirology:</b> All research relating to the virus; its characteristics, genetic make-up, phylogenetic analyses
<b>&nbsp;</b><b><span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b>Diagnostics / Pathogen detection:
</b>&nbsp;All studies on identification of the virus; culture, PCR, antibody/antigen tests etc.<b>
</b><b><span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b>Therapeutics: </b>Studies of substances that may be used to treat infected hosts including passive immunization products.<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b>Vaccine Research: </b>&nbsp;Studies of vaccine candidates to prevent infection with 2019-nCoV including clinical trials.<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1"><b>Public Health Priorities: </b>These citations will focus on what the current research priorities are and/or where knowledge gaps exist.<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b>Public Health interventions*:
</b>Any study evaluating how effective a public health intervention is or maybe (in the case of a predictive model).<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b>Public Health response: </b>
Articles in this category include: COVID-19 AND substance abuse, domestic violence, social media analysis, adherence to public health measures and knowledge, attitudes and beliefs studies related to the pandemic.
<b>&nbsp;</b><b><span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b>Infection Prevention and Control/</b>
<b>Prévention et contrôle des infections (IPAC/PCI): </b>Any research on the effectiveness of IPC interventions should also be tagged as IPC<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1"><b>Health care Response: </b>This foci would include a description of activities to deal with 2019-nCoV cases including, but not limited to:&nbsp; set up of a special emergency multi-disciplinary intensive care team; Bed and medical equipment
 preparation/ stock piling supplies; Education and training of staff; Early case recognition and classification of disease severity.
<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US">
<o:p></o:p></span></p>
<p class="wordsection1"><b>Economics</b>: papers discussing/ forecasting the economics of COVID-19 pandemic.<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1"><b>Immunology:</b> the study of the immune system and includes serology studies in conjunction with other foci (e.g. epidemiology or diagnostics)<span class="MsoHyperlink"><span style="color:windowtext"><o:p></o:p></span></span></p>
<p class="wordsection1"><b>Animal Model<span class="MsoHyperlink"><span style="color:windowtext">:
</span></span></b><span class="MsoHyperlink"><span style="color:windowtext">An animal model is a living, non-human, often genetic-engineered animal used during the research and investigation of human disease, for the purpose of better understanding the disease
 process without the added risk of harming an actual human.</span></span><span class="MsoHyperlink"><b><span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;color:windowtext;mso-fareast-language:EN-US"><o:p></o:p></span></b></span></p>
<p class="wordsection1"><b>Zoonotic<span class="MsoHyperlink"><span style="color:windowtext">:
</span></span></b>all literature discussing the transmission to and from or occurrence of naturally acquired SARS-COV-2 infection in animals.<span style="font-size:8.0pt">&nbsp;
</span><o:p></o:p></p>
<p class="wordsection1"><b>Review Literature:&nbsp; </b>All articles that summarize the published literature can be tagged as a review.&nbsp; This includes systematic review, meta-analysis, scoping review, overviews, umbrella reviews*
<b><span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1"><b>Commentary/Editorial: </b>For commentaries, editorials, letters to the editor, other types of opinion pieces where there is no new data collected by the author or analysis conducted by the author, please tag these within the commentary
 category. <span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US">
<o:p></o:p></span></p>
<p class="wordsection1"><b>News</b> articles that have not scientific information.<span style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;background:yellow;mso-highlight:yellow;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><i><span lang="FR-CA">*Lists are not exhaustive</span></i><i><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></i></p>
<p class="wordsection1CxSpMiddle" style="margin-bottom:10.0pt;mso-add-space:auto">
<b><span lang="FR-CA">Annexe</span></b><span lang="FR-CA">: Processus et définitions.&nbsp;
</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1CxSpMiddle" style="margin-bottom:10.0pt;mso-add-space:auto">
<span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p>&nbsp;</o:p></span></p>
<p class="wordsection1CxSpMiddle" style="margin-bottom:10.0pt;mso-add-space:auto">
<span lang="FR-CA">Une recherche quotidienne des nouvelles publications est effectuée dans PubMed, Scopus,
</span><a href="https://www.biorxiv.org/search"><span lang="FR-CA">BioRxiv</span></a><span lang="FR-CA"> and MedRxiv,
</span><a href="https://www.ssrn.com/index.cfm/en/"><span lang="FR-CA">SSRN</span></a><span class="MsoHyperlink"><span lang="FR-CA">,
</span></span><a href="https://www.researchsquare.com/"><span lang="FR-CA">Research Square</span></a><span class="MsoHyperlink"><span lang="FR-CA">,
</span></span><a href="https://arxiv.org/"><span lang="FR-CA">arXiv</span></a><span class="MsoHyperlink">
</span><span lang="FR-CA">pour toutes les publications relatives à la maladie COVID-19 ou au SRAS-CoV-2 en utilisant les termes de recherche (COVID-19 OU SARS-CoV-2 OU «&nbsp;novel CoV&nbsp;» OU «&nbsp;novel coronavirus&nbsp;» OU nCoV).&nbsp; La saisie renvoie à des annonces de publication
 sur les tableaux de bord du nCoV mis en place par un certain nombre d'éditeurs et par Google.&nbsp; Parmi les éditeurs figurent
</span><a href="https://www.thelancet.com/coronavirus"><span lang="FR-CA">Lancet</span></a><span lang="FR-CA">,
</span><a href="https://www.elsevier.com/connect/coronavirus-information-center"><span lang="FR-CA">Elsevier</span></a><span lang="FR-CA">,
</span><a href="https://www.nejm.org/coronavirus?utm_source=Nature&#43;Briefing&amp;utm_campaign=42f46b0957-briefing-dy-20200131&amp;utm_medium=email&amp;utm_term=0_c9dfd39373-42f46b0957-44724905"><span lang="FR-CA">The New England Journal of Medicine</span></a><span lang="FR-CA">,
</span><a href="https://www.bmj.com/coronavirus?utm_source=Nature&#43;Briefing&amp;utm_campaign=42f46b0957-briefing-dy-20200131&amp;utm_medium=email&amp;utm_term=0_c9dfd39373-42f46b0957-44724905"><span lang="FR-CA">BMJ</span></a><span lang="FR-CA">,
</span><a href="https://novel-coronavirus.onlinelibrary.wiley.com/"><span lang="FR-CA">Wiley</span></a><span lang="FR-CA">,
</span><a href="https://www.springernature.com/gp/researchers/campaigns/coronavirus?utm_source=Nature&#43;Briefing&amp;utm_campaign=42f46b0957-briefing-dy-20200131&amp;utm_medium=email&amp;utm_term=0_c9dfd39373-42f46b0957-44724905"><span lang="FR-CA">Springer Nature</span></a><span class="MsoHyperlink"><span lang="FR-CA">,
</span></span><a href="http://weekly.chinacdc.cn/en/search"><span lang="FR-CA">ChinaCDCweekly</span></a><span lang="FR-CA">.&nbsp; En outre, la base de données renvoie à d'autres survols de publications<span class="MsoHyperlink">,</span> et à des activités des collaborateurs.&nbsp;
 Les membres du groupe scientifique émergent préparent des résumés en 1 ou 2 points de chaque publication. Pour en savoir plus, veuillez envoyer un courriel à Lisa Waddell au&nbsp;:
</span><a href="mailto:Lisa.Waddell@canada.ca"><span lang="FR-CA">Lisa.Waddell@canada.ca</span></a><span class="MsoHyperlink"><span lang="FR-CA">.
</span></span><span lang="FR-CA">&nbsp;Les références sont compilées dans une base de données Refworks qui contient des citations depuis le début de l'épidémie.&nbsp; Toutes les références sont accessibles à partir de ce
</span><a href="http://www.refworks.com/refshare2?site=031021128139200000/71471580905923745/All_References"><b><span lang="FR-CA">lien</span></b></a><span lang="FR-CA"> et par les catégories énumérées ci-dessous. L'analyse quotidienne a également été compilée
 dans une feuille Excel et des copies peuvent être fournies sur demande ou consultées
</span><a href="https://drive.google.com/drive/folders/1dk9gOzOl1UvbwAwK7vANk6XiOF8CrD2M?usp=sharing"><span lang="FR-CA">ici.</span></a><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1CxSpMiddle" style="margin-bottom:10.0pt;mso-add-space:auto">
<span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p>&nbsp;</o:p></span></p>
<p class="wordsection1CxSpMiddle" style="margin-bottom:10.0pt;mso-add-space:auto">
<u><span lang="FR-CA">Définitions des catégories&nbsp;: </span></u><u><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></u></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b><span lang="FR-CA">Modélisation / prédiction&nbsp;:</span></b><span lang="FR-CA"> La modélisation prédictive est un processus qui utilise l'exploration de données et la probabilité pour prévoir les résultats.
 Chaque modèle est composé de plusieurs prédicteurs, qui sont des variables susceptibles d'influencer les résultats futurs.</span><b><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b><span lang="FR-CA">Épidémiologie&nbsp;:
</span></b><span lang="FR-CA" style="background:white">Branche de la médecine qui traite de l'incidence, de la répartition et du contrôle éventuel des maladies et d'autres facteurs liés à la santé. Comprend le taux de reproduction de base (Ro), les taux d'attaque,
 le temps de doublement du nombre de cas, le taux de létalité, l'intervalle sériel, le taux d'attaque clinique, la fraction asymptomatique, la proportion de cas asymptomatiques et infectieux*.</span><b><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b><span lang="FR-CA">Transmission&nbsp;:
</span></b><span lang="FR-CA">Passage d'un agent pathogène causant une maladie transmissible d'un hôte infecté à un hôte non infecté par des voies directes ou indirectes.
</span><b><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b><span lang="FR-CA">Données cliniques
</span></b><span lang="FR-CA">des cas&nbsp;: Comprend les paramètres cliniques tels que la période d'incubation, la période de latence, la période de contagiosité, la durée de la maladie, la durée de l'hospitalisation, les facteurs de risque de l'hôte, ainsi que
 les profils cliniques des patients; les symptômes présentés, les symptômes au cours de la maladie, les séquelles, les comorbidités.*&nbsp;
</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b><span lang="FR-CA">Séquelles à long terme:
</span></b><span lang="FR-CA">Données ou études décrivant les effets à long terme du COVID-19, des symptômes persistants aux affections graves qui persistent après la résolution de l'infection aiguë.</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b><span lang="FR-CA">Santé mentale:
</span></b><span lang="FR-CA">Toutes les études sur les impacts ou les conséquences de la pandémie sur la santé mentale tant pour la population générale que pour les travailleurs de la santé<b>.</b></span><b><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b><span lang="FR-CA">Surveillance&nbsp;</span></b><span lang="FR-CA">: La surveillance de la santé publique est la collecte, l'analyse et l'interprétation continues et systématiques de données relatives à la santé.&nbsp;
 Les données de surveillance concerneront probablement le nombre de cas suspects / confirmés, le nombre de décès, le nombre de personnes guéries. *</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b><span lang="FR-CA">Coronavirologie&nbsp;:</span></b><span lang="FR-CA"> Toutes les recherches relatives au virus, ses caractéristiques, sa constitution génétique et les analyses phylogénétiques.
<b>&nbsp;</b></span><b><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b><span lang="FR-CA">Diagnostics / Détection d'agents pathogènes&nbsp;:</span></b><span lang="FR-CA"> Toutes les études sur l'identification du virus&nbsp;: culture, PCR, tests de dépistage d'anticorps ou d’antigènes,
 etc.<b> </b></span><b><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b><span lang="FR-CA">Thérapeutique&nbsp;:
</span></b><span lang="FR-CA">Étude des substances pouvant être utilisées pour traiter les hôtes infectés, y compris les produits d'immunisation passive.</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b><span lang="FR-CA">Recherche sur les vaccins&nbsp;:</span></b><span lang="FR-CA"> Études des candidats à la vaccination pour prévenir l'infection par le 2019-nCoV, y compris des essais cliniques.</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1"><b><span lang="FR-CA">Priorités de santé publique&nbsp;: </span>
</b><span lang="FR-CA">Ces citations porteront sur les priorités actuelles de recherche et/ou sur les lacunes dans les connaissances.</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b><span lang="FR-CA">Interventions de santé publique*&nbsp;:
</span></b><span lang="FR-CA">Toute étude évaluant l'efficacité (réelle ou possible) d'une intervention de santé publique (dans le cas d'un modèle prédictif).</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b><span lang="FR-CA">Réponse de la santé publique&nbsp;:
</span></b><span lang="FR-CA">Les articles de cette catégorie comprennent: COVID-19 ET toxicomanie, violence domestique, analyse des médias sociaux, respect des mesures de santé publique et études sur les connaissances, les attitudes et les croyances liées
 à la pandémie.</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><b><span lang="FR-CA">Prévention et contrôle des infections/Infection Prevention and Control (PCI/IPAC)&nbsp;:
</span></b><span lang="FR-CA">Les recherches sur l'efficacité des interventions en PCI doivent également être marquées comme PCI.</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1"><b><span lang="FR-CA">Réponse des soins de santé&nbsp;: </span>
</b><span lang="FR-CA">Ce point comprendrait une description des activités pour traiter les cas de 2019-nCoV, notamment&nbsp;:&nbsp; mise en place d'une équipe multidisciplinaire spéciale de soins intensifs d'urgence; préparation des lits et des équipements médicaux
 / stockage des fournitures; sensibilisation et formation du personnel; reconnaissance précoce des cas et classification de la gravité de la maladie.
</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1"><b><span lang="FR-CA">Immunologie</span></b><span lang="FR-CA">&nbsp;: l'étude du système immunitaire et comprend des études sérologiques en conjonction avec d'autres foyers (p. ex. épidémiologie ou diagnostic)</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1"><span class="MsoHyperlink"><b><span lang="FR-CA" style="color:windowtext">Modèle
</span></b></span><b><span lang="FR-CA">animal<span class="MsoHyperlink"><span style="color:windowtext">:
</span></span></span></b><span class="MsoHyperlink"><span lang="FR-CA" style="color:windowtext">Un modèle animal est un animal vivant, non humain, souvent génétiquement modifié, utilisé lors de la recherche et de l'investigation des maladies humaines, dans
 le but de mieux comprendre le processus de la maladie sans risque supplémentaire de nuire à un humain réel.</span></span><span class="MsoHyperlink"><b><span style="color:windowtext"><o:p></o:p></span></b></span></p>
<p class="wordsection1"><b>Zoonotic<span class="MsoHyperlink"><span style="color:windowtext">:
</span></span></b>all literature discussing the transmission to and from or occurrence of naturally acquired SARS-COV-2 infection in animals.<span style="font-size:8.0pt">&nbsp;
</span><o:p></o:p></p>
<p class="wordsection1"><b><span lang="FR-CA">Économie:</span></b><span lang="FR-CA"> documents discutant / prévoyant l'économie de la pandémie de COVID-19</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1"><b><span lang="FR-CA">Revue de la documentation&nbsp;:&nbsp; </span>
</b><span lang="FR-CA">Tous les articles qui résument les documents publiés peuvent être marqués comme une revue.&nbsp; Cela comprend les revues systématiques, les méta-analyses, les études de la portée, les aperçus, les examens généraux*.
</span><b><span lang="FR-CA" style="font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></b></p>
<p class="wordsection1"><b><span lang="FR-CA">Commentaires/Éditorial&nbsp;: </span></b><span lang="FR-CA">Pour les commentaires, éditoriaux, lettres à la rédaction, autres types d'articles d'opinion pour lesquels aucune nouvelle donnée n'est collectée ou aucune
 analyse n'est effectuée par l'auteur, veuillez les marquer dans la catégorie des commentaires.
</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1"><b><span lang="FR-CA">journaux </span></b><span lang="FR-CA">Articles de presse qui n'ont pas d'informations scientifiques.</span><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;background:yellow;mso-highlight:yellow;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1" style="margin-bottom:4.0pt"><i><span lang="FR-CA">* Les listes ne sont pas exhaustives</span></i><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:EN-US"><o:p></o:p></span></p>
<p class="wordsection1"><span lang="FR-CA" style="font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;color:#1F497D;mso-fareast-language:EN-US"><o:p>&nbsp;</o:p></span></p>
</div>
</body>
</html>
